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This thesis, which is divided into two parts, describes the use of non-ambient 
crystallisation techniques, in particular high-pressure, to explore on one hand inclusion complex 
formation of cyclodextrins with drug molecules (part 1), and on the other hand the solid-state 
behaviour of imidazolium-based ionic liquids (part 2). Much of this thesis is devoted to 
establishing detailed crystallisation protocols for the compounds studied and to reporting full 
structural analysis of the resulting crystals, which have been investigated by single-crystal X-ray 
diffraction using both laboratory and synchrotron sources. 
This work shows that the application of pressure has different effects on cyclodextrin-
based inclusion complexes. When water is used as pressure transmitting medium, cyclodextrins 
undergo dissolution as function of increasing pressure, regardless of the inclusion state. Upon 
further pressurisation three events have been observed to take place: no crystallisation, 
crystallisation of host and guest molecules as separate entities or crystallisation of inclusion 
complexes. It has not been possible to rationalise the observed behaviour or predict which of the 
three events is most likely to occur for a given system. During the course of this work, novel 
inclusion complexes for α- and β- cyclodextrin have been obtained at both ambient- and high-
pressure conditions; full structural characterisation has enabled to identify two novel packing 
motifs.  
As demonstrated for imidazolium-based ionic liquids, high-pressure is a powerful external 
factor for triggering crystal formation and phase transitions in this class of compounds. The solid-
state behaviour of ionic liquids at high pressure has been correlated with the one at low 
temperature, proving that a thorough understanding and exploration of the crystallisation 
diagrams necessitates the use of both non-ambient techniques. The studies performed in this thesis 
demonstrate the importance of characterising crystalline phases by single-crystal X-ray diffraction 
methods. Thanks to the availability of accurate structural data it has been possible to unravel the 
elusive polymorphism of the most widely studied imidazolium-based ionic liquid, 1-butyl-3-
methylimidazolium hexafluorophosphate, which had been the subject of much debate and 
speculation in the literature. For 1-decyl-3-methylimidazolium chloride, structural data have 
enabled to distinguish between three distinct packing types of this ionic liquid in its hydrated 
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Chapter 1. Introduction  
 General introduction 1.1.
In this thesis, the term “physical form” defines any form in which an organic molecule can 
exist in the solid state. This definition encompasses crystalline as well as amorphous materials, 
although only crystalline materials are the subject focus of this thesis. If upon crystallisation the 
resulting crystal structure contains only the compound of interest, i.e. a single component crystal is 
formed, the physical form is commonly termed a crystalline polymorph of that particular 
compound. If the solid form is composed of distinct chemical species, the solid phase is referred to 
as a multicomponent crystal.  Hydrates, solvates, salts, co-crystals and inclusion complexes are all 
examples of multicomponent crystals.  
In text books, polymorphism is often described through the allotropy of carbon; the term 
allotropy is more pertinent here since carbon is an element. Carbon exists in several different 
natural and synthetic solid forms, namely diamond, lonsdaleite, graphite, graphene, carbynes, 
fullerenes and nanotubes (Figure 1.1).1  
 
 
Figure 1.1. Examples of allotropes of carbon. a) diamond (cubic); b) lonsdaleite (hexagonal); c) graphite;  
d) C60 fullerene; e) single walled carbon nanotube.2 
 
One of the earliest und undisputed definitions of polymorphism introduced by Haleblian 
and McCrone in a seminal paper about the subject was: “a polymorph is a solid crystalline phase of a 
given compound resulting from the possibility of at least two different arrangements of the molecules of that 
compound in the solid state”.3 In simpler words: “Polymorphism is the phenomenon in which the same 
chemical compound exhibits different crystal structures”.4 According to an extension of these 
definitions, in principle multicomponent crystals can also exist in different polymorphic forms. 
Because in theory any compound can show polymorphism and different polymorphs have 
different physical and chemical properties, polymorphism is an area of intense research not only at 
the academic level but also within an industrial context. In industry, it plays a particularly 
prominent role in materials science (e.g. for dyes, agrochemicals, pigments, energetic materials, 
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ceramic and metal engineering), food science (e.g. for chocolate or margarine) and pharmaceutical 
sciences.5  
 Polymorphism in the pharmaceutical industry 1.1.1.
The considerable attention and importance of drug polymorphism in the pharmaceutical 
industry was triggered in the 1990s by the accounts of Abbot Laboratories in the now well-known 
“Ritonavir story”.6–8 Abbots Laboratories had reported and patented only one crystal form of 
Ritonavir by the end of 1993. In mid-1998 and after only 18 months of marketing, several batches of 
Ritonavir (Figure 1.2), a protease inhibitor used to treat human immunodeficiency virus (HIV) 
infection and commercialised by the same company under the trade name Norvir®,6 failed the 
dissolution testing. After investigating the dissolution failure, the pharmaceutical company 
discovered that the active ingredient underwent a phase transition within the gel capsule to a 
thermodynamically more stable form, termed form II. The poor solubility of this form II (less than 
50% than form I) caused a low bioavailability of Ritonavir. The pharmaceutical company was 
imposed to temporarily withdraw the drug from the market to investigate a reformulation 
procedure. Eventually, a new formulation was developed, approved and marketed in 1999, though 
this process proved very costly (ca. 250 million USD).8  
 
Figure 1.2. Chemical diagram of Ritonavir. 
 
By the end of the 1990s, the Ritonavir story generated an extremely heated discussion and 
was the trigger of significant reconsiderations by pharmaceutical industries concerning the 
polymorphic behaviour of active pharmaceutical ingredients in and even before all development 
stages. This example had repercussions on the perception of polymorphism among pharmaceutical 
companies and led to the implementation of stricter industrial polices for its detection and control, 
which are also enforced by health agencies, such as the Food and Drug Administration (FDA) in 
the United States of America, the European Medicines Agency within the European Union (EMA), 
and at the international level by the International Conference on Harmonisation (ICH).  
Conversely, beneficial opportunities for both the company and the patient can be created 
by a thorough understanding of solid-state properties of drug. The differences in the properties 
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between two polymorphs are due to structural differences, which are governed by intermolecular 
interactions and possibly by different molecular conformations. The properties affected by drug 
polymorphism are numerous; they include lattice energies, density, melting points, solubility, 
dissolution rate, bioavailability, stability and processability. Hence, understanding the solid-state 
behaviour of drugs is of great interest to pharmaceutical companies in order to achieve the best 
efficiency in drug manufacturing. In addition, polymorphism of drugs enables great and lucrative 
opportunities for securing and controlling intellectual property.5,9  
 Exploring drug polymorphism in pharmaceutical industry vs. academic research   1.1.2.
The prevalence of drug polymorphism has been estimated from 32 to 51% within the 
family of small drug molecules,10 and to 85% if solvates and hydrates are included.11  Nowadays, 
thorough exploration of the polymorphic behaviour of drug substances is an indispensable step in 
drug development, as shown schematically in Figure 1.3.  
 
Figure 1.3. The drug development process. Figure modified from page 9 of reference 9.  
 
The conventional methods used by pharmaceutical companies for screening the 
polymorphic behaviour of drug candidates are solvent- and temperature based. In a very recent 
paper, Lee summarised and referenced more than 15 different methods of polymorphic screening,12 
such as: solvent selection (single or binary mixtures), thermal methods, mechanical activation, 
exposure to humidity and organic vapours, and other exotic techniques such as laser-induced 
crystallisation and addition of tailor-made additives. Within this article, references are made to 
mechanical activation processes13,14 involving applying mechanical stress in the form of grinding 
and compression,13 or applying pressure and shear forces.14 These processes can induce solid-to-
solid phase transitions. Braga et al.14 further introduced “less conventional techniques” to 
investigate drug polymorphism, among which high-pressure crystallisation is reported.  
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The pressure variable in polymorphism investigations is still rarely used in the 
pharmaceutical industry. High-pressure research on organic molecules is a relatively young 
research field, which has proven to be particularly fruitful with respect to producing new 
polymorphs.15–17 High-pressure research using diamond-anvil cells (DAC) is a well-established 
method in Physics and Geoscience; it has only recently been branched and introduced to organic 
molecules, as described by Boldyreva.18 In the past two decades, the use of high-pressure 
techniques has been enormously simplified both in terms of sample preparation and of data 
collection/processing strategies, thanks to progress in the design of new DACs,19–22 the high 
brilliance of synchrotron light sources, as well as progress in laboratory X-ray sources, detectors 
and easy-to-use software. The wide range of compounds now routinely amenable to such studies is 
exemplified in three recent special issues published in Acta Crystallographica,23 Zeitschrift für 
Kristallographie24 and High-Pressure Research and a dedicated article in IUCrJ.25 These 
technological achievements have extended the range of compounds amenable for high-pressure 
studies. Indeed, X-ray diffraction on a single-crystal in a DAC can now be performed routinely in 
the laboratory.  
 Aim of the PhD project:  1.1.3.
In his book on “Polymorphism in Molecular Crystals”, Bernstein quotes a speech delivered 
by Eugene Sun (Abbott laboratories) during a press conference in 1998 about Norvir®, saying: 
“There are many mysteries of nature that we have not yet solved. Hurricanes, for example continue to occur 
and often cause massive devastation. Meteorologists cannot predict months in advance when and with what 
velocity a hurricane will strike a specific community. Polymorphism is a parallel phenomenon. We know that 
it will probably happen, but not why or when. Unfortunately, there is nothing we can do today to prevent a 
hurricane from striking any community or polymorphism from striking any drug.”5  
While there is some level of truth in this statement, the polymorphic behaviour of a drug 
substance can be handled best if different methods are used to explore its solid-state behaviour.  
This work focuses on the use of non-ambient techniques, especially high pressure, to 
investigate physical forms of drug molecules, cyclodextrins (CDs) and ionic liquids (ILs), 
comparing and contrasting the results with the behaviour observed at ambient conditions. CDs are 
regarded as a new class of pharmaceutical excipients, and have been proven efficient in the 
formulation of inclusion complexes of drug compounds.26 Ionic liquids are typically regarded as 
green solvents, by virtue of their negligible vapour pressure, and are slowly gaining importance in 
the pharmaceutical field as solvents.27,28 This thesis covers the use of non-ambient techniques, 
especially high pressure, to investigate 1) CD inclusion complex formation with drug molecules, 
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and 2) the solid-state behaviour of commonly used ILs using non-ambient crystallisation 
conditions, and subsequently using them as potential crystallisation solvents for drug molecules. 
 
 Materials and Methods 1.2.
 Materials  1.2.1.
Each material used in this work is described in detail in the appropriate section of each 
chapter. 
 Methods 1.2.2.
Different analytical methods are used in pharmaceutical science to explore the 
polymorphic behaviour of drug molecules and the formation of multicomponent crystals.5,10,12,29  
Methods can be broadly classified as follows: a) thermal methods such as thermogravimetry, 
differential scanning calorimetry or differential thermal analysis; b) vibrational spectroscopic 
methods such as Raman, infrared and UV-Vis spectroscopy; c) nuclear magnetic resonance 
spectroscopy in both solution and solid states; d) solubility or dissolution studies; e) microscopy 
methods such as polarised optical microscopy, often coupled with a hot/cooling stage, scanning 
electron microscopy; f) X-ray diffraction methods for the analysis of powder and single-crystal 
samples.  
Single-crystal X-ray diffraction is the method of choice when it comes to unveiling the 
structure at the atomic level of novel physical forms. Accurate and precise knowledge of atomic 
coordinates enables in depth studies of a structure beyond atomic connectivity and the derivation 
of structure-property relationships. For instance, it enables detailed studies of hydrogen-bonding 
patterns and other intermolecular interactions; it enables the calculation of lattice energies and 
intermolecular interaction energies by means of more sophisticated computational studies, e.g. by 
DFT of semi-empirical methods.30–32 
In this work, experimental investigations of novel physical forms of drug molecules has 
been carried out primarily by means of X-ray diffraction on single crystals at high pressure in a 
DAC, or at low temperature at ambient pressure. The studies made extensive use of polarised 
optical microscopy (POM) at variable temperature conditions and in some cases of Raman 
spectroscopy as a fingerprinting technique. Single-crystal X-ray diffraction is a very well-
established technique and numerous books are dedicated to this subject. Each book provides ample 
details of the theory of diffraction as well as principles and practice of data collection data 
reduction, structure solution and structure refinement. References 33–38 provide excellent starting 
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points for further reading. In this thesis, details of data collection strategies, structure solution and 
refinement are given in full details in each relevant chapter. 
1.2.2.1. High-pressure crystallography 
Since the pioneering work of Bridgman,39,40 a series of multiple innovations have had a 
tremendous impact on the scope of high-pressure research and the feasibility and ease of 
performing high-pressure experiments. As described by several authors,41–44 some of the principal 
milestones include a) the design and production of DACs in the 1950s,45,46 which rapidly became an 
easy-to-use multidisciplinary tool for discovering new states of matter; b) the introduction of the 
pressure calibration by the ruby fluorescence method and the advent of Merrill-Bassett DACs in 
the 1970s;47 c) advances in instrumentation (e.g. the Paris-Edinburgh cell for neutron diffraction) 
and data collection strategies at large scale facilities and in the laboratory starting from the 1990s. 
High-pressure crystallography on organic materials became facile and spread rapidly after the 
introduction of area detectors in the late 1990s.48 Applying pressure on organic liquids or materials 
in solutions was quickly revealed to be a very effective approach for studying crystal 
polymorphism in a wide range of molecular compounds, including drugs and biomolecules.15–17  
 
Figure 1.4. A Merrill-Bassett DAC. a) photographic image with colour coded guide pins and Allen screws; b) 
Exploded view of (a) modified from reference 22. 
 
In a typical DAC two diamonds, acting as anvils, press on a metallic gasket; the gasket 
contains a cylindrical hole, which is the sample chamber. The diamonds are supported by two 
metallic plates, called backing seats usually made of steel or tungsten carbide in modern cell 
designs. Each seat is supported by a plate made of steel or another strong alloy. The plates are 
designed so that one can be secured to the other one through the use of screws. Tightening the 
screws has the effect of bringing the two diamonds close together, thereby generating high 
pressure inside the sample chamber. Figure 1.4 represents one of most common DACs, namely a 
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Merrill-Bassett DAC.19,22 For more details about DACs the reader should consult Miletich et al.49 
and Katrusiak16, which offer comprehensive reviews of the different types of DACs available, their 
uses and physics of X-ray diffraction experiments using DACs.49 The different types of DACs that 
have been used throughout this work and the related technical details, as well as those of the X-ray 
diffraction studies, are described as appropriate in each chapter.  
1.2.2.2. Raman spectroscopy  
It is beyond the scope of this introduction to give a detailed account of Raman 
spectroscopy; references 50–52 provide a good starting point for further reading. Raman 
spectroscopy enables a rapid qualitative appreciation of the composition and purity of matter. The 
technique is based on exciting matter with monochromatic radiation, usually a laser in the visible 
region, and collecting the scattered light using a CCD detector. When interacting with the sample, 
most of the light is scattered without modification of the wavelength; this radiation is called 
Rayleigh scattering and is filtered out using a notch filter. A small portion of the light is scattered 
inelastically, giving rise to the Raman effect, and collected on the CCD detector after being split by 
a diffraction grating (Figure 1.5).  
In the Raman effect, molecules respond to the collision with the radiation by vibrating. The 
vibration or stretching is exclusive to the chemical nature of the atoms and bonds within the 
matter.51 Hence, Raman spectroscopy is a very sensitive technique; the complexity of a Raman 
spectrum is proportional to the complexity of the chemical species within the sample. In contrast to 
IR spectroscopy, collection of a Raman spectrum requires no sample preparation; modern Raman 
spectrometers are usually coupled with high-resolution microscopes and can easily accommodate a 
large variety of sample environments, such as DACs and heating/cooling stages.  
In this thesis, Raman spectroscopy has been used as a fingerprinting method in the 
investigation of the polymorphic behaviour of ionic liquids, and contributed to a qualitative 
interpretation of the stoichiometry of inclusion complexes at high pressure. Experimental details 
are described in more details in the relevant chapters (Chapter 4 and Chapter 7).  




Figure 1.5. Cartoon summarising the Raman spectroscopy technique. 
 
1.2.2.3. Heating and cooling stage microscopy  
Heating and cooling stage microscopy is a microanalytical method combining optical 
microscopy with temperature control.53 Hot stage microscopy can be qualitatively compared to a 
micrographic DSC device.54,55 The sample is introduced into the stage and placed on a small 
heating block equipped with a glass window. Because of the electrical resistance of the block, the 
latter can be easily heated by applying electrical current. The temperature of the block is measured 
via a thermocouple. Cooling can be achieved by applying a stream of cold nitrogen going through a 
tubular gallery within the block; an alternative gas port uses the same nitrogen stream to replace 
the atmospheric air within the stage. An automatic and quick alternation between heating and 
cooling enables accurate temperature control.  
The history of heating and cooling stages as well as the advances of the techniques have 
been well documented in the literature.53,54,56 Details on the experimental setup are described in the 
relevant chapters (Chapters 7 and Chapter 8).  
1.2.2.4. Other experimental methods  
Sample handling differs from one compound to another; for each of the compounds 
studied detailed and tailor-made crystallisation protocols have been established. These are 
described in the experimental section of each chapter.  
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Chapter 2. Introduction to Part I  
 Introduction 2.1.
Native cyclodextrins (CDs) are cyclic oligosaccharides composed of six or more units of α–
D-glucopyranose linked by α–(1→4) glycosidic bonds (Figure 2.1). Depending on the number of 
glucopyranose units, native CDs have been classified as α-, β- and γ-CD having 6, 7 and 8 pyranose 
units, respectively. A CD molecule has a hollow truncated cone-like shape where the primary 
hydroxy groups sit on the narrow side of the truncated cone and the secondary ones on the wide 
side (Figure 2.1). The architecture of CDs molecules favours the partition of the structure into an 
outer surface and an inner cavity, which are hydrophilic and hydrophobic in character, 
respectively (Figure 2.2).1 α- and γ-CDs have considerably higher water solubility compared to β-
CD, with values of 145, 232, and 18.5 g/L, respectively.2 The very low water solubility of β-CD has 
been ascribed to the formation of intramolecular hydrogen bonds between glucose molecules in 
solution.3 Chemical modifications, mainly by methylation or hydroxypropylation, have been 
applied on CDs to improve their water solubility creating so-called CDs derivatives. 
 
Figure 2.1. Chemical diagram of α–D-glucopyranose unit (left)  
and the general shape of a CD molecule (right) 
 
CDs were extracted for the first time in 1891 by Villiers while studying the bacterial 
transformation of starch into dextrin by Bacillus amylobacter:4 CDs were thought to be the product 
of the fermentation of starch, and were named “dextrin precipitate” by Villiers. Twelve years later, 
Schardinger, while studying thermophilic bacteria producing the same “cellulosine” as a product 
of degradation of starch, reported that Villiers’ bacterial cultures were not pure, and “cellulosine” 
or “crystalline dextrin” was produced by Bacillus macerans.5 This marked the beginning of a 
pioneering work on “Schardinger sugars” initiated by Schardinger and undertaken later on by 
several research groups. The first report on inclusion complex formation was a suggestion made by 
Cramer in the 1940s, which was equally accepted and disapproved by the chemical community.6 
Cramer followed his idea and proved by experimental means not only that “Schardinger sugars” 
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form inclusion complexes, but also that they are enantiomer selective and have catalytic properties. 
These findings started a worldwide interest in “cyclodextrins” and especially in inclusion complex 
formation. Cramer’s work has been well summarised and referenced by Stoddart in 1989.7  
In 1957, French reported that a Schardinger-sugar-based diet on rats caused their death 
within a week.8 This led to a temporary distrust of the scientific community towards cyclodextrins 
for using them as prominent drug carriers. Fortunately, Anderson et al. counter-published a 
thorough toxicological study on rats, based on a marked 14C-cyclodextrins diet, showing that native 
cyclodextrins are safer than initially thought, and that the initial report about lethality was due to 
insufficient food intake.9 This triggered a particular interest in CD application as drug carrier and 
pioneering work in this area was undertaken by different groups, notably by Saenger’s in 
Germany.10 
 
Figure 2.2. Chemical diagram of α-, β- and γ-CD 
 
The advances in biotechnology and genetic engineering of the 1970s facilitated and boosted 
CD production. Specifically, CD were found to form due to an enzymatic degradation of starch by 
the family of cyclodextrin glycosyltransferase found in several bacterial species.11 The type of CD 
formation can be oriented depending on the origin of the enzyme,11 but more commonly through 
the purification process by either 1) precipitation, 2) chromatography/adsorption techniques, or 3) 
filtration.11 Purification by precipitation is the easiest process and particularly elective for the 
production of β-CD taking advantage of its low solubility in water.2 These advances caused a drop 
in CDs’ prices; as the compounds became more accessible, their properties were explored and 
exploited by an increasing number of research groups. This translated into a tremendous inflation 
in the number of CD-based-literature since the 1980s. For further reading, Szejtli summarised 
nicely the history of cyclodextrins in two of his reviews.3,12 
Nowadays, CDs find a broad application and are mostly attractive thanks to their inclusion 
complex formation property. They are for instance used in a) the pharmaceutical industry to 
enclose drug molecules and indirectly improve their solubility and bioavailability; b) the food 
Chapter 2. Introduction to Part I    17 
 
 
industry as masks of taste and smell, and as flavour protectors; c) the chemical industry as catalysts 
and retention agents in chromatography; d) cosmetics as stabiliser. Martin del Valle reported an 
extensive list of CDs properties and applications.13 
In 1976, α- and β-CD were approved as food additives in Japan and within the same year 
the first CD-based pharmaceutical products, encapsulated prostaglandins14, were commercially 
available.15 Nowadays, CDs are used worldwide and a non-exhaustive list of CD-based products 
can be found in the references by Szejtli16 as well as Loftsson and Duchêne.15 
The literature reveals, to the best of our knowledge, that structural studies of CDs and CD 
inclusion complexes have always been carried out using ambient-pressure techniques. High-
pressure techniques have been shown to be a suitable method for obtaining novel crystal forms of 
pharmaceutical compounds, in particular for exploring the phenomenon of polymorphism and 
solvate formation more thoroughly.17,18 Investigating inclusion complex formation of cyclodextrins 
would be an interesting extension of the technique: can cyclodextrin complex formation be 
achieved at high pressure or would individual crystal components crystallise separately, and if so, 
which ones? In this section, examples of successful in-situ complex formation as well as unexpected 
results are presented for α- and β-cyclodextrin with active pharmaceutical ingredients using water 
as crystallisation medium.  
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Chapter 3. α-Cyclodextrin∙succinic acid inclusion complex: a novel packing type 
of α-cyclodextrin  
 Synopsis  3.1.
This chapter describes a new packing type of α-cyclodextrin inclusion complexes, obtained 
here with succinic acid at low-temperature crystallisation conditions. The new structure is 
characterised by heavy disorder of the guest, the solvent, and part of the host molecules. The 
complex could not be obtained by high-pressure crystallisation, an observation which may be 
closely related to the disordered nature of the structure. 
 Introduction   3.2.
The work presented here is part of an ongoing investigation of cyclodextrin inclusion 
complex and hydrate formation at both ambient- and high-pressure crystallisation conditions 
using water as crystallisation medium.1,2 α-CD, the smallest natural cyclic oligosaccharide with six 
sugar units, was adopted for studying and comparing inclusion complex formation with small 
molecules (molecular weight < 500 Daltons),3,4 regardless of their water solubility, in order to 
explore the effect of pressure on the complexation and decomplexation processes. 
Succinic acid (SA), an aliphatic dicarboxylic acid, is essential in aerobic cellular metabolism 
by intervening in the citric acid cycle, a metabolic pathway for the regeneration of adenosine 
triphosphate (ATP), which is the main energy source of most cellular functions.5 
The structure of a β-CD∙SA inclusion complex (CSD refcode KUJSEC) has been previously 
obtained while investigating the enhancement of succinic anhydride’s reactivity using β-CD as 
molecular cages in aqueous solutions.6 We found that this complex can easily be obtained with SA 
instead of succinic anhydride (See Chapter 5); the large cavity size of β-CD, which is 6.0-6.5 Å in 
diameter,7 can easily accommodate SA and the crystal structure of the complex shows several 
intermolecular interactions between host, guest and solvent molecules.6 We hypothesised that with 
a width [5.265(13) Å, see fig. 1] commensurable with the cavity diameter of α-CD (4.7-5.3 Å),7 SA 
could in principle form a crystalline complex with α-CD. The literature shows that similar linear 
compounds form inclusion complexes with α-CD (see for example CSD refcodes BUPDEV,8 
CDKABA9 and XIGBOE10). Exploration of the SA/α-CD/water system is interesting for 
investigating complex formation at both ambient- and high-pressure conditions and, if successful, 
for comparing the structures of α-CD∙ and β-CD∙SA inclusion complexes. 
Three packing types have been described for both CD hydrates and inclusion complexes: 
two of these belong to the cage type and are known as herringbone- and brick-type cages, and the 




third one is the channel type.11 The packing preference of CD molecules for one of these types is 
closely related to the size and shape of the guest molecule.11 A Cambridge Structural Database12 
(CSD) search (the CSD, V. 5.36 including updates to Nov. 2014 was searched for structures with 3-
D coordinates) shows that α-CD crystallises in the channel packing type in 52 % of the total 96 hits, 
followed by the brick-type in 26 % and the herringbone-type in 22 % of the structures. The channel-
packing type of the structures is favoured by α-CD small and narrow size of the cavity: most guest 
molecules are inserted lengthwise into CDs cavities and form infinite columns.13 
 
Figure 3.1. Diagrams and numbering schemes of: (a) succinic acid: the meanO3-O4 distance was computed 
from 72 structures of SA in the CSD, the width of SA is the [meanO3-O4 + 2 × (rvdW)O]14; (b) α-CD and (c) α-D-
glucopyranose 
 Experimental  3.3.
 Ambient-pressure crystallisation 3.3.1.
Both α-CD and SA were bought from Fluka and SIGMA, respectively, and used without 
further treatment. An undersaturated solution with a 1:1 molar ratio mixture of α-CD (194.57 mg) 
and succinic acid (23.6 mg) was prepared in approximately 2 ml of demineralised water. Fast 
evaporation of the solution yielded a glass at ambient condition. A combination of cold 
temperatures (ca. 277 K) and very slow evaporation over the course of six months led to the 
crystallisation of hexagonal prism-shaped crystals (Figure 3.2.a). When the experiment was 
repeated using a more concentrated solution, crystallisation occurred within a week at the same 
low-temperature conditions. X-ray data were collected on a single crystal specimen at 90 K. 
 Multi-temperature experiment 3.3.2.
A subsequent experiment was performed at low-temperature conditions using the same 
procedure described above on a second single-crystal specimen. Data sets were collected on the 
same single crystal using the same data collection strategy at 100, 120, 150, 180, 210, 240 and 270. 




The purpose of this experiment was to monitor structural changes, i.e. phase transitions, and 
possible crystal decay as function of temperature.  
 High-pressure crystallisation  3.3.3.
The high-pressure experiment was carried out using a Merrill-Bassett diamond anvil cell 
(DAC),15 with a half opening angle of 45°. The DAC was equipped with 800 µm culet diamonds of 
low fluorescence grade and Inconel gaskets with a starting diameter hole of 350 μm. Pressure was 
monitored using the ruby fluorescence method described by Piermarini et al.16 Several experiments 
were performed as detailed below. In all experiments it was observed that the initial crystal 
undergoes dissolution as function of increasing pressure, temperature or both. Hence, all 
experiments aimed at compressing crystals grown at ambient pressure past their dissolution 
pressure in the hope of triggering a crystallisation event. The first experiment consisted of loading 
a crystal of the complex grown at ambient pressure conditions together with its mother liquor into 
the DAC (Figure 3.2.a-c). Subsequent experiments focused on loading crystals of the complex and 
using demineralised water as crystallisation medium (Figure 3.2.d-f).  
The in situ dissolution process is also dependent on crystal size: although temperature was 
cycled using a heatgun up to 373 K, incomplete dissolution was achieved if the DAC contained too 
much crystalline material. Although considerable time was spent in order to vary and optimise the 
crystallisation conditions, cycling the pressure in the range of 0.1 MPa – 0.72 GPa did not initiate 
the recrystallisation process. Reducing the temperature of the DAC to 277 K was also not helpful. 
Overall, high-pressure techniques did not lead to crystallisation of any crystalline form of α-CD or 
SA. 
 
Figure 3.2. High-pressure crystallisation attempts of α-CD∙SA inclusion complex. (a) Single crystal of α-
CD∙SA inclusion complex in its mother liquor; (b) and (c) Mother liquor used as crystallisation medium: (b) 
Incomplete dissolution of the single crystal at 0.17 GPa, (c) Dissolution remains incomplete at 0.49 GPa and 
393 K; (d) Single crystal out of the mother liquor; (e) and (f) Demineralised water used as crystallisation 
medium: (e) Complete dissolution at 0.17 GPa; (f) No crystallisation on compression to 0.72 GPa. 




 Data collection and reduction 3.3.4.
Several crystals were tested on the diffractometer. Although the crystals did not show 
cracks under the microscope when left out of the mother liquor (Figure 3.2.d), they were found to 
be unstable at room-temperature conditions, yielding poor diffraction quality even at low 
temperature. Maintaining low temperature from the moment the crystal was extracted from the 
mother liquor until final mounting on a glass fibre on the goniometer’s head was essential to have 
good diffraction quality: in order to achieve this, a drop containing mother liquor and crystals was 
pipetted onto a microscope slide that had previously been cooled using an ice bath beneath the 
slide. Subsequently, the crystal was moved from the mother liquor to a cold drop of mounting oil 
and then to the goniometer’s head under a cold and dry nitrogen stream.17 
Data collection was undertaken using a Bruker-AXS APEX II diffractometer equipped with 
graphite-monochromatic Mo-Kα and an Oxford Cryosystems low-temperature device. Data 
integration and global-cell refinement were performed with the program SAINT.18 Absorption 
correction was performed with SADABS.19 Structure solution of this medium-sized structure was 
based on Patterson-seeded dual-space recycling in the SHELXD program.20 Structures were refined 
by full-matrix least squares against F2 using SHELXL-2014/721 through the SHELXLE GUI.22 
Stereochemical restraints for the host and guest structures were applied to increase the robustness 
of the refinement: restraints were generated by the GRADE program using the GRADE Web 
server.23 A GRADE dictionary for SHELXL contains target values and standard deviations for 1,2-
distances (DFIX) and 1,3-distances (DANG), as well as restraints for planar groups (FLAT). 
Anisotropic displacement parameters were refined using the new rigid bond restraint (RIGU) 
implemented in the SHELXL2014 program.24 All H-atoms of α-CD and SA were placed 
geometrically and allowed to ride on the parent atoms. H-atoms belonging to ordered water 
molecules were clearly visible in difference Fourier maps and their positions were refined subject 
to distance restraints. Uiso(H) values were assigned in the range 1.2–1.5 times Ueq of the parent 
atom. Details on the treatment of disorder are detailed in the discussion below and crystallographic 
details can be found in Table 3.1. 
 Results & discussion  3.4.
Mixing an equimolar ratio of α-CD with SA in water, and using low temperature 
conditions, led to the crystallisation of hexagonal prism shaped crystals. A first microscopic 
analysis of the crystals through the hexagonal face (Figure 3.2.a Figure 3.2.d) by using polarised 
light showed an absence of light extinction: this is an indication of two crystallographically 
equivalent directions being perpendicular to the polarised light (a=b), a characteristic of uniaxial 




crystals; in this case the ab plane corresponds to the hexagonal face of the crystal. The crystal thus 
belongs to trigonal, tetragonal, or hexagonal crystal system.  
 
Figure 3.3. Crystal packing of α-CD molecules viewed along the b-axis. H atoms, disorder of α-CD C, SA 
and water molecules have been omitted for clarity. Symmetry-equivalent molecules are colour-coded. 
 
This microscopic analysis endorsed the choice of the unit cell from X-ray diffraction, with 
successful indexing of the reflections using a rhombohedral unit cell. The reflections could also be 






The choice of a rhombohedral crystal system dictates that both host and guest molecules sit 
on a 3-fold rotation axis going through α-CD cavities. Heavy disorder of the guest, evident from 
the electron density maps, could be modelled in the higher symmetry space group and this was 
finally chosen for refinement.  
The inclusion complex crystallises in rhombohedral space group R32 with 3 × ⅓ α-CD 
molecules in the asymmetric unit, here named A, B and C (Figure 3.3). Each α-CD encloses one SA 
molecule disordered over six positions, in other words there are two SA molecules, with ⅙ site 
occupancy each, per α-CD cavity disordered over the 3-fold rotation axis, overall giving an α-
CD∙SA 1:1 complex. α-CD C is further disordered over two positions with ⅔ (C) and ⅓ (C’) site 
occupancies. In addition, the unit cell contains ca. 12 water molecules making the complex a pseudo 
dodecahydrate. 





Figure 3.4. Projection of α-CD∙SA structure along the b-axis. H atoms, SA and water molecules have been 
omitted for clarity. The distances refer to gap in Å between the least-square planes formed by all O4 atoms 
involved in the glycosidic bonds. 
α- and β-CD molecules in the solid state have always been known, to the best of our 
knowledge, to pack as distinct entities or dimers.13,25 In this work, a new building block is observed: 
α-CD molecules form trimers packed along the c-axis. Each trimer is made of crystallographically 
independent molecules assembled in a stacked vase-like cluster (Figure 3.3). The stacked trimer is 
not unknown for γ-CD molecules (see for example CSD refcodes FEJFIJ, FEJFOP, NUNRIX, 
SIBJAO, SIBJES);26–28 however the concept of vase-like packing has not been previously reported. It 
has also been reported that β-CD molecules crystallise as trimers (CSD refcodes RIPKIL, OCIGAK)29,30 
or tetramers.31,32 The structure of the title compound appears to be very similar to that of α-CD∙hexa-
ethylene glycol reported by Harada et al. (CSD refcode LOJTUZ, no 3D coordinates deposited in the 
CSD)33; however, this thesis neither describe the distinctive trimer arrangement in detail, nor identifies 
a new packing type. In contrast, in a conference abstract, Caira et al. have recently reported that the 
α-CD-lipoic acid system “crystallizes in the trigonal system, space group R32, with three 
independent CD molecules in the asymmetric unit and is not isostructural with any known CD 
complex”31. These observations make the reported packing type rare but not unknown.  
The vase-like cluster is formed by two sub-dimers: 1) a head-to-head dimer, which is 
stabilised by H-bonds between secondary hydroxy groups of α-CDs A and B, and 2) a tail-to-tail 
dimer between α-CDs A and C interconnected through a cluster of water molecules. Analysis of 
the glycosidic planes of CD molecules shows that the distance between these planes in the head-to-
head dimer is 7.024 Å, compared to a mean distance of 9.05997 Å for the tail-to-tail dimer ( 
Figure 3.4). Successive vase-like clusters, stacked via 2-fold rotation symmetry, are 
separated by a layer of water molecules forming a complex H-bonded network which holds two 
vase-like structures together.  
The three α-CD molecules forming the vase-like cluster are parallel and exhibit an almost 
ideal cylindrical shape. They form infinite linear channels extending along the c-axis of the unit 




cell. These channels are forming a honeycomb packing type where each α-CD molecule is 
surrounded by a hexagonal layer of six neighbouring α-CD molecules (Figure 3.5). A honeycomb 
or quasi-hexagonal pattern is typical for effective close packing,28,34 unlike the square or rectangular 
patterns, and it was reported for the first time by Saenger in 1980, while describing the general 
arrangement of CDs in crystals, as “hexagonal packing of stacks”.35 Although a careful analysis of the 
reported channel type structures of α-CD inclusion complexes, including hydrates, in the CSD 
shows that α-CD molecules exhibit the honeycomb packing type in 2710,36–56 out of 50 structures 
(CSD refcodes of these structures are reported in the Appendix 3.7), the hexagonal packing type 
has been rarely reported.37,40,48 Instead, authors usually report the type of α-CD dimer arrangement, 
whether it is head-to-head or head-to-tail, in channel-type structures.10,36–52 Harada et al. are the 
only authors naming the hexagonal arrangement as honeycomb for α-CD∙hexa-ethylene glycol, a 
highly similar structure to the structure of the title compound (CSD refcode LOJTUZ, no 3D 
coordinates deposited in the CSD).33  
 
Figure 3.5. The honeycomb packing mode of α-CD∙SA structure along the c-axis. H atoms and water 
molecules have been omitted for clarity. 
 
One of the features of CDs is the flexibility of the primary-hydroxy groups. The 
conformation of the hydroxy group is defined by the value of the O(5)–C(5)–C(6)–O(6) torsion 
angle: a preferred (–)-gauche conformation in which the hydroxy group is facing the exterior of the 
cavity, and a less preferred  (+)-gauche conformation where the hydroxy group is facing the inner 
cavity.57 All but one primary hydroxy groups in α-CD C exhibit the (–)-gauche conformation and 
are directed away from the cavity. The rotation of the primary hydroxy group to the less favoured 
(+)-gauche conformation can be explained by the formation of the short H-bonds [2.53(4) and 
2.79(1) Å] with a disordered water molecule. A CSD (V 5.36) search shows that (–)-gauche 
conformers are not unknown for α-CD inclusion complexes and indicate the absence of direct H-




bonds between the guest and the host molecules, which could explain the high degree of rotational 
disorder of the guest observed here. In contrast, in the structure of β-CD∙SA which contains one 
full guest and host molecules in the asymmetric unit, SA is H-bonded to two primary CD hydroxy 
groups, which are facing the inner cavity, through one water molecule each. Interestingly, the SA 
molecule in the β-CD∙SA inclusion complex does not exhibit disorder. 
A search in the CSD (V 5.36) based on the C(1)–C(2)–C(3)–C(4) torsion angle of the guest 
(Figure 3.1.a) shows that SA molecules exhibit two conformations in the solid state, trans and 
gauche, with an incidence of 90 and 10 %, respectively, out of a total of 165 structures. Lisnyak et al. 
reported that the trans conformer is energetically more favourable than the gauche one with an 
energy difference of 31.4 kJ∙mol-1.6  Whilst SA molecules exhibit the gauche conformer inside β-CD 
cavity (CSD refcode: KIJSEC),6 the electron density maps of α-CD∙SA point to the trans 
conformation with SA molecules extended along the c-axis. Thanks to the extended conformation, 
SA and water molecules form infinite H-bonded chains embedded inside the vase-like clusters 
(Figure 3.6). In the B-A head-to-head dimer, both SA molecules are directly H-bonded to each other 
through the carboxylic groups while in the A-C tail-to-tail dimer SA molecules are linked via H-
bonding to water. The planes formed by the glycosidic O-atoms of the ordered CD molecules A 
and B in the head-to-head dimer are almost orthogonal to the planes formed by the SA molecules 
inside the respective cavities [SA planes were calculated using C(1), C(2), C(3), C(4)]. For α-CD C, 
similar calculations show that the same planes are 13 to 18° off from being orthogonal.  
 
Figure 3.6. H-bonded motif formed by SA molecules in the asymmetric unit viewed a) along the a-axis and 
b) along the b-axis. . O∙∙∙O contacts are represented by dashed green lines. H-atoms (in b), α-CD and water 
molecules have been omitted for clarity.  
 




 Modelling of disorder 3.4.1.
The structural refinement of α-CD∙SA was particularly challenging due to the heavy 
disorder of the host, guest and solvent molecules. The disordered α-CD C molecule was modelled 
using a free variable fraction which refines to a final value of 0.673(5) for the major component. The 
effect of disorder is to elongate the vase-like cluster (Figure 3.3). At 90 K, a careful inspection of the 
difference Fourier maps permits the refinement of 33 positions of water molecules which are 
distributed heterogeneously over the asymmetric unit and of which only two are fully occupied. 
For these two water molecules, H-atoms could be located in difference Fourier maps.  
 
Figure 3.7. Fobs-Fcalc maps in green showing the electron density before (a) and after (b) modelling SA 
inside α-CD B molecule. The peaks Q1 and 3×(Q4) are forming a tetrahedron. H-atoms and the rest of the 
structure have been omitted for clarity. Displacement ellipsoids are drawn at the 50 % probability level. 
 
The channel-type structure of α-CD∙SA favours the guest to be in the trans, planar 
conformation. The 3-fold rotation axis, going through the centre of the host, is incompatible with 
the guest molecular symmetry and imposes the presence of disorder, which was modelled as 
exemplified by α-CD molecules B (Figure 3.7) as follows: electron density maps inside the α-CD 
cavity show tetrahedral features, incompatible with a single SA molecule. The difference electron 
density peak Q(1), sitting on the 3-fold rotation axis, was assigned to the carbon atom C(1) of the 
carboxylic group. The coordinates of C(1) were constrained to make model building more 
straightforward. By using stereochemical restrains generated with the GRADE webserver23 all 
other Q peaks were correctly assigned, i.e. Q(4) to O(1) and O(2), Q3 to C(2), Q(2) to C(4)..etc 
(Figure 3.7). Finally, all atomic coordinates were freely refined. Two SA molecules fit inside the 




disordered electron density; the negative PART instruction was used in the program SHELXL to 
exclude the generation of special position constraints and dissociate bonding to symmetry 
generated atoms within the same PART group.  
After several trials, the best refinement strategy consisted of gradually modelling the 
electron density of the host molecules and the reliably localised solvent peaks, followed by the 
guests, and finally the rest of the disordered solvent molecules. In order to avoid over-
parametrisation, site-occupancy factors of the disordered water molecules were fixed to the 
initially refined values. Those of the guest molecules were constrained to ⅙ each. H-atoms 
belonging to disordered water molecules were not placed during refinement but were taken into 
account for the calculation of F000 and derived properties. 
Due to the limited resolution and structural complexity of the model, soft restraints on all 
bond lengths and angles were applied using the GRADE webserver.23 Following a CSD search on 
structures containing SA-SA H-bonded dimer, SA molecules were restrained to be planar.58–62 
Restraints for both SA and α-CD were also applied on the atomic displacement parameters by 
using SIMU, DELU and RIGU SHELXL instructions.24 ISOR restrains were used on a handful of 
atoms to cure ill-defined ADPs.  
 Insights into the disorder: 3.4.2.
In an attempt to gain a better insight into the disorder of α-CD∙SA inclusion complex and 
to investigate whether a temperature-dependent phase transition takes place, we extended our 
initial work to a multi-temperature investigation covering the 100–270 K temperature range, in an 
ascending temperature ramp. 
The crystallographic data of all structures summarised in Table 3.1 show small differences 
in the lattice constants across the temperature range. The lattice parameters were normalised to the 
unit cell values of the 100 K crystal structure and are visually represented in Figure 3.8. They 
describe thermal expansion up to 180 K for both the c- and a-axes. For the unit cell volume, the 
thermal expansion is approximately linear and isotropic up to this temperature. From 180 K to 240 
K, the complex overall expands but the c-axis shows negative thermal expansion. The negative 
thermal expansion for this axis is very marked between 240 and 270 K so that a slight volume 
contraction is concomitantly observed.  
These variations in the unit-cell constants can be related to the following structural 
features: 1) the isotropic and linear expansion of the a-axis (a=b) is associated with the expansion of 
the intermolecular contacts between adjacent α-CD molecules along the same axes; 2) the negative 
thermal expansion along the c-axis is associated with a shortening of the vase-like cluster (Figure 




3.9): the small water layer stabilising the α-CD A-C tail-to-tail dimer (Figure 3.3) compresses as 
function of increasing temperature causing a shortening of the α-CD A-C dimer.  
The small water layer is formed by one disordered water molecule [named O(10)_91 in the 
structure] H-bonded to the (+)-gauche, above mentioned, primary hydroxy group of α-CD C 
molecule. The distance between the O(6)-atom of this hydroxy group and the water molecule 
increases from 2.80(2) to 3.01(5) Å, at 100 and 270 K, respectively. Ordering of α-CD C is observed 
at 270 K although the structure has large temperature factors. This is in fact an indication of 
dynamic disorder where low temperatures freeze the movement of α-CD C into two distinct 
positions, and at higher temperatures α-CD C vibrates along the c-axis fitting only one position in 
the electron density map. Ordering is associated with a rearrangement of hydroxy groups: α-CD C 
has two (+)-gauche primary hydroxy conformers, instead of one observed at low temperature. The 
new (+)-gauche conformer, pointing towards the inner cavity, is H-bonded to the disordered water 
molecule O(10)_91 with a distance of 2.64(9) Å. This indicates that there is interplay between 
movement of α-CD and water molecules towards stabilisation of the structure. These small 
movements generate overall changes in the structure seen along the c-axis (See appendix 3.7, 
Figure 3.27).  
 
Figure 3.8. The evolution of the normalised unit cell parameters as function of temperature.  































Figure 3.9. Evolution of the normalised distances between dimers in α-CD∙SA.  
Distances were calculated based on the O(4) glycosidic planes using MERCURY.63 
 
The 100 K structural model was refined based on the atomic coordinates of the 90 K model, 
and was then used as a starting model for all other temperature points. Modelling of disordered 
water molecules in a highly hydrated structure is subject to user bias. Temperature factors and site 
occupancy parameters are correlated and in the absence of independent information, e.g. on water 
content determined by thermal analysis, the user must make judicious use of refinement tools in 
order to obtain a reasonable model, which does not necessarily lead to the lowest R-factor. 
Comparing Fourier and difference Fourier maps can give an indication of the mean position and 
site occupancy of the atoms provided a consistent data reduction and refinement strategy for all 
data points are applied. To minimise model bias and double check the stability of the model, the 
SHELXL WIGL command was used as a cross-validation method during the refinement.64 Two sets 
of results are reported. In the first set, all water molecules were placed and refined according to the 
difference Fourier electron density maps (results in Table 3.1). In the second set, all water 
molecules were omitted during refinement in order to compare the evolution of the maps as a 
function of increasing temperature. The latter set of structures can be used to emphasise the change 
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Table 3.1: Crystallographic data of the multi-temperature structures of α-CD∙SA inclusion complex 
 Crystal 1 Crystal 2 



















Crystal system Trigonal Trigonal 
Space group R 3 2 :H R 3 2 :H 
a=b/Å 23.6625(6) 23.645(3) 23.6608(7) 23.6781(6) 23.6951(5) 23.7133(6) 23.738(13) 23.757(10) 
c/Å 55.7235(15) 55.706(7) 55.722(2) 55.7898(18) 55.8490(15) 55.8345(17) 55.76(3) 55.62(2) 
α=β /° 90 90 
γ/° 120 120 
V/Å3 27020.3(16) Å3 26973(7) Å3 27015.8(19) Å3 27088.1(16) Å3 27155.8(14) Å3 27190.5(16) Å3 27212(34) Å3 27183(26) Å3 
Z 18 18 
Z’ 1 1 
Dcalc/g cm-3) 1.448 1.451 1.451 1.433 1.416 1.403 1.383 1.357 
Meas. / uniq. / obs. 
Reflectionsb 
118804 / 11028 
/ 9148 
45399 / 6390 / 5109 46751 / 6302 / 4512 47260 / 6315 / 4645 47564 / 6328 / 5099 47801 / 6347 / 5061 21178* / 6034 / 3799 29882* / 6298 / 3592 
dmax/Å 0.83 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Completeness to dmax 0.999 0.991 0.977 0.974 0.974 0.976 0.969 0.974 





6390/4279/1247 6302/4284/1211 6315/4257/1201 6328/4209/1225 6347/3267/1147 6034/3263/1110 6298/2079/903 
R1c 0.0470 0.0487 0.0573 0.0561 0.0691 0.0717 0.0724 0.0826 
wR2d 0.1142 0.1046 0.1180 0.1191 0.1523 0.1649 0.1718 0.2041 
a These values refer to the temperature at which diffraction data were collected. b Criteria for observed reflections: I > 2σ(I); . c [F2 > 2σ(F2)]. d (F2). * The marked decrease in the number of measured 
reflections at 240 K and 270 K is explained by a slight movement of the single crystal on the goniometer head at 240 K. 
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 a) An analysis with SHELXLE GUI22 
allows a qualitative analysis of the changes in 
the difference density as a function of 
temperature. Figure 3.10 clearly illustrates the 
loss of this signal from the solvent region as 
temperature is increased.  
b) Void analysis performed with 
Mercury63 using a probe radius of 1.2 Å and a 
grid spacing of 0.2 Å,  calculated using the 
contact surface algorithm, reveals that the 
volume occupied by the solvent does not change 
significantly as temperature is increased: water 
molecules occupy a mean volume of 19.4(2)% of 
the total unit cell volume (Figure 12). α-CD C’ 
was not taken into account for void analysis. 
A third method would consist of using 
The SQUEEZE65 algorithm implemented in the 
PLATON program which also gives an 
indication of the solvent accessible volume.66,67 
The SQUEEZE routine is typically used to obtain 
the electron count in a disordered region and 
hence aid in the assignment of type and number 
of disordered solvent molecules. However, to 
obtain meaningful electron count numbers, the 
data should be of sufficient resolution and, more 
importantly, all low order reflections should be 
measured. Since this was not the case in this 
study, details of electron count as well as the 






Figure 3.10. SHELXLE Fobs-Fcalc maps of α-CD∙SA 
complex. SHELXLE Fobs-Fcalc maps (at 0.40 e-/Å3) of α-
CD∙SA inclusion complex at 100 K and the respective 
solvent regions on both ends of the vase-like cluster 
at the different temperatures showing the decrease of 
the signal as a function of increasing temperature.  

















Figure 3.11. The solvent accessible void volume calculated using MERCURY63  
(grid spacing = 0.2 Å; probe radius = 1.2 Å). 
 
An analysis, based on the fully refined structures, of the anisotropic displacement 
parameters (ADP) as function of temperature indicates larger thermal motion at higher 
temperatures, as expected. (See Appendix Figure 3.12–26). Analysis of the refined Uij values of 
O(1)→O(6) water molecules, which are located in the space between adjacent α-CD columns 
(Figure 3.3), show comparable expansion of the three diagonal elements U11, U22, U33 of the ADP 
tensor. These diagonal elements are parallel to the reciprocal unit-cell axes a*, b* and c*, respectively, 
and in the case of a rhombohedral crystal system, U33 is parallel to the c-axis. For α-CD atoms, the 
expansion of U33 is much more pronounced compared to the two other directions. Hence, while 
water molecules increase their vibrations in all directions as temperature increases, α-CD 
molecules have more freedom along the c-direction.  
To summarise, the loss of diffraction quality at higher temperatures can be directly 
ascribed to structural disorder, primarily of the solvent region. It is not unlikely that at even higher 
temperatures, water molecules vibrate excessively leading to disruption of the crystal packing and 
structural instability as testified by complete loss of diffraction at 298 K. Given the channel-type 
packing adopted by the structure, it is conceivable that water molecules find their way out of the 
structure. Moreover, the multi-temperature study also shows that the guest molecules inside α-CD 
cavities are freely rotating with no apparent ordering induced by lowering the temperature. This is 
due to the lack of H-bond interactions between the guest and the host molecules, which, in theory, 
should help stabilising the position of the guest molecules. A CSD search reveals that the lack of 
direct intermolecular contacts between host and guest molecules is not unusual for CD inclusion 
complexes, and that the guest is indirectly H-bonded to the host via water molecules.  
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 High-pressure results:  3.4.3.
Our high-pressure re-crystallisation attempts of α-CD∙SA inclusion complex were 
unsuccessful for the selected pressure and temperature ranges. It has been reported previously that 
“α-CD (hydrate) shows an unusual trend in solubility as a function of pressure, that is, when 
increasing pressure crystals tend to dissolve rather than grow”.1 A similar behaviour was observed 
for α-CD∙SA inclusion complex with a partially dissolved crystal; however, unlike α-CD hydrate, 
the crystal does not grow back with pressure release. The reason of the observed solubility trend is 
still unknown but currently under investigation and is believed to be associated with water 
mobility into α-CD cavities through flip-flop H-bonding.1 On pressure release, there was also no 
microscopic evidence for crystallisation of either SA or α-CD alone. Given the smaller size of the 
crystal at the end of the experiment, the solution in the DAC must become more saturated with 
respect to both components but a too high level of supersaturation could hinder crystallisation. It is 
also possible that kinetic effects are affecting crystallisation or that a particularly stable complex in 
solution is stabilised at high pressure. Finally, it is also conceivable that structural disorder is 
essential for stability of the α-CD∙SA complex and that high pressure, favouring denser, more 
ordered states, hinders the in situ formation of the complex.   
 Conclusions  3.5.
The crystal structure of α-CD∙SA inclusion complex has been elucidated using single-
crystal X-ray diffraction. α-CD molecules adopt a rounded shape allowing the complex to 
crystallise in a high symmetry space group, unreported previously for α-CD inclusion complexes. 
The structure exhibits a honeycomb arrangement of channels. The building block of the channels 
has been described as a vase-like cluster formed by a trimer of α-CD molecules.  
The disorder of the sample has been assessed by means of a multi-temperature X-ray 
diffraction experiment. Careful analysis of Fourier maps proved that the disorder is of a dynamic 
nature. Structural comparison of α-CD∙SA complex at the different temperature shows that in the 
low-temperature regime disorder is attributed to thermal vibrations, however above a certain 
temperature vibrations of water molecules accentuate the disorder and lead eventually to the 
decomposition of the crystal.  
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  Appendix 3.7.
 CSD refcodes of the all α-CD structures available in the CSD:  3.7.1.
The following is a list of all the recodes resulting of searching the CSD, V. 5.36 including 
updates to November 2014, for structure of α-CD with 3-D coordinates. The refcodes were 
categorised according to the packing type described by Saenger and Steiner.11  
a) Herringbone-type cage: ARACEB, BANXUJ, BOBPAK, BUPDEV, CDEXKR10, 
CDEXME10, CDEXTI10, CHXAMH, CHXAMH02 (redetermination, excluded), 
CHXAMH03, CHXAMH04 (redetermination, excluded), CYDXKR10, DAXTEB, DEGTEO, 
GEVTOQ, GULTUC, HOGCIP, LOVVAT, QERVUE, QOHMEF, RAXPOV, REGPAW, 
YENQAK. 
b) Brick-type cage: ACDHBA, ACDMFM, ACDMSM, ACDPNP, ACDPRO, BOBNUC, 
BOLVUT, BORYOX, CDEXIA01 (redetermination, excluded), CDEXIA10, CHAIPL, 
EJOVOO, GOQZUH, IFOBUB, INUPAI, INUPEM, MESYEO, PAZKOS, QENTIN, 
QENTOT, QIZMIW, RIRZUN (α-cycloaltrin, excluded), TUSHEV, TUSHIZ, VEHQAA, 
WEXKOZ, ZEJDEX. 
c) Channel type (pseudohexagonal and hexagonal/honeycomb): BAJJAX, BIJHOR, 
CAQPEP, CDNOAN, CIGLAG, CYDXLI10, JEHYIE, JEMGUD, JUMYOF, JUMYUL, 
KIRJOK10, KIWYUK, KIWZEV, KOBLOC, KOGKEW, KOGKIA, LIZQAO, MOVFUY, 
PEPBUH, PUPTEZ, QACCEE, QACCII, WEXLEQ, XIGBOE, YIHJOQ, YIHJUW, ZASYOH.  
Channel type (other): ACDMNP, ACDPRS, CAQPAL, CDKABA, CDXBZS, CDXKOM, 
CDXSOM, CHAMPA, EJOVUU, KEZGAZ, MESYAK, NIMROR, QOHMIJ, RAGZOO, 
SAQMII, TEXTEX, TEXTIB, WILJAC, WIZQEB, WUQKEZ, WUQKID, WUQKOJ, 
ZZZANG10. 
 The evolution of the normalised unit cell parameters as function of temperature 3.7.2.
The normalised unit cell parameters are plotted against the temperature. Data at 100 K 
were taken as a reference (a100=a0, c100=c0 and V100= V0). To avoid the overlap of the error bars, Tc and 
TV were shifted by +1 and -1 K, respectively. The uncertainty of the ratio σ(a/a0) was calculated 















The same equation was used for generating σ(c/c0) and σ(V/V0). 
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Table 3.2: evolution of the normalised unit cell parameters as function of temperature. 
 
T /K a /Å σ(a) /Å a/a0 3∙σ(a/a0) 
100 23.645 0.003 1 0.000538 
120 23.6608 0.0007 1.000668 0.000391 
150 23.6781 0.0006 1.0014 0.000388 
180 23.6951 0.0005 1.002119 0.000386 
210 23.7133 0.0006 1.002889 0.000388 
240 23.738 0.013 1.003933 0.001686 
270 23.757 0.01 1.004737 0.001319 
T /K c /Å σ(c) /Å c/c0 3∙σ(c/c0) 
101 55.706 0.00700 1 0.000533 
121 55.722 0.00200 1.000287 0.000392 
151 55.7898 0.00180 1.001504 0.000389 
181 55.849 0.00150 1.002567 0.000385 
211 55.8345 0.00170 1.002307 0.000388 
241 55.76 0.03000 1.000969 0.001657 
271 55.62 0.02000 0.998456 0.001143 
T /K V /Å σV /Å V/V0 3∙σ(V/V0) 
99 26973 7 1 0.001101 
119 27015.8 1.9 1.001587 0.000807 
149 27088.1 1.6 1.004267 0.000798 
179 27155.8 1.4 1.006777 0.000794 
209 27190.5 1.6 1.008064 0.000798 
239 27212 34 1.008861 0.003828 
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 Analysis of the anisotropic displacement 3.7.3.
parameters 
The value of the ADPs were taken from 
the result file of the refinement of SHELX (.res). 
O(1) to O(6) are water molecules located in the 
interstices. The numbering suffix refers to the 























































































































































































































































































































































Figure 3.27. Overlay of α-CD∙SA structures at 180 K and 270K viewed along the b-axis. (1) overlay using α-










Chapter 4. A new high-pressure form of β-cyclodextrin∙paracetamol inclusion 
complex 
 Synopsis  4.1.
In this chapter, a new form of a β-CD∙paracetamol inclusion complex obtained exclusively 
at high pressure is reported. This form, here termed form V, was obtained by first dissolving in situ 
in a DAC the ambient-pressure form of the complex, form I, and then further increasing pressure 
to 0.8 GPa to induce crystallisation. High-pressure single-crystal diffraction data were collected 
using both laboratory and synchrotron X-ray radiation. The presence of the guest in the 
cyclodextrin cavity was also confirmed by Raman spectroscopy. One of the most striking structural 
features of form V is the exceptionally high number of water molecules, over 24 per inclusion 
complex unit, incorporated in the crystal. Comparative crystal structure analysis indicates that the 
mode of packing in form V is intermediate between the known screw channel and chessboard 
packing types. The results of compression studies of form I using different pressure-transmitting 
media are also reported in this chapter; these studies revealed that no phase transition occurs up to 
0.95 GPa but that structure of form I responds differently according to the nature of the pressure-
transmitting medium used. 
 Introduction 4.2.
Among the natural occurring α-, β- and γ-cyclodextrins (CD), β-CD (Figure 4.1.b) is the 
most frequently investigated with respect to inclusion complex formation. β-CD is composed of 
seven D-glucopyranose units (Figure 4.1.c) linked together by α(1→ 4) glycosidic bonds (Figure 
4.1.b). Within the family of native CDs, β-CD is the least soluble in water with a reported solubility 
value of 18.5 g/l, compared to α- and γ-CDs with values of 145 and 232 g/l, respectively.1 It seems 
paradoxical to report that on one hand β-CD is the most used CD to improve drug solubility in 
water,2–9 and on the other hand it is a poorly soluble natural CD. Chen et al. reported, by 
calculating the host-guest binding energy and comparing it to experimental data,10 that β-CD, 
when compared to α- and γ-CD, binds in a more efficient manner to guest molecules.11 Moreover, 
α-CD and γ-CD cavities are respectively too small and too large to incorporate and stabilise as 
many drug compounds as β-CD. Another important reason why β-CD is favoured over α- and γ-
CDs is the production cost: the low water solubility of β-CD makes the purification process much 
simpler, and hence more cost effective.12,13  
Although cyclodextrins have been extensively studied as potential drug carriers, as 
described in several reviews,2,4–8,14 the use of high-pressure techniques to extend the investigations 




on host-guest inclusion complex formation was, to the best of our knowledge, prior to our work 
largely unexplored. Inclusion complex formation and phase transitions investigations have been 
reported at ambient and low-temperature conditions only. Here we demonstrate that high-
pressure techniques can be used to add a further dimension in the experimental search of inclusion 
complexes. 
 
Figure 4.1. Diagrams and numbering schemes of: (a) β-CD; (b) α-D-glucopyranose and (c) paracetamol. 
 
The work presented in this chapter focuses exclusively on the β-CD∙paracetamol system. 
Although other drug molecules have been investigated, see Chapter 5, a large portion of time was 
dedicated to paracetamol (Figure 4.1.a). The motivation for this work is multifold: first of all, 
paracetamol has been known for decades as an effective analgesic and antipyretic substance, and is 
such an emblematic drug molecule that is often used as a model molecule for teaching purposes.15 
Second, paracetamol is known to form a complex with β-CD at conditions of ambient pressure and 
temperature, here termed form I.16 Finally, the work carried out in our group has shown that high-
pressure and low-temperature crystallisation techniques lead to the formation of three further 
forms: form II and III obtained at low temperature and form IV obtained at high pressure,17 as 
summarised in Figure 4.2.    
The aim of this study can be summarised as follows:  
a) Confirm and tune the high-pressure crystallisation protocol of form IV;17 
b) Check whether direct compression can induce the form I→II transition. The literature  
shows that polymorphs of molecular crystals obtained at low-temperature conditions 
can sometimes  be obtained at high pressure as well.18  
c) Investigate whether new forms can be obtained by varying parameters such as 
pressure, temperature and concentration.  
 





Figure 4.2. Crystallisations procedures of previously known β-CD∙paracetamol inclusion complexes 
 Experimental 4.3.
 Ambient-pressure crystallisation 4.3.1.
The crystallisation of the known β-CD∙paracetamol complex, form I, is very facile. It was 
described one and a half decades ago by Caira and Dodds and involves slow cooling of a β-CD and 
paracetamol equimolar aqueous solution, which yields large prismatic crystals.16 We found that 
slow evaporation instead of slow cooling also yields crystals suitable for diffraction. Single-crystal 
X-ray data were collected in house to redetermine the structure of form I at ambient-temperature 
and ambient-pressure conditions. 
 High-pressure in situ crystallisation of β-CD∙paracetamol form V 4.3.2.
Crystallisation of the β-CD∙paracetamol∙water system at high pressure is complex. 
Numerous crystallisation trials were carried out in the DAC; three starting conditions were tested 
and used for the trials: (1) loading small single crystals of β-CD∙paracetamol form I together with 
their mother liquor; (2) loading a large single crystal of form I, which fills more than 60~70 % of the 
gasket hole, in demineralised water; (3) loading a hot supersaturated equimolar aqueous solution 
of β-CD∙paracetamol (ca. 353 K). The concentration of β-CD and paracetamol in the DAC is highest 
in trials (1) and lowest in trials (3). 
In (1) and (2), the crystals of form I undergo an unexpected dissolution process at pressures 
higher than 0.2 GPa. Dissolution is generally complete above 0.5 GPa. In-situ crystallisation of a 
new β-CD∙paracetamol∙water phase, form V, is observed at pressures above 0.6 GPa. When 
pressure is released, the reverse process is observed: form V dissolves at pressures below 0.6 GPa 
and form I recrystallises back from solution. Another crystallisation path for obtaining form V 
consists of loading crystals as described in (1) (Figure 4.3.a), heating the sample in the DAC (Figure 
Form I Form II 
Form III 
Flash cool  
to 120 K 
Form IV 
β-CD:paracetamol 1:1 aqueous 
solution 
Crystallise by slow evaporation 
at 295 K or slow cooling16      
Crystallise 
at 278 K 
Crystallise 
at 0.9 GPa 




4.3.b-d) at pressures below 0.2 GPa using a heatgun until complete dissolution (Figure 4.3.e), and 
then increasing pressure above 0.6 GPa (Figure 4.3.f) to induce crystallisation. 
 
Figure 4.3. Dissolution process of β-CD∙paracetamol form I. (a) Single crystals of β-CD∙paracetamol form I 
loaded in their mother liquor into the DAC, P adjusted to 0.2 GPa; (b-e) progressive dissolution of the crystals 
in (a) by heating at 373 K at 0.2 GPa; (f) a new high pressure phase crystallises after increasing the pressure to 
0.98 GPa. 
 
The experiment in (3) was designed to reproduce the crystallisation of form IV and explore 
the formation of other forms.17 This procedure failed to reproduce the crystallisation of form IV, 
with only small crystals of form V obtained instead (Figure 4.4), as obtained by synchrotron single-
crystal X-ray diffraction. Crystallisation of needle-like crystals was observed when pressure was 
increased rapidly in one step to 1.2 GPa. These crystals correspond to a monohydrate form of 
paracetamol (see Chapter 7), which can be dissolved by releasing pressure to 0.6 GPa; on further 
slow pressurisation, crystallisation of form V can be induced.  
 
Figure 4.4. Crystallisation of β-CD∙paracetamol form V from saturated solution. (a) hot saturated solution of β-
CD:paracetamol 1:1 loaded into a DAC and pressure increased to 0.14 GPa; (b) no crystallisation after 
increasing pressure to 0.86 GPa; (c) crystallisation after increasing pressure to 0.94 GPa and cooling to 285 K 
for 16 h; (d) maximum growth of crystals after 2 days at room temperature. 
 
After several experiments, the chosen single crystal of form V for 
diffraction measurement (Figure 4.5. Crystal 1) was obtained by loading a 
large (250×180×100 µm) single crystal of form I into the DAC and using 
demineralised water as pressure transmitting medium. The crystal filled 
more than 70% of the gasket hole. Pressure was gradually increased to 
dissolve the crystal and after 12 hours crystallisation of form V was complete 
at a pressure of 0.8 GPa. Subsequent experiments showed that cycling 
temperature on form V crystals to grow one single crystal always led to the 
Figure 4.5. Crystals of 
β-CD∙paracetamol 
form V crystallised at 
0.8 GPa. 




formation of multiple nucleation sites; cycling temperature was thus not investigated further.  
 X-ray diffraction and Raman spectroscopy 4.3.3.
4.3.3.1. In-house X-ray diffraction 
Unit cell determination and diffraction quality check of β-CD∙paracetamol form V were 
carried out in-house using a Bruker AXS SMART Apex II CCD diffractometer equipped with Mo 
Kα sealed-tube radiation of λ = 0.71073 Å. To improve access to reciprocal space and better 
characterise the inclusion complex, synchrotron radiation was favoured over in house 
measurements. However, low-order data were collected on the same Bruker machine to complete 
and improve the saturated low angle reflections collected at the Doris and Petra synchrotron.  
4.3.3.2. Synchrotron X-ray diffraction 
Data on form V (Figure 4.5. Crystal 1) were collected using a wavelength of 0.50000 Å at 
beamline F1 of the former DORIS synchrotron ring at Hasylab/DESY (Hamburg, Germany). A 
Huber 4-circle diffractometer equipped with a Mar165 CCD detector was used for the experiment. 
Using available slits, a beam of 150×150 µm was chosen to minimise diffraction from the gasket. 
Crystal 1 (Figure 4.5) was measured using four runs (φ scans) by choosing an exposure 
time of 60 s per frame with a Δφ of 0.5°. Two different orientations of the DAC were measured to 
improve completeness (71.7%) and redundancy (13.94 up to dmax = 1.1 Å). Data were converted 
from TIF to Bruker format using the programs CMH, which updated the frames’ headers with 
information about the diffractometer angles and monitor counts, and M2B, which converts 
MarCCD165 data frames to Bruker-Nonius Smart format.19 Subsequently, the latter were converted 
to Bruker SFRM frame format using the conversion script implemented into the APEXII software.20   
In an attempt to improve the resolution of data measured at F1, diffraction data were 
measured a second time at the extreme conditions beamline P02.2 of the PETRA synchrotron ring 
at DESY (Hamburg, Germany). The high brilliance of the microfocused beam (λ = 0.28962 Å, 5×2 
µm) and the large amorphous silicon Perkin Elmer XRD 1621 detector enabled data collection up to 
a dmax of 1.0 Å. Data were collected on a single orientation of the DAC using 1 s, 0.5° φ scans 
covering a total of 82°.  Two issues were observed by using the flat panel detector: 1) so-called 
“ghost peaks”, which originate from a previous high dose of X-rays or very fast acquisition time;21 
ghost peaks have intensities much lower than that of the mean intensity of the background because 
of a change in the detector pixel sensitivity;22 and 2) very strong diamond reflections, which 
generate a large vertical band of high intensity across the image. Hence, careful data integration 
and analysis of the Fcalc vs. Fobs plot during structure refinement was carried out; suspected ill 
reflections were inspected on the frames and omitted if needed.  




Following the Raman spectroscopy results (see section 4.4.4.2), X-ray data were collected 
for the small crystal 3 (Figure 4.5) using 1 s exposure, 2° φ rotation scans covering a total of 80°.  
 Compression studies of form I: 4.3.4.
In order to investigate a possible single-crystal to single-crystal phase transition in β-
CD∙paracetamol form I triggered by applying high pressure, two compression studies were carried 
out using perfluorotributylamine (FC43), and tetrahydrofuran (THF) as pressure transmitting 
medium. A single crystal of β-CD∙paracetamol form I was loaded into a DAC filled with FC43, and 
X-ray diffraction was carried out at Doris F1 beamline (λ = 0.50000 Å): data were collected on the 
single crystal at 0.13 GPa using two orientations of the DAC and 40 s exposure, 0.5° φ rotation 
scans, and at 0.95 GPa also using two orientations of the DAC, 80 s exposure, 1° φ rotation scans. 
Changes in unit-cell parameters were monitored at intermediate pressures (0.45, 0.61 and 0.78 
GPa). For the compression study using THF as pressure transmitting medium, data were collected 
at PETRA 02.2 beamline (λ = 0.28962 Å); data sets were collected at three pressure points 0.16, 0.6 
and 0.95 GPa (Figure 4.6) using 1 s exposure, 1° φ rotation scans covering a total of 80°. Data were 
collected using two orientations of the DAC at 0.16 GPa, three orientations at 0.6 GPa and a single 
one at 0.95 GPa.   
 
Figure 4.6. Compression study of β-CD∙paracetamol form I using FC43 and THF. (a-b) FC43: (a) single 
crystal of form I at 0.13 GPa, (b) the same single crystal at 0.95 GPa; (c-e) THF: (c,e) a single crystal of form I at 
0.16 and 1.02 GPa; (d) a second single crystal of form I at 0.6 GPa. 
 
 Data processing 4.3.5.
The program SAINT23 was used for integration and global-cell refinement. A two-stage 
absorption correction was performed with SHADE24 and SADABS25. Friedel pairs in all data sets 
(measured in house and the synchrotron) were merged with SADABS25 assuming the effects of 
anomalous dispersion are negligible. All structures were solved with macromolecular phasing 
methods using SHELXD.26 Fragment seeding using the β-CD backbone (the 3D coordinates of the 
CSD27 refcode FALDUS28 were used as seeding model; H-atoms, all hydroxy groups and water 
molecules were deleted before use). Full-matrix least-squares structure refinement against F2 was 
performed using SHELXL201426 through the SHELXLE GUI.29 Stereochemical restraints for the host 




and guest molecules were applied to increase the stability of the refinement: restraints were 
generated by the GRADE program using the GRADE Web server.30 A GRADE dictionary for 
SHELXL contains target values and standard deviations for 1,2-distances (DFIX) and 1,3-distances 
(DANG), as well as restraints for planar groups (FLAT). Anisotropic displacement parameters 
were refined for only the host molecules using the new rigid bond restraint (RIGU) implemented 
in the SHELXL2014 program.31 All H-atoms of the guest and host molecules were placed 
geometrically using the riding model. H-atoms belonging to water molecules were not visible in 
difference Fourier maps but were taken into account for calculating F000 and density. Uiso(H) values 
were assigned in the range 1.2–1.5 times Ueq of the parent atom. Full details on the treatment of 
disorder can be found below. 
 Raman spectroscopy 4.3.6.
Raman spectra were measured on a Horiba Jobin Yvon HR800 UV Micro-Raman 
spectrometer equipped with an air-cooled 20 mW 488 nm Ar-laser. Spectra were collected in the 
100–3200 cm-1 range with a spectral resolution of ca. 2.2 cm-1 using a grating of 600 grooves per mm 
and a Peltier-cooled CCD (Andor, 1024×256 pixels). The spectra were calibrated with the Raman 
scattering frequency of Si before and after each measurement. 
 Results and discussion 4.4.
 Description of the structure 4.4.1.
Form V of β-CD∙paracetamol inclusion complex, which can be exclusively obtained by 
high-pressure crystallisation, crystallises in the orthorhombic crystal system in the space group 
C2221 with a single β-CD molecule in the asymmetric unit. Unlike all other forms, which crystallise 
as 1:1 complexes (Table 4.1), this new high-pressure phase contains a lower non-stoichiometric 
amount of paracetamol. The site occupancy factor of paracetamol refines to a value of ca. 0.3 which 
was later fixed during the refinement. The absence of the guest in the structure is compensated by 
an extensively disordered water network.  
The number of water molecules has been refined to a value of 24.20 per inclusion unit. This 
is to the best of our knowledge the largest hydration number for an inclusion complex of β-CD and 
we refer to this here as “super hydration”. With two exceptions, all primary hydroxy groups of β-
CD are facing the exterior of the cavity, thus exhibit the preferred (–)-gauche conformer (details on 
how to define the conformation are in Chapter 3); two hydroxy groups were found to be 
disordered over two positions, with the disordered counterparts exhibiting the (+)-gauche 
conformer and site occupancies of 0.60 and 0.33. Both (+)-gauche conformers are stabilised by H-




bonds to a water molecule inside the cavity. Details about the refinement of the structure and 
assignment of water molecules are discussed below. 
Table 4.1. Crystallographic data of the five forms of β-CD∙paracetamol inclusion complexes  



















Space group C2 C2 P21 P1 P1 C2221 
a/Å 19.207(7) 18.9343(8) 18.9045(13) 17.9671(13) 15.273(4) 19.6621(11) 
b/Å 24.48(1) 24.4136(11) 24.4918(17) 15.2364(11) 15.576(2) 24.0977(12) 
c/Å 15.700(5) 15.5941(7) 15.7281(12) 15.3783(11) 15.4464(19) 33.071(4) 
α/° 90 90 90 103.240(3) 79.562(9) 90 
β/° 109.52(29) 110.798(3) 109.186(4) 113.260(3) 74.575(17) 90 
γ/° 90 90 90 99.323(3) 88.190(17) 90 
V/Å3 6959(5) 6738.7(5) 6877.7(9) 3611.8(5) 3483(1) 15669(2) 
Z’ 1 1 2 2 2 1 
Dcalc/g cm-3 1.456 1.403 / / / 1.370 
Pressureb 0.1 MPa 0.1 MPa 0.1 MPa 0.1 MPa 0.9 GPa 0.8 GPa 







/ / / 58384/3328/ 
2747 
Parameters 458 847 / / / 1018 
Restraints / 2365 / / / 2615 
Rint 0.0302 0.0705 / / / 0.0940 
dmax/Å / 1.0 / / / 1.0 
Complet. to 
dmax 
/ 0.896 / / / 0.748 
R1e 0.1345 0.0750 / / / 0.0843 
Rfreee  
(obs. Refl.) f 
/ 0.1012 
(605) 
/ / / 0.1285 
(330) 
wR2g / 0.1852 / / / 0.2355 
a This work. b These values refer to the pressure at which diffraction data were collected. c Criteria for observed reflections: I 
> 2σ(I). d Criteria for observed reflections: I > 3σ(I). e [F2 > 2σ(F2)].f 10% of unique reflections g (F2). 
 
In form V the inclusion complex crystallises as dimers of CD molecules, which is the most 
frequently encountered packing motif for CD molecules in the solid state, as is discussed 
throughout this chapter. Molecular dynamics calculations performed in vacuum demonstrate that 
the head-to-head dimer, as encountered in this structure, is the most energetically stable motif.32 A 
dimer is formed by two host molecules H-bonded by their secondary hydroxy groups, and is 
commonly named a head-to-head dimer. Other names for this type of dimer are also found in the 
literature, such as “basket”,33 which we personally find inaccurate, and “barrel-like motif”,3,34 
which expresses adequately the shape of the dimer. The barrel-like dimer can be thought as the 
building block of form V. Dimers stack to form infinite wavy channels when viewed along the [1 1 
0] direction (Figure 4.8.a), that can also be described as zigzag or screw channels. Although this is 
the first time where this packing is observed for β-CD∙paracetamol, it is not unknown for other β-
CD inclusion complexes. 
There are two seminal papers devoted to the classification of crystal packing in β-CD 
inclusion complexes by Mentzafos et al.35 and Saenger and Steiner.33 The classification systems can 
be combined and are illustrated in Figure 4.7. Saenger and Steiner33 tried to come up with uniform 




and widely applicable scheme of the packing of β-CD, without focussing on any space group 
classification, whilst Mentzafos et al.35 were more interested in a classification that takes the 
incidence of space groups into account. 
 
 
Figure 4.7. Summary and examples of β-CD packing types in the literature interpreted from references 
33,35. 
 
 Mentzafos et al.35 previously classified β-CD inclusion complexes crystallising in space 
group C2221 and having a unit cell with orthogonal axes of 19, 24 and 32 Å as having a “chessboard” 
packing motif (CB). The CB motif is formed by adjacent layers of dimers related by a 21-screw axis: 
“Each dimer is located above the interdimer space of the dimeric layer underneath”, i.e. when one layer is 
seen along the a-axis as in Figure 4.8.b. The packing of β-CD inclusion complexes has also been 
described as “wave-like polymeric supermolecules”.36 Mentzafos et al. also described a screw-channel 
(SC) packing type characteristic of P21 structures, in which dimers are stacked above each other to 
form a channel with a screw-like appearance (Figure 4.8.a). The same authors further ascribed the 
presence of dimers in these structures to pseudo-centred dimeric layers, i.e. the P21 unit cells can be 
transformed to pseudo C-centred lattices similar to the C2221 type. Mentzafos et al. also reported that 
there is almost no superposition of the projection of two adjacent dimers related by the 21 screw 
axis in C2221 structures whereas the ones of P21 structures partially overlap.35 From our work, the 




structure of β-CD∙paracetamol form V appears to be equally describable by either the CB or the SC 
packing features (Figure 4.8.a). This might be an indication of similarities between both CB and SC 
packing types, which is investigated in greater detail in the following section. 
 
 
Figure 4.8. Packing feature of β-CD∙paracetamol form V inclusion complex. (a) seen along the a-axis (CB 
motif); (b) seen along the [1 1 0] direction (SC motif). H atoms, guest and water molecules have been omitted 
for clarity. 
 
 Crystal packing similarities between C2221 and P21 structures 4.4.2.
In order to better investigate the packing mode of β-CD∙paracetamol form V and identify 
packing similarities with structurally related inclusion complexes, a CSD (V. 5.36 including 
updates to May 2015) study was carried out. For the search in CONQUEST,37  the values of the 
reduced unit cell parameters of form V were chosen, using a tolerance of 5% based on the length of 
the longest axis. 37 hits (excluding 2 redeterminations) corresponding to structures of β-CD 
inclusion complexes reported in P1, C2, P21 and C2221 space groups (Table 4.2) were identified. The 
majority of the structures belong to either P21 or C2221 space groups, with 16 and 14 hits, 
respectively. These structures crystallise in either the SC or CB packing types, respectively. P1 and 
C2 structures, in which β-CD dimers pack in different modes, were not taken into account for the 
analysis. 
In the following discussion individual structures are referred to by their CSD refcodes, 
and structural groups by the space group. For reasons discussed below, our β-CD paracetamol 
form V structure is distinct from the C2221 and P21 groups.  




The first comparison of P21 and C2221 structures focuses on the metric symmetry of the 
system: space group P21 is a subgroup of C2221. Hence, the C2221 lattice can be easily transformed 






Conversion of a P21 unit cell to an orthorhombic C2221 supercell, by using the inverse of 
the matrix (I.2.1), is only possible if (a=c) (Figure 4.9.b). All P21 structures have (ac) but only one 
(KIFPAQ)38 strictly fulfils the rule (a=c) and can be transformed to the C2221 space group. 
Moreover, from the C2221→ P21 transformation matrix it is noticeable that the a- and c-axes of the 
monoclinic unit cell correspond to the [1 -1 0] and [1 1 0] directions of the orthorhombic cell, 
respectively. Hence, screw channels reported in the P21 structural group and viewed along the a- or 
c-axis can also be seen in the C2221 structural group when viewing the packing along [1 -1 0] and [1 
1 0] direction, though the degree of displacement of dimers is much greater and is ultimately 
responsible for grouping these structures in another group (CB, brick type). In other words, CB 
structures can also be described as SC structures if the direction of view is other than the unit cell 
directions.  
 
Figure 4.9. Relationship between monoclinic (orange, seen along b) and orthorhombic (blue, seen along c) 
unit cells. (1) a≠c in the monoclinic cell, hence 21-screw axes in the orthorhombic and monoclinic unit cells 
mismatch; (2) monoclinic a=c and 21-screw axes of both unit cells overlap perfectly. 
 
The Crystal Packing Similarities plugin available in MERCURY39 was used to further 
confirm the similarities between P21 and C2221 structures. The β-CD backbone was used as 
comparison motif: all guest and solvent molecules, as well as hydroxy groups of β-CD were 
omitted in all structures prior to the comparison. Crystal Packing Similarities compares each pair of 
structures within a defined coordination shell, and outputs the number of overlaying molecules, 
the relative root mean square difference (RMSD) and powder X-ray diffraction (PXRD) similarity 
values. 
A first calculation on a single dimer (two β-CD molecules) shows that although the dimer 
is formed by symmetry related molecules in the C2221 structural group, the one found in the P21 




group is related by a pseudo-symmetry element (a 2-fold rotation axis). The analysis shows that in 
all structures the dimers are practically indistinguishable. They have root mean square deviations 
(RMSD) values varying between 0.03 and 0.3 Å (see 4.7.Appendix - Table 4.5). The high values of 
the range are mainly caused by the CDETAN structure: bond lengths and angles in this structure 
(R-factor  0.25) appear chemically incorrect although the structure was nicely described by 
Tokuoka et al.40 (a geometry check using MOGUL41 shows a high number of unusual bond lengths 
and angles). This analysis suggests that the two β-CD backbones within the frequently observed β-
CD dimeric arrangement could be, at least in the case of P21 structures, associated by a local 2-fold 
rotation. 
Subsequent crystal packing similarities calculations using a coordination shell of 30 
molecules, geometric tolerances of 30% on the interatomic distances and of 30° on the interatomic 
angles, were carried out. We discovered that the LACTAL structure,42 although reported as β-CD 
by the authors, actually has the wrong handness. 3D coordinates in LACTAL have been inverted 
prior to the calculations. The results of Crystal Packing Similarities, listed in Table 4.3, show the 
following points: 
1) Within the same structural group, all C2221 structures, and all but two (KIFPAQ, 
BEGWEQ)  of the P21 structures overlay perfectly with each other, but the overlay 
between both groups is not as good. This confirms these are two distinct packing 
types; 
2) All powder X-ray diffraction patterns are at least 97% similar (See Appendix - Table 
4.6);  
3) KIFPAQ is an outlier in the P21 structural group and fits nicely in the C2221 group, 
which is in line with its observed higher symmetry. This strongly suggest the 
reported low-symmetry space group is incorrect;  
4) RMSD values in the C2221 structural group are in the range 0.092–0.398 Å and are 
lower than those of P21 structures 0.109–2.132 Å, with KIFPAQ here treated as C2221 
structure;  
5) RMSD values comparing C2221 vs P21 structures are in the range 2.795–3.313 Å 
expressing larger packing differences; 
6) Although β-CD∙paracetamol form V is a C2221 structure having a SC packing motif, 
the RMSD table (Table 4.3) shows that its packing is different from either that of both 
C2221 and P21 structures, but overall when considering the number of molecules in 
the cluster for comparison (top row of table 3), form V structure fits better in the 
C2221 structural group 




7) In the P21 structural group, BEGWEQ43 deviates more from the other P21 structures, 
and appears to be an outlier in the P21 group.  This is investigated in more details 
below. 
In order to complement the analysis of the crystal packing similarities, visual inspection 
of the structures in MERCURY and computation of packing parameters have been carried out. To 
simplify the calculations, β-CD backbone was substituted by the respective centroid of the seven 
glycosidic O(4) atoms. The packing features of the SC structural group were defined in the P21 
setting using the following parameters: the inner spacing of the channel seen along the monoclinic 
b-axis (i.e. c-axis in C2221), which corresponds to the distance between the projections of the 
centroids of non-symmetry related molecules on the ac plane; the same spacing projected onto the a 
and the c-axes; and the angle (Ψ) between the planes formed by the SC and the (10-1) plane (i.e. the 
orthorhombic ac plane). Both parameters are graphically detailed in Figure 4.10 and their values 
compiled in Table 4.2. An additional parameter corresponding to the opening of an SC channel 
described by the angle (ξ) between O(4) planes of two consecutive dimer related by the 21-screw 
axis, and reported by Mentzafos et al. of about 20° is consistent within all structures.  
The SC inner spacing and the angular difference (Ψ) with the monoclinic (10-1) plane are 
driving the large RMSD shifts between C2221 and P21 structures seen in Table 4.3, as these values 
are related with the general position of the dimer in the asymmetric unit: 1) in C2221 structures the 
dimer forming the SC is constrained by a 2-fold rotation axis to be perpendicular to the monoclinic 
(10-1) plane (i.e. the orthorhombic ac plane), whilst in the P21 group, the SCs are symmetrically 
more relaxed, and they form an angular difference varying between 3.7 and 23.7° with the majority 
below 9°; 2) the spacing of C2221 SCs, i.e.  when structures seen along the monoclinic b-axis, is 
homogeneous throughout all structures within the group with a mean value of 8.5 Å. In the P21 
structural group, the dimers are closer in space and the mean spacing value is ca. 4 Å: BEGWEG as 
well as KIFPAQ have highly divergent values and were not included in the calculation of the mean 
spacing value.  
These two packing parameters fully explain the packing differences seen in all C2221 and 
P21 structures as reported in Table 4.2: the homogenous trend seen in the RMSD values of the C2221 
group can be explained by the fact that C2221 structures are affected only by the SC spacing as they 
are constrained to be directed perpendicularly to the monoclinic (10-1) plane, with a spacing 
distance varying from 7.6 to 8.8 Å. In contrast, although the lower symmetry in the P21 structural 
group makes the dimers more relaxed, the spacing of the SC is homogenous and varies from 3.5 to 
4.7 Å (BEGWEG and KIFPAQ not included), the angular difference of the SC structural group with 
the (10-1) plane correlates more closely with the RMSD shifts.  
  




Table 4.2. β-CD inclusion complex structures reported in the CSD and similar to β-CD∙paracetamol form V. 















 /° a /Å b /Å c /Å α /°  β /° γ /° V /Å³ 
BOSZUF
36
 2009 0.1077 C2221  293 1 8 15.36701 15.36701 32.311 90 90 101.8058 7469 90 7.69 5.439 5.439 19.80 
BOTBAO
36
 2009 0.0860 C2221  100 1 8 15.31715 15.31715 32.864 90 90 101.3525 7560 90 7.71 5.45 5.45 20.00 
DEVTON44 1984 0.1300 C2221  295 1 8 15.4869 15.4869 32.84 90 90 101.5826 7716 3D coordinates unavailable 
DEVTUT
44
 1984 0.1200 C2221  295 1 8 15.43908 15.43908 32.58 90 90 103.6251 7547 3D coordinates unavailable 
DUYVID45 2010 0.0512 C2221  173 1 8 15.38309 15.38309 32.596 90 90 102.9829 7516 90 8.68 5.405 5.405 19.57 
FALDUS
28
 2004 0.1244 C2221  293 1 8 15.53346 15.53346 32.62 90 90 101.4534 7714 90 8.57 5.423 5.423 18.40 
FASXUS
46
 1985 0.1150 C2221  113 1 8 15.34196 15.34196 32.597 90 90 102.7096 7485 90 8.47 5.292 5.292 19.30 
GIPFEQ47 1988 0.1000 C2221  295 1 8 15.4718 15.4718 32.503 90 90 102.2021 7605 90 8.48 5.328 5.328 18.68 
KEMZIN
48
 2013 0.1051 C2221  100 1 8 15.32311 15.32311 32.554 90 90 102.3997 7465 90 8.83 5.53 5.53 21.22 
KOFJEU35 1991 0.1127 C2221  295 1 8 15.52019 15.52019 32.808 90 90 103.5983 7681 90 8.69 5.372 5.372 19.50 
LACTAL
42
 2004 0.1355 C2221  293 1 8 15.51729 15.51729 32.806 90 90 102.8701 7701 90 8.70 5.423 5.423 19.45 
MEGQUK
49
 2000 0.1082 C2221  110 1 8 15.33049 15.33049 32.67 90 90 102.7271 7490 90 8.71 5.437 5.437 21.16 
WEZSIE50 2007 0.1103 C2221  173 1 8 15.39446 15.39446 32.471 90 90 103.5959 7480 90 8.52 5.272 5.272 19.45 
XUXFAY
51
 2009 0.0903 C2221  113 1 8 15.36045 15.36045 32.4473 90 90 102.699 7468 90 8.79 5.492 5.492 20.47 
This Work 2015 0.0742 C2221  298 1 8 15.5507 15.5507 33.071 90 90 101.576 7834  90 3.97 2.508 2.508 22.27 
BEGWEQ43 2003 0.0662 P21  173 1 2 15.2262 15.6739 31.4771 90 90 104.32 7279 23.65 7.01 3.232 6.829 20.88 
BOTBES
36
 2009 0.0662 P21  100 2 4 15.3151 15.3818 31.5498 90 90 101.661 7279 4.22 4.15 3.396 3.023 20.24 
CIVBUE52 1984 0.1600 P21  295 1 2 15.229 15.562 33.189 90 90 104.854 7603 3D coordinates unavailable 
CDETAN40 1981 0.2501 P21  295 2 4 15.3 15.584 32.311 90 90 102.4 7524 8.83 3.53 2.346 3.075 17.14 
DUTLIN53 1986 0.1210 P21  128 2 4 15.277 15.316 32.232 90 90 101.18 7399 3D coordinates unavailable 
DUTLIN1054 1988 0.1080 P21  123 2 4 15.277 15.316 32.232 90 90 101.18 7399 6.31 3.98 3.334 2.786 20.60 
FODBIK55 2005 0.0972 P21  293 2 4 15.46 15.512 32.209 90 90 103.096 7523 6.32 4.61 3.396 3.8 19.35 
GETPAW56 1988 0.0810 P21  138 1 2 15.26 15.35 32.76 90 90 101.5 7520 8.83 4.43 3.31 3.539 21.13 
GETPEA56 1988 0.1060 P21  138 1 2 15.277 15.31 32.124 90 90 100.76 7381 5.76 3.99 3.315 2.798 19.91 
KIFPAQ38 1999 0.1169 P21  295 2 4 15.428 15.437 32.545 90 90 103.56 7535 90 8.73 5.405 5.399 19.52 
MACDAW34 2003 0.0868 P21  293 2 4 15.394 15.621 31.995 90 90 103.738 7474 7.19 3.99 3.406 2.836 18.98 
NAJJAK57 2004 0.1163 P21  200 2 4 15.184 15.639 32.51 90 90 102.62 7533 7.43 3.98 3.364 2.812 19.75 
NAJJAK0158 2006 0.1163 P21  200 2 4 15.184 15.639 32.51 90 90 102.62 7533 3D coordinates unavailable 
NIZGUY59 1996 0.1080 P21  295 1 2 15.324 15.342 32.54001 90 90 102.44 7471 3D coordinates unavailable 
OKAQAT60 2011 0.1169 P21  120 2 4 15.3332 15.54 31.7 90 90 102.459 7376 3.71 4.10 3.002 3.369 19.95 
QACXEX61 1999 0.0584 P21  20 2 4 15.255 15.454 31.693 90 90 102.92 7282 5.6 4.05 2.931 3.383 19.49 
XEYDIQ62 2012 0.1046 P21  100 2 4 15.2946 15.3936 32.5293 90 90 102.17 7487 8.99 3.85 3.33 2.593 21.33 
YOJHUC63 2012 0.1128 P21  100 2 4 14.8541 15.7645 32.3999 90 90 103.75 7370 11.64 3.53 2.383 3.101 20.49 
DEVVEF64 1984 0.2190 P1 295 1 1 15.529 15.568 32.32715 99.8915 93.4746 103.82 7434           
ASEWAX65 2011 0.1566 C2 150 0.5 2 15.38554 15.38554 33.34401 96.0563 96.0563 104.1396 7540       
EZEYAJ66 2004 0.1032 C2 293 2 8 15.47755 15.47755 33.457 98.5991 98.5991 102.2555 7607       
HAHVIW67 2004 0.0605 C2 293 2 8 15.34915 15.34915 32.58 92.3404 92.3404 103.0436 7462       
KOLGAU68 2008 0.0801 C2 298 1 4 15.55352 15.55352 32.9754 98.9353 98.9353 102.7705 7535       
MACCUP34 2003 0.0826 C2 293 2 8 15.47886 15.47886 33.315 98.6366 98.6366 102.7758 7556       
WANMII69 2005 0.1021 C2 293 0.5 2 15.45985 15.45985 32.776 92.4825 92.4825 102.3829 7633       
The CSD search included the default β-CD diagram found in CONQUEST,37 and the values of the reduced unit cell parameters of form V using a tolerance of 5% based on the length of the longest axis. Structures are colour coded 
according to the comparability of the packing types: blue, green, red and dark green for C2221 (CB), P21 (CB), P1 and C2, and form V structural groups, respectively. Structures for which 3D coordinates are not available are coloured in 
grey. a space group, b angular difference (Ψ) with the monoclinic (10-1) plane, c distance between the projections of the centroids of non-symmetry related molecules on the monoclinic ac plane, d the same spacing as in (c) projected onto 
the a and the c-axes, e angular difference (ξ) between O(4) planes of two consecutive dimers. All these parameters are further detailed in Figure 4.10. 




Table 4.3. RMSD values (Å) and maximum number of fitted molecules up to a maximum number of 30 molecules in a cluster, calculated using Crystal Packing Similarities in 
MERCURY.39 




























































































































































30 30 30 30 30 30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
BOTBAO
36
 2.32 0.25 
 
30 30 30 30 30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
DUYVID
45
 2.27 0.19 0.29 
 
30 30 30 30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
FALDUS
28
 2.23 0.23 0.33 0.31 
 
30 30 30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
FASXUS
46
 2.21 0.20 0.29 0.10 0.31 
 
30 30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
GIPFEQ
47
 2.16 0.19 0.32 0.20 0.18 0.19 
 
30 30 30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
KEMZIN
48
 2.38 0.17 0.26 0.16 0.33 0.21 0.29 
 
30 30 30 30 30 27 27 20 27 28 28 27 30 27 27 27 27 27 27 
KOFJEU
35
 2.21 0.32 0.39 0.18 0.33 0.21 0.23 0.31 
 
30 30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
LACTAL
42
 2.22 0.26 0.33 0.17 0.23 0.20 0.16 0.27 0.12 
 
30 30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
MEGQUK49 2.31 0.19 0.25 0.09 0.33 0.15 0.25 0.10 0.24 0.22 
 
30 30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
WEZSIE50 2.18 0.28 0.40 0.14 0.38 0.15 0.23 0.28 0.17 0.22 0.21 
 
30 26 26 20 26 28 28 26 30 26 26 26 26 26 26 
XUXFAY51 2.35 0.16 0.27 0.11 0.32 0.18 0.25 0.09 0.26 0.24 0.10 0.22 
 
26 26 20 26 28 28 26 30 26 26 26 26 26 26 
BEGWEQ43 2.66 3.18 3.18 3.22 3.23 3.28 3.29 3.20 3.28 3.25 3.18 3.31 3.16 
 
22 20 20 28 26 20 26 22 22 22 22 20 20 
BOTBES36 2.41 2.99 2.99 3.03 3.00 3.06 3.05 3.02 3.08 3.05 3.01 3.09 2.99 1.79 
 
30 30 30 30 30 26 30 30 30 30 30 30 
CDETAN40 2.36 2.83 2.83 2.82 2.87 2.84 2.87 2.80 2.85 2.84 2.81 2.86 2.80 2.00 0.60 
 
30 30 30 30 20 30 30 30 30 30 30 
DUTLIN1054 2.39 3.05 3.04 3.08 3.06 3.10 3.11 3.08 3.13 3.09 3.06 3.13 3.04 1.53 0.27 0.53 
 
30 30 30 26 30 30 30 30 30 30 
FODBIK55 2.92 3.05 3.06 3.05 3.10 3.09 3.11 3.00 3.09 3.08 3.03 3.09 3.02 1.99 0.33 0.48 0.32 
 
30 30 28 30 30 30 30 30 30 
GETPAW56 2.84 3.12 3.11 3.13 3.16 3.16 3.18 3.08 3.17 3.16 3.10 3.17 3.09 2.13 0.45 0.53 0.22 0.38 
 
30 28 30 30 30 30 30 30 
GETPEA56 2.07 3.09 3.07 3.11 3.10 3.14 3.15 3.12 3.18 3.13 3.10 3.17 3.08 1.55 0.28 0.55 0.11 0.39 0.28 
 
26 30 30 30 30 30 30 
KIFPAQ38 2.27 0.26 0.37 0.10 0.35 0.16 0.24 0.23 0.14 0.18 0.17 0.11 0.17 3.23 3.05 2.82 3.10 3.05 3.13 3.13 
 
26 26 26 26 26 26 
MACDAW34 2.48 2.93 2.94 2.96 2.92 3.00 2.98 2.97 2.99 2.96 2.95 3.04 2.93 1.80 0.37 0.55 0.43 0.16 0.48 0.49 2.98 
 
30 30 30 30 30 
NAJJAK57 2.41 2.96 2.95 2.99 2.95 3.01 3.00 3.00 3.02 2.99 2.97 3.04 2.96 1.85 0.44 0.59 0.35 0.28 0.31 0.43 3.00 0.30 
 
30 30 30 30 
OKAQAT60 2.45 3.03 3.04 3.06 3.04 3.09 3.10 3.06 3.11 3.08 3.04 3.12 3.02 1.80 0.22 0.53 0.35 0.27 0.50 0.37 3.08 0.34 0.50 
 
30 30 30 
QACXEX61 2.42 2.92 2.93 2.97 2.93 3.00 2.98 2.97 3.00 2.97 2.95 3.03 2.93 1.78 0.22 0.57 0.35 0.24 0.47 0.40 2.99 0.21 0.36 0.26 
 
30 30 
XEYDIQ62 2.41 3.04 3.02 3.05 3.03 3.07 3.08 3.08 3.11 3.06 3.04 3.10 3.02 1.85 0.41 0.49 0.22 0.27 0.14 0.30 3.07 0.37 0.25 0.42 0.38 
 
30 
YOJHUC63 2.37 2.99 2.99 3.01 2.99 3.03 3.03 3.05 3.05 3.01 3.01 3.06 2.99 1.94 0.70 0.76 0.65 0.56 0.58 0.72 3.03 0.49 0.39 0.76 0.56 0.52 
 
RMSD values calculated using the Crystal Packing Similarities plugin available in MERCURY for all C2221 (blue), P21 (light green) and β-CD∙paracetamol form V (dark green) structures. RMSD values are given below the diagonal and 
the number of molecules compared is given above the diagonal. Values are colour coded from light to dark according to a decreasing quality of matching. RMSD values have been rounded up to the second decimal.  





Figure 4.10. Packing parameters describing C2221 and P21 structural groups. All interpretations have been 
made in the monoclinic setting. β-CD∙paracetamol and GETPAW structures were used to draw the packing 
parameters for the orthorhombic and monoclinic settings, respectively. Each β-CD backbone has been 
substituted by the centroid of the seven glycosidic O(4) atoms to facilitate the calculations. The packing 
parameters have been defined as follows: the SC inner spacing is the distance between P21 related dimers, 
spacing (c) and (a) are the projection of the inner spacing on the c- and a-axes, respectively; Ψ is the angle 
formed between the SC plane and the monoclinic (10-1) plane; ξ is the angle between P21 related dimers, 









The packing of BEGWEQ and KIFPAQ was reported to be of the SC mode, although both 
structures are not isostructural with β-CD dimeric, screw-channel P21 structures.34,43,70 Giastas et al. 
stated that both structures can be considered as pseudo-CB structures if the guest’s symmetry is not 
taken into account.34 In this work, BEGWEQ is considered as an atypical SC P21 structure on the 
grounds of a SC spacing comparable to that found in C2221 structures, and of the largest angular 
difference with the monoclinic (10-1) plane in the P21 pool. BEGWEQ has been nicely described by 
Caira et al. as an “elongated SC structure”.43 All values describing the P21 structure of KIFPAQ 
confirm that it belongs in fact to the higher symmetry space group C2221, where the adamantanone 
guest molecule would be disordered over a two-fold rotation axis. The structure of KIFPAQ can be 
correlated to the recently published DUYVID structure of β-CD∙adamantan inclusion complex 
reported in space group C2221.45  
The screw channel in the structure of β-CD∙paracetamol form V has the geometrical 
constraints of CB C2221 structures but a spacing comparable to SC P21 structures, explaining the 
homogeneous but high RMSD values with P21 and C2221 structures. Hence, β-CD∙paracetamol 
form V structure is neither isostructural with the C2221 nor with P21 structural groups but is best 
described as an intermediate between the two.  
 
Figure 4.11. Comparison between C2221, P21 and β-CD∙paracetamol form V packing types. β-CD dimers 
represented by the volume delimited by the 14 O(4) atoms. The superposition of the dimers shows the 21-
screw relationship. 
 
Several authors relate the packing differences in the dimeric β-CD structures to the shape, 
size and nature of guest molecules.34,36,43,71,72 Giastas et al. attempted to hypothesise an association of 
β-CD packing type with the type of functional group(s) of the guest emerging from the primary 
faces of the barrel. The hypothesis is based on the contact of the functional groups of the guest with 
the interstitial aqueous environment: a hydrophilic or a hydrophobic group favours a CB or a SC 
type packing, respectively. However, it is difficult to generalise the influence of the guest on the 
packing mode in all β-CD inclusion complex structures.34 In the case of β-CD∙paracetamol form V, 
on one hand, although the hydroxy group of paracetamol molecules are on the primary opening of 




the dimer, the SC mode is favoured over a true CB packing. On the other hand, the guest 
stoichiometry is so low that the packing cannot be fully related to the presence of guest molecules. 
This new distinct packing may be associated with a pressure-driven phenomenon of super 
hydration of β-CD molecules, although in the absence of further examples this is only a 
speculation.  
 Structural comparison with form I 4.4.3.
The structure of β-CD∙paracetamol inclusion complex form I was reported by Caira and 
Dodds in 2000.16 The complex is reported to crystallise in the C2 space group and exhibits a 
collinear channel (CH)-type structure (Figure 4.7) in which CD molecules are arranged as dimers. 
The lack of 3D coordinates in the CSD for this structure prompted us to redetermine its structure. 
When compared to form I, the overall water content per β-CD unit in form V almost 
doubles, increasing from a refined value of 12.3 water molecules per β-CD (13.3 measured by 
thermogravimetry)16 for form I at ambient conditions to a value of 24.20 for form V at high-
pressure conditions. In form I, only two water molecules are fully ordered in an extended 
disordered solvent region which is present outside the channels, and only one water molecules is 
disordered over two positions inside the channels. 
At ambient conditions β-CD∙paracetamol crystallises as a 1:1 dimeric complex stacked in 
channels parallel to the c-axis,16 a well-known packing motif for similar C2 structures,35 whereas the 
complex in form V crystallises as an intermediate SC-CB structural motif at high-pressure 
conditions with a stoichiometry well below unity for the guest molecule. The conservation of the 
dimeric arrangement in form I and V was checked using the Crystal Packing Similarities plugin in 
MERCURY: both dimers are similar within an RMSD value of 0.16 Å when β-CD backbone is 
compared, or 0.19 Å when the whole β-CD molecule is compared excluding O(6) hydroxy groups, 
which are disordered. At ambient conditions the guest molecules exhibit disorder occupying two 
positions with equal site occupancy. At high-pressure conditions paracetamol is, as far as the data 
can tell, ordered with site occupancy of 0.3. The inclination of the guest molecule inside the 
macrocycle is consistent in both structures: in form I, the values of the angle formed between the 
glycosidic O(4) ring and the phenyl ring are 70.5 and 72.6° for form I, and 74.7° in form V. However 
the conformation of the guest differs: in form I, the acetamide end of the paracetamol molecule 
forms a relatively small dihedral angle with the plane of the phenyl ring (2.6° and 5°), whereas in 
form V the same angular difference is 58°; this value, although high, is still tolerable in the case of 
form V where the acetamide group is involved in short H-bonds with water molecules inside the 
cavity (Figure 4.12). A CSD search reveals that this angular difference is between the acetamide 
and the phenyl ring is not unusual for paracetamol molecules: with the angle varying between 3 




and 55° in a total of 83 hits with an average of 21° (the CSD, V. 5.36 including updates to May 2015 
was searched for structure with 3-D coordinates).  
 
Figure 4.12. H bonds formed by paracetamol and water molecules inside β-CD cavity. H atoms have been 
omitted for clarity. 
  
 Refinement and modelling of the structure of form V 4.4.4.
4.4.4.1. Structure solution and refinement (early stage) 
Structure solution by isomorphous 
replacement using similar structures reported in the 
C2221 space group and subsequent structure 
refinement was unsuccessful. Space group 
assignment was investigated further. From the 
diffraction frames there was no indication of split 
reflections. Twinning through pseudo-merohedry 
using a smaller non-centered monoclinic P21 unit 
cell was ruled out on the basis of |E² − 1 | values, which were not suspiciously low (Figure 4.13). 
Other statistical indications were also deemed to be normal, e.g. Rint values for different Laue 
groups or the Fcalc vs. Fobs plot during structure refinement. In the end, the structure was solved by 
dual space recycling and fragment seeding in SHELXD26 using the backbone of the structure 
FALDUS28.  
Refinement in the lower symmetry space group (C2), with two β-CD molecules in the 
asymmetric unit was also tested but did not bring an improvement in the model or R-factor and 
Figure 4.13. |E2–1| graph after merging all data 
in SADABS 




the high symmetry space group was therefore favoured. The significantly different crystal packing 
of form V (see section 4.4.2.) clarifies the failure of the isomorphous replacement. 
Due to the high number of parameters and the low number of reflections (Table 4.1), the 
refinement was subject to cross validation by the Rfree, a commonly used cross validation technique 
in protein crystallography.73 10% of the total number of reflections were flagged in XPREP and 
used subsequently and exclusively to compute the value of R1free in SHELXL74. In order to increase 
the robustness of the refinement, stereochemical restrains generated with the GRADE webserver30 
were applied to the host and guest molecules. Structure solution gave an incomplete model of the 
β-CD molecule, which was subsequently completed throughout a few least squares’ cycles of 
refinement and inspection of Fourier maps. The electron density map of the guest molecule was 
not clear during the early stage of the refinement but improved after careful location and treatment 
of several solvent molecules, and suggested an occupancy factor significantly less than 1; the 
nature of the guest molecule was confirmed using Raman spectroscopy. 
4.4.4.2. Validation of the guest molecule by Raman spectroscopy 
Raman spectroscopy permits a very rapid and qualitative analysis of materials, and is very 
sensitive for components which are present at low concentration. A series of Raman spectra were 
collected to probe the presence of the guest molecule, and to evaluate approximately the amount of 
guest on the basis of the relative intensity between the guest and β-CD Raman bands. In order to 
locate the specific bands of β-CD and paracetamol molecules, spectra were collected at ambient 
conditions on crystals of β-CD hydrate,75 paracetamol form I,76 β-CD∙paracetamol form I,16 in 
addition to the large crystal of form V at 0.8 GPa, three further crystals visible in the DAC were 
also investigated by Raman spectroscopy (Figure 4.5). All Raman spectra are presented in Figure 
4.14. 
The Raman spectra of both β-CD hydrate and paracetamol form I are complex due to the 
chemical diversity and different bond types in both compounds. However, singular bands specific 
to paracetamol molecules can be observed in the 1500-1700 cm-1 range, the first four of which are 
assigned to an in plane deformation of the phenyl ring and the last one, at ca. 1648 cm-1, to the 
stretching of the carbonyl bond (Figure 4.14).77 In the same wavenumber region, no Raman bands 
are observed in the spectrum of β-CD hydrate. In the Raman spectrum of β-CD∙paracetamol form I, 
the bands of paracetamol are preserved. The Raman spectrum of β-CD∙paracetamol form V (crystal 
1) shows the same peaks, although much weaker in intensity, confirming the presence of 
paracetamol in the crystal structure of form V. The high frequency region confirms the 
preservation of the aromatic C–H stretching bands attributable to paracetamol at 3066 and 3013 cm-
1 in both forms I and V of the inclusion complex. A comparison of the relative intensity of β-CD and 




paracetamol bands clearly indicates that the paracetamol signal is substantially lower in form V 
than in form I. While effects such as structural changes and orientation of the single crystals 
examined might cause differences in the Raman bands between two forms, the intensity change is 
considerable and can only be explained by the release of paracetamol molecules from inside β-CD 
cavities.  
 
Figure 4.14. Raman spectra of β-CD hydrate, paracetamol form I, β-CD∙paracetamol form I and the three 
crystals obtained at high-pressure in a DAC (see Figure 4.5). Characteristic paracetamol bands are 
highlighted. The Raman spectrum of the small crystal 4 is almost identical to that of crystal 2, hence only one 
spectrum is shown. 
 
To confirm the theory of partial decomplexation observed for form V at high-pressure, and 
to locate the “missing” paracetamol, Raman spectra on crystals 2, 3 and 4 contained in the DAC as 
well as the liquid part were collected. Raman spectrum of the latter presented very strong 
fluorescence and Raman bands were undistinguishable (Figure 4.18). The composition of the 
solution phase therefore remains unknown. Whilst the Raman spectrum of crystal 2 is almost 
identical to that of β-CD∙paracetamol form V (crystal 1), crystal 3 gave a Raman spectrum highly 
similar to that of paracetamol with some differences in peak intensities. Subsequent X-ray 
diffraction on crystal 3 using synchrotron radiation (microfocus beam on station P02.2 at PETRA) 
confirmed that crystal 3 is the orthorhombic form of paracetamol. This is a likely confirmation that 
the stoichiometric (1:1) crystal of β-CD∙paracetamol form I undergoes dissolution upon pressure 
increase in the DAC, and recrystallises at higher pressures to give a partial inclusion complex form 
V, as well as paracetamol.  
 




4.4.4.3. Finalising the refinement  
Once the existence of the guest molecule in the crystal of β-CD∙paracetamol form V was 
confirmed by means of Raman spectroscopy, modelling of paracetamol inside β-CD cavity 
proceeded in a fairly straightforward manner: after attributing ca. 50% of the electron density to 
water molecules inside β-CD cavity, the difference electron density maps of the phenyl ring as well 
as part of the acetamide moiety were visible (Figure 4.15.a). Because of the low site occupancy of 
paracetamol, parts of the electron density maps can also be modelled with water molecules (Figure 
4.15.c). For modelling paracetamol molecule, interatomic distances and angles were subject to 
restraints using target values generated using the GRADE Web server.30 The site-occupancy factor 
of the guest molecule was refined to complement the one of water molecules sharing the same 
position making sure that the sum of both sites did not exceed unity, and it converged to a value of 
ca. 0.3, which was subsequently constrained during the refinement. The atomic displacement 
parameters of paracetamol were refined isotropically and constrained to have equal values.  
 
 
Figure 4.15. Structural model and electron density maps of paracetamol and water molecules generated 
with shelXle. (a) Paracetamol model fitted in the Fobs– Fcalc maps before the refinement (maps at 0.30 e-/Å3); (b) 
Fobs of paracetamol alone after the refinement (maps at 0.80 e-/Å3); (c) Fobs of paracetamol and water molecules 
sharing the same sites (maps at 0.80 e-/Å3). 
 
Although it is clear that form V contains a very large amount of water, some uncertainty is 
associated with reporting an accurate value. In order to corroborate the water content in a crystal 
structure, authors commonly report the use of thermal analysis methods.16,43,59 Such analysis 
requires considerable quantities of sample and are performed at conditions of ambient pressure or 
modest high pressures. Given form V is not recoverable to ambient pressure, such analysis could 




not be carried out. Instead, in addition to the Rfree method, calculation of the average non-hydrogen 
atomic volume was adopted to validate the model.78 The average atomic volume per non-hydrogen 
atom, which is commonly accepted to be 18 Å³ for crystals of organic compounds at ambient 
pressure conditions, was calculated for all C2221 and P21 structures compared in this work. All 
values are summarised in Table 4.7 and give an average value of 18.6 Å³. This value is not very 
sensitive to changes in temperature but is extremely sensitive to pressure, which allows large 
variations in unit-cell volumes, as is detailed in Table 4.8 (see Appendix). Overall, the assignment 
of water molecules was subject to 1) careful inspection of the electron density maps, 2) careful 
assignment/refinement of the site-occupancy factors and displacement parameters, 3) checking the 
stability of the model after applying random shifts of 0.4 Å to the coordinates using the SHELXL 
command WIGL, 4) chemical meaningfulness of the geometries and inspection of intermolecular 
interactions especially H-bonds network formation. 
The structure of β-CD∙paracetamol contains over 24 water molecules per formula unit 
distributed over 47 positions, of which only 9 are fully ordered and fully occupied outside the 
cavity. Using this number, the atomic volume per non-hydrogen atom for form V is 18.75 Å³. This 
value is in our opinion quite large for such a system at 0.8 GPa, and the presence of further highly 
disordered water molecules in regions of low diffuse electron density appears likely.  
 Compression study of form I: 4.4.5.
In order to study a possible pressure-induced transition of form I to the low-temperature 
form transition which proceeds in a single-crystal-to-single-crystal manner at 120 K,17 compression 
experiments on form I were carried out in suitable pressure-transmitting media. Water cannot be 
used here as dissolution takes place when pressure is applied to the system. To overcome this 
problem, we switched to 1) a more hydrophobic and bulky perfluorinated oil (FC43), and 2) 
tetrahydrofuran (THF), in which β-CD is poorly soluble.79  
The structure of form I was used as a starting model for refinement of the compressed 
structures. Redetermination of the crystal structure of form I was carried out in house. To 
overcome the usual problems associated with the low completeness of high-pressure data, the 
number of restraints on both the host and guest molecules were maximised using the GRADE web 
server, and 10% of each data set was flagged to compute R1free. The WIGL command was 
introduced systematically at different stages of the refinement, and electron density maps were 
carefully inspected to investigate any structural changes associated with each of the host, guest and 
solvent molecules. Crystallographic data are summarised in Table 4.4.  
 
 




Table 4.4. Crystallographic data of the compression study of β-CD∙paracetamol form I inclusion complex 
 






















Space group C2 C2 C2 C2 C2 
a/Å 18.9343(8) 18.832(3) 18.497(12) 18.8131(16) 18.6154(16) 
b/Å 24.4136(11) 24.363(3) 24.051(14) 24.321(2) 24.2776(8) 
c/Å 15.5941(7) 15.516(2) 15.189(9) 15.5384(9) 15.340(3) 
α/° 90 90 90 90 90 
β/° 110.798(3) 110.713(5) 110.272(17) 111.088(8) 110.302(16) 
γ/° 90 90 90 90 90 
V/Å3 6738.7(5) 6658.4(16) 6339(7) 6633.5(10) 6501.9(15) 
Z’ 1 1 1 1 1 
Dcalc/g cm-3 1.403 1.424 1.516 1.380 1.373 
Pressureb 0.1 MPa 0.13 GPa 0.95 GPa 0.16 GPa 0.60 GPa 













Parameters 847 842 473 835 409 
Restraints 2365 2337 1315 2321 1231 
Rint 0.0705 0.0493 0.1123 0.0850 0.0622 
dmax/Å 1.0 1.10 1.09 0.90 1.10 
Completeness to 
dmax 
0.896 0.778 0.794 0.663 0.526 
R1e 0.0750 0.0721 0.14 0.941 0.0994 
Rfreee 











wR2g 0.1852 0.1852 0.3243 0.2469 0.2562 
a Redetermination in this work. b These values refer to the pressure at which diffraction data were collected. c Criteria for 
observed reflections: I > 2σ(I). d Criteria for observed reflections: I > 3σ(I). e [F2 > 2σ(F2)].f 10% of unique reflections g (F2). 
  
4.4.5.1. Compression study in FC43 
The principal structural difference between β-CD∙paracetamol form I at ambient conditions 
and at 0.13 GPa is the ordering of one of the primary hydroxy groups: at ambient-pressure 
conditions all hydroxy groups exhibit the preferred (–)-gauche conformation with three of them 
further disordered to the non-favoured (+)-gauche conformation. Of these three gauche 
conformers, one contributes to the stability of a displaced tail-to-tail dimer, a second is H-bonded 
to the hydroxy group of the guest molecule, and the third one has both types of contacts. The  
(–)-gauche conformer of the latter, originally H-bonded to a water molecule at ambient-pressure 
conditions, rotates to the (+)-gauche conformer at 0.13 GPa. In addition to this conformational 
change, a previously unobserved H2O molecule with site-occupancy factor of ¼ appears inside the 
β-CD cavity creating a H-bond with the hydroxy group of paracetamol. The two positions of the 
guest molecule are comparable (50:50 disorder) and do not change significantly (Figure 4.16.a-b) 
between the two pressure points. At 0.9 GPa (Figure 4.16.c), the phenyl ring of one of the guest 
molecules rotates to an almost orthogonal position compared to that of the phenyl ring of the 
second paracetamol molecule: the dihedral angle between the phenyl rings of the two positions, 




calculated by means of the corresponding least-square planes containing all phenyl-C atoms, are 
44, 50 and 81° for ambient pressure, 0.13 and 0.95 GPa structures, respectively. The rotation of the 
ring observed at 0.95 GPa could be related in fact to water ordering inside the channels, which is 
also observed at that pressure. Having gone beyond the hydrostatic limit of the fluid (0.9 GPa 
observed in this work), no further data points were collected. 
 
 
Figure 4.16. Compression study of β-CD∙paracetamol form I in FC43. (a) structure of the complex at room 
temperature; (b) the complex at 0.13 GPa; (c) the complex at 0.95 GPa. The apparent change in the paracetamol 
hydroxyl H-atom at high pressure was not determined experimentally but arises from the riding restraint 
command chosen for refinement (AFIX 83 command in SHELXL), i.e. it may be an artefact. 
 
4.4.5.2. Compression study in THF 
Similarly to what was observed in FC43, compression of β-CD∙paracetamol form I in THF 
generates ordering of the same primary hydroxy group to a (+)-gauche conformer. However in 
THF, we observed an overall deficiency in the electron density maps inside the cavity interpreted 
as a loss of water content (Figure 4.17). At 0.6 GPa the loss of electron density is very marked to the 
extent that half of the guest’s contribution is lost: the paracetamol molecule can only be refined as 
being ordered and showing large isotropic displacement parameters and an overall site occupancy 
factor of 0.5 (Figure 4.17.c). In addition, the structure at 0.6 GPa partially recovers the water loss 
observed at 0.16 GPa, taking up 2.4 water molecules inside the cavity. 
The decrease in water content at 0.16 GPa can be related to the crystal environment: THF 
is water miscible, and the channel structure of β-CD∙paracetamol form I favours the mobility of the 




solvents molecules, thus water molecules might find their way out of the crystal, accounting for the 
loss of electron density. At 0.6 GPa, the loss of guest molecules must be related to a partial 
decomplexation process: THF is known to be a good solvent for paracetamol at ambient pressure 
conditions,80 and it is not unlikely that THF favours to some extent a gradual dissolution of 
paracetamol molecules and their substitution by water molecules. As far as the data can tell, there 
is no evidence for inclusion of THF in the structure of the complex. Further pressure increase to 1 
GPa exacerbates loss of data quality: reflections found to be severely split and resolution dropped 
below 1.4 Å; however, data indexing still indicates the unit-cell parameters of form I. Figure 4.6.e 
shows the resulting crystal form I in THF at 1 GPa. Poor data quality could be associated with an 




Figure 4.17. Compression study of β-CD∙paracetamol form I in THF. (a) structure of the complex at room 
temperature; (b) the complex at 0.16 GPa; (c) the complex at 0.60 GPa. The apparent change in the paracetamol 
hydroxyl H-atom at high pressure was not determined experimentally but arises from the riding restraint 










 Conclusion  4.5.
A new crystal form of β-CD∙paracetamol inclusion complex, form V, has been characterised 
by means of single-crystal X-ray diffraction using synchrotron radiation and Raman spectroscopy. 
Form V crystallises exclusively at high pressure and, unlike similar inclusion complexes, it 
incorporates a very large number of water molecules. Similar dimeric inclusion complexes 
crystallising in the C2221 space group pack in parallel and displaced dimeric arrangements related 
by a 21 screw axis, known as a chessboard packing motif: form V exhibits the same packing mode 
with compressed screw channels and a larger unit cell volume to incorporate the excess of water 
molecules. The packing mode of form V has also been compared to that of P21 β-CD inclusion 
complexes crystallising in the screw channel packing type. The Crystal Packing Similarities plugin 
available in MERCURY has been used to output RMSD differences between C2221 and P21 
structures, which were ascribed to the spacing and arrangement of the screw channels towards the 
equivalent orthorhombic ac and the monoclinic (10-1) planes. The arrangement of the screw 
channels in P21 structures is almost perpendicular to the one in C2221 structures. The analysis 
shows also that form V structure of the title compound is an intermediate structure between both 
C2221 and P21 groups.  
When compressed in water, form I dissolves as function of increasing pressure and 
recrystallises at higher pressures into form V. The dissolution process is an essential step to 
incorporate more water molecules in the crystal structure as expressed by the 274 Å³ increase per 
CD unit, while the dimeric arrangement of β-CD molecules is conserved in both forms confirming 
the robustness of this motif.  
Compression studies of form I using FC43 and THF as pressure transmitting media show 
that in the explored pressure ranges 1) single-crystal-to-single-crystal phase transitions do not 
occur in both systems; 2) water ordering is associated with the nature of the pressure transmitting 
medium as well as pressure: ordering is obtained when using FC43 while THF “draws out” water 
from the structure; and 3) the guest molecule can rotate as well as leave the β-CD cavity.   
This work exemplifies the great structural variability of β-CD∙paracetamol inclusion 
complexes and proves the virtues of the use of high-pressure techniques to explore the solid-state 
behaviour of CD-based inclusion complexes.   
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2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
BOSZUF 0.12 
 
2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
BOTBAO 0.15 0.16 
 
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
DUYVID 0.12 0.04 0.15 
 
2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
FALDUS 0.12 0.10 0.19 0.10 
 
2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
FASXUS 0.13 0.06 0.17 0.05 0.11 
 
2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
GIPFEQ 0.11 0.06 0.19 0.07 0.08 0.08 
 
2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
KEMZIN 0.14 0.06 0.17 0.05 0.11 0.07 0.08 
 
2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
KOFJEU 0.11 0.06 0.18 0.04 0.09 0.07 0.07 0.07 
 
2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
LACTAL 0.11 0.07 0.19 0.06 0.09 0.07 0.05 0.08 0.05 
 
2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
MEGQUK 0.12 0.05 0.15 0.04 0.11 0.06 0.08 0.04 0.06 0.07 
 
2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
WEZSIE 0.12 0.05 0.17 0.04 0.10 0.06 0.06 0.07 0.04 0.05 0.05 
 
2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 
XUXFAY 0.12 0.06 0.15 0.04 0.12 0.07 0.09 0.06 0.06 0.08 0.05 0.05 
 
2 2 1 2 2 2 2 2 2 2 2 2 2 2 
BEGWEQ 0.18 0.22 0.18 0.21 0.23 0.22 0.23 0.23 0.23 0.23 0.21 0.22 0.21 
 
2 1 2 2 2 2 2 2 2 2 2 2 2 
BOTBES 0.15 0.16 0.14 0.15 0.18 0.17 0.18 0.17 0.17 0.18 0.16 0.17 0.15 0.17 
 
1 2 2 2 2 2 2 2 2 2 2 2 
CDETAN 0.25 0.22 0.27 0.22 0.23 0.22 0.23 0.22 0.23 0.23 0.22 0.23 0.22 0.28 0.23 
 
1 1 1 2 1 1 1 1 1 2 1 
DUTLIN10 0.17 0.19 0.10 0.19 0.21 0.20 0.21 0.20 0.21 0.21 0.19 0.21 0.18 0.17 0.10 0.24 
 
2 2 2 2 2 2 2 2 2 2 
FODBIK 0.14 0.12 0.19 0.11 0.14 0.12 0.13 0.13 0.11 0.12 0.12 0.11 0.12 0.21 0.11 0.24 0.17 
 
2 2 2 2 2 2 2 2 2 
GETPAW 0.17 0.18 0.09 0.17 0.20 0.19 0.20 0.18 0.20 0.21 0.17 0.19 0.17 0.18 0.12 0.24 0.08 0.18 
 
2 2 2 2 2 2 2 2 
GETPEA 0.20 0.23 0.12 0.22 0.24 0.24 0.24 0.24 0.25 0.25 0.22 0.24 0.21 0.20 0.13 0.31 0.08 0.21 0.11 
 
2 2 2 2 2 2 2 
KIFPAQ 0.13 0.06 0.17 0.04 0.10 0.06 0.07 0.06 0.05 0.06 0.06 0.05 0.06 0.21 0.17 0.22 0.20 0.12 0.19 0.24 
 
2 2 2 2 2 2 
MACDAW 0.15 0.14 0.22 0.13 0.15 0.13 0.14 0.14 0.13 0.12 0.14 0.13 0.14 0.21 0.14 0.24 0.21 0.06 0.21 0.25 0.13 
 
2 2 2 2 2 
NAJJAK 0.14 0.16 0.15 0.15 0.17 0.16 0.17 0.16 0.16 0.17 0.15 0.16 0.15 0.14 0.14 0.23 0.14 0.15 0.14 0.17 0.15 0.16 
 
2 2 2 2 
OKAQAT 0.15 0.15 0.17 0.14 0.15 0.14 0.15 0.15 0.15 0.15 0.15 0.15 0.13 0.20 0.13 0.25 0.17 0.09 0.17 0.20 0.15 0.13 0.17 
 
2 2 2 
QACXEX 0.16 0.15 0.20 0.14 0.16 0.14 0.15 0.15 0.14 0.15 0.14 0.14 0.14 0.19 0.11 0.23 0.17 0.08 0.18 0.21 0.14 0.07 0.13 0.13 
 
2 2 
XEYDIQ 0.13 0.12 0.09 0.12 0.15 0.13 0.15 0.12 0.14 0.15 0.11 0.13 0.11 0.18 0.09 0.25 0.10 0.12 0.08 0.14 0.13 0.15 0.12 0.13 0.13 
 
2 
YOJHUC 0.17 0.21 0.17 0.21 0.22 0.21 0.21 0.21 0.21 0.21 0.21 0.21 0.21 0.13 0.18 0.28 0.17 0.21 0.16 0.18 0.21 0.19 0.13 0.21 0.18 0.17 
  
 


























































































































































































                                                    
BOSZUF 0.989 
                          BOTBAO 0.994 0.997 
                         DUYVID 0.991 0.998 0.998 
                        FALDUS 0.993 0.998 0.997 0.998 
                       FASXUS 0.992 0.998 0.999 1.000 0.998 
                      GIPFEQ 0.992 0.999 0.998 0.999 0.999 0.999 
                     KEMZIN 0.991 0.999 0.998 1.000 0.998 1.000 0.999 
                    KOFJEU 0.993 0.996 0.997 0.999 0.997 0.998 0.998 0.997 
                   LACTAL 0.994 0.997 0.998 0.999 0.998 0.998 0.999 0.998 1.000 
                  MEGQUK 0.992 0.998 0.999 1.000 0.998 1.000 0.999 1.000 0.998 0.998 
                 WEZSIE 0.990 0.998 0.996 1.000 0.997 0.999 0.999 0.999 0.998 0.998 0.999 
                XUXFAY 0.990 0.999 0.997 1.000 0.997 0.999 0.999 1.000 0.997 0.998 0.999 0.999 
               BEGWEQ 0.972 0.989 0.982 0.988 0.985 0.985 0.987 0.987 0.986 0.985 0.986 0.989 0.989 
              BOTBES 0.980 0.992 0.987 0.991 0.988 0.989 0.990 0.991 0.989 0.988 0.990 0.992 0.992 0.996 
             CDETAN 0.986 0.993 0.991 0.995 0.992 0.994 0.994 0.994 0.995 0.994 0.995 0.996 0.996 0.991 0.994 
            DUTLIN10 0.988 0.994 0.993 0.995 0.992 0.995 0.993 0.995 0.993 0.993 0.995 0.996 0.996 0.991 0.996 0.998 
           FODBIK 0.983 0.991 0.987 0.993 0.989 0.991 0.991 0.992 0.993 0.992 0.992 0.994 0.993 0.993 0.996 0.999 0.997 
          GETPAW 0.991 0.992 0.994 0.995 0.992 0.995 0.993 0.995 0.995 0.994 0.996 0.995 0.994 0.985 0.991 0.996 0.998 0.995 
         GETPEA 0.987 0.995 0.993 0.995 0.992 0.994 0.994 0.995 0.993 0.993 0.995 0.996 0.996 0.992 0.997 0.997 1.000 0.996 0.997 
        KIFPAQ 0.990 0.998 0.996 1.000 0.997 0.999 0.999 0.999 0.999 0.999 0.999 1.000 0.999 0.989 0.991 0.996 0.995 0.994 0.995 0.995 
       MACDAW 0.978 0.988 0.984 0.990 0.986 0.988 0.988 0.989 0.990 0.989 0.989 0.992 0.991 0.995 0.996 0.997 0.995 0.999 0.992 0.995 0.992 
      NAJJAK 0.987 0.991 0.990 0.995 0.990 0.993 0.992 0.994 0.995 0.993 0.994 0.995 0.994 0.991 0.994 0.999 0.998 0.999 0.998 0.997 0.995 0.997 
     OKAQAT 0.980 0.991 0.986 0.991 0.988 0.989 0.990 0.991 0.990 0.989 0.990 0.992 0.992 0.996 0.999 0.996 0.996 0.998 0.992 0.997 0.992 0.998 0.996 
    QACXEX 0.977 0.989 0.984 0.990 0.986 0.988 0.988 0.990 0.988 0.987 0.989 0.991 0.991 0.997 0.999 0.995 0.996 0.997 0.991 0.996 0.991 0.998 0.996 1.000 
   XEYDIQ 0.989 0.992 0.992 0.995 0.991 0.995 0.993 0.995 0.995 0.994 0.995 0.996 0.995 0.988 0.994 0.998 0.999 0.998 0.999 0.998 0.996 0.995 0.999 0.995 0.994 
  YOJHUC 0.984 0.989 0.987 0.991 0.988 0.990 0.989 0.990 0.991 0.990 0.991 0.992 0.991 0.990 0.993 0.996 0.997 0.997 0.996 0.996 0.992 0.996 0.998 0.995 0.995 0.997 
  
  




Figure 4.18. Raman spectrum of the solution surrounding the crystal of β-CD∙paracetamol form V. 





















This work 8(1) C42 H70 O34 0.3 (C8 H9 N O2) 3.3 24.15 104.45 15669.452 1958.68 18.75 
BOSZUF 8(1) C42 H70 O34 C10 H8 N2 12 13.50 102.50 14937.358 1867.17 18.22 
BOTBAO 8(1) C42 H70 O34 C12 H10 N2 14 10.50 101.50 15119.059 1889.88 18.62 
DUYVID 8(1) C42 H70 O34 1.5(C10 H16) 15 10.10 102.10 15032.646 1879.08 18.40 
FALDUS 8(1) C42 H70 O34 C6 H14 O2 8 9.00 94.00 15428.193 1928.52 20.52 
FASXUS 8(1) C42 H70 O34 C11 H18 O 12 11.00 100.00 14969.107 1871.14 18.71 
GIPFEQ 8(1) C42 H70 O34 C3 H12 Cl2 N P Pt 8 5.50 90.50 15209.367 1901.17 21.01 
KEMZIN 8(1) C42 H70 O34 C10 H16 10 10.00 97.00 14930.602 1866.33 19.24 
KOFJEU 8(1) C42 H70 O34 C11 H16 O 12 10.00 99.00 15362.281 1920.29 19.40 
LACTAL 8(1) C42 H70 O34 C14 H16 N2 16 8.00 101.00 15401.574 1925.20 19.06 
MEGQUK 8(1) C42 H70 O34 C10 H14 N2 O 13 10.50 100.50 14979.156 1872.39 18.63 
WEZSIE 8(1) C42 H70 O34 0.5(C14 H12 O3 S) 9 10.00 96.00 14959.292 1869.91 19.48 
XUXFAY 8(1) C42 H70 O34 C11 H16 O S2 14 12.50 103.50 14936.908 1867.11 18.04 
BOTBES 4(2) C42 H70 O34 C12 H10 N2, 0.25(C H4 O) 14.5 11.25 102.75 7278.91 1819.73 17.71 
BEGWEQ 4(2) C42 H70 O34 0.5(C19 H20 F N O3) 12 14.00 103.00 7278.73 1819.68 17.67 
CDETAN 4(2) C42 H70 O34 C8 H11 N 9 16.00 102.00 7524.36 1881.09 18.44 
DUTLIN10 4(2) C42 H70 O34 C15 H14 O3 18 12.50 107.50 7398.60 1849.65 17.21 
FODBIK 4(2) C42 H70 O34 C12 H11 N3 15 10.75 102.75 7523.32 1880.83 18.30 
KIFPAQ 4(2) C42 H70 O34 C10 H14 O 11 7.25 95.25 7534.92 1883.73 19.78 
MACDAW 4(2) C42 H70 O34 C12 H12 N2 14 12.35 103.35 7473.72 1868.43 18.08 
NAJJAK 4(2) C42 H70 O34 1.5(C8 H6 S2) 15 10.50 102.50 7533.40 1883.35 18.37 
OKAQAT 4(2) C42 H70 O34 C15 H11 N 16 9.13 102.13 7375.00 1843.75 18.05 
QACXEX 4(2) C42 H70 O34 C12 H10 N2 O2 16 12.75 105.75 7282.49 1820.62 17.22 
XEYDIQ 4(2) C42 H70 O34 C10 H20 O 11 13.50 101.50 7486.55 1871.64 18.44 
YOJHUC 4(2) C42 H70 O34 C12 H12 N2 S2 16 11.75 104.75 7369.57 1842.39 17.59 
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Table 4.8. Effect of Pressure and temperature on the average atomic volume  





HXACAN09 1.00 RT 711.734 4 11 16.18 
HXACAN10 2.00 RT 672.012 4 11 15.27 
HXACAN11 3.00 RT 651.428 4 11 14.81 
HXACAN12 4.00 RT 621.881 4 11 14.13 
Piracetam82 
BISMEV06 0.45 RT 334.013 2 10 16.70 
BISMEV07 0.70 RT 325.534 2 10 16.28 
BISMEV08 0.90 RT 314.262 2 10 15.71 
BISMEV09 2.50 RT 292.826 2 10 14.64 
BISMEV10 4.00 RT 280.206 2 10 14.01 
Ruberene83 
/ AP RT 697.9 1 42 16.62 
/ 0.15 RT 687.2 1 42 16.36 
/ 1.21 RT 633 1 42 15.07 
/ 2.42 RT 598.4 1 42 14.25 
/ 3.58 RT 577.6 1 42 13.75 
/ 4.65 RT 559 1 42 13.31 
/ 5.91 RT 542.8 1 42 12.92 
/ 7.12 RT 1040.3 2 42 12.38 
N-Acetyl-L-
hydroxyproline84 
POKKAD05 AP 9 924.5 4 13 17.78 
POKKAD06 AP 30 924.7 4 13 17.78 
POKKAD07 AP 50 926.2 4 13 17.81 
POKKAD08 AP 75 928.7 4 13 17.86 
POKKAD09 AP 100 931.06 4 13 17.91 
POKKAD10 AP 150 936.55 4 13 18.01 
POKKAD11 AP 200 941.99 4 13 18.12 
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Chapter 5. Screening of inclusion complex formation at ambient- and high-
pressure conditions  
 Synopsis  5.1.
This chapter summarises the majority of the experiments conducted to explore inclusion 
complex formation at ambient- and high-pressure conditions, using α-, β- and hydroxypropyl-β-
cyclodextrins together with several organic molecules. The original idea was to induce complex 
formation by applying pressure; however our experiments have quickly shown that water 
solubility of cyclodextrins increases drastically as function of pressure, thus a “reverse” 
mechanism, where guest molecules crystallise out of CD cavities at high pressure, takes place. A 
new route for inclusion complex formation in solution at high pressure that exploits the observed 
increased solubility trend of CD is described herein.  
 Introduction 5.2.
High-pressure crystallisation techniques proved to be a powerful means of investigating 
drug polymorphism in binary (solute/solvent) systems.1–5 Our high-pressure studies on the tertiary 
β-CD∙paracetamol∙water system (see Chapter 4) give reason to assume that by applying pressure, 
water molecules partially drive the guest molecules out of the cyclodextrins cavities, giving a 
guest-deficient complex and crystals of the guest molecules alone. In order to further support and 
investigate this theory, more experiments were conducted using different organic molecules. The 
scope of these studies was to first explore inclusion complex formation at ambient conditions, and 
then, if complex formation was successful, explore the solid-state behaviour of the complex at high 
pressure. The second aim was to use high-pressure techniques directly to investigate inclusion 
complex formation from supersaturated solutions by in situ crystallisation. The screening was 
carried out using α-, β- and hydroxypropyl-β-cyclodextrin. The latter is a derivative of β-
cyclodextrin. Inclusion complex formation was investigated on the following compounds:  
 aspartame, an artificial dipeptide sweetener serendipitously discovered in 1965 and used 
worldwide as artificial sweetener to control conditions, such as obesity, caused by glucose;6  
 gabapentin, an analogue of γ-aminobutyric acid, used as an anticonvulsant and analgesic 
drug;7  
 L-dopa, a pre-neurotransmitter used for treating Parkinson’s disease;8  
 piracetam, a nootropic drug used as cognitive enhancer;9  
 5-fluorouracil (5FU), an anti-cancer drug;10  
 L-ascorbic acid, commonly known as vitamin C, an antioxidant agent;11  
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 ampicillin and amoxicillin, broad bacterial antibiotics of the penicillin’s family;12  
 and finally 6-aminopenicillanic acid (6-APA), a natural compound constituting the core of 
penicillins and used in their semisynthesis.13 
  
 
Figure 5.1. Chemical diagrams of the investigated compounds. 
 
 Experimental  5.3.
 Material 5.3.1.
All compounds were purchased from Sigma-Aldrich and used as supplied without further 
treatment. Approximate water solubility values are listed in Table 5.1. 
Table 5.1. List of the studied compounds and their water solubility values. 
Compound Solubility in water (g/L) 
Temperature 
(°C) 
α-CD 14514 RT 
β-CD 18.514 RT 
hp-β-CD 230015 24 
6-APA 2.4616 20 
Amoxicillin 3.43017 not specified 
Ampicillin 10.117 21 
Aspartame 10.518 25 
Carbamazepine 0.017717 not specified 
5FU 11.117 22 
Gabapentin 4.4917 not specified 
L-ascorbic acid 40017 40 
L-dopa 517 20 
Piracetam 7219 25 
Succinic acid 83.217 25 
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 Crystallisation at ambient conditions 5.3.2.
A screening of inclusion complex formation was carried out using α-, β- and 
hydroxypropyl-β-CDs. Approximately equimolar aqueous solutions of each CD with a drug 
molecule were prepared with a slight excess of the drug molecule to allow maximisation of the 
number of filled CD-cavities in case of complex formation. All experiments are listed in Table 5.2. 
Additionally, reference vials of aqueous solutions of CD and drug molecules as single components 
were prepared to compare microscopically the outcome of the co-crystallisation experiments. After 
dissolving both compounds in demineralised water, the solutions were heated up to 353 K to 
dissolve any remaining solid. The inclusion complex formation was investigated using the slow 
evaporation method at room temperature and crystallisation was monitored using polarised 
optical microscopy.  
 
Table 5.2. Summary of the experimental inclusion complex screening at ambient-pressure condition.   
 in α-CD∙water in β-CD∙water in hp-β-CD∙water 
Carbamazepine 
Carbamazepine is poorly soluble; fast 
evaporation leads to the precipitation 
of amorphous material 
Carbamazepine is poorly soluble – 
heating induces the complete 
dissolution, fast crystallisation 
observed after the heat source is off 
Carbamazepine is poorly soluble – 
heating induces the complete 
dissolution, fast crystallisation 
observed after the heat source is off 
Aspartame 
Aspartame forms aggregates and does 
not completely dissolve 
Aspartame forms aggregates – heating 
induces dissolution;  crystallisation 
observed on cooling 
Aspartame forms aggregates and does 
not completely dissolve 
5FU Solubility of 5FU increases markedly 
and crystallisation of large crystals is 
observed 
Solubility of 5FU increases markedly 
and crystallisation of large crystals is 
observed 
This combination has not been 
investigated 
6-APA α-CD does not improve 6-APA water 
solubility, and does not prevent its 
degradation – No evidence of 
crystallisation 
β-CD does not improve 6-APA water 
solubility, and does not prevent its 
degradation – No evidence of 
crystallisation 
Hp-β-CD does not improve 6-APA 
water solubility, and does not prevent 
its degradation – No evidence of 
crystallisation 
Amoxicillin α-CD does not improve amoxicillin 
water solubility, and does not prevent 
its degradation – No evidence of 
crystallisation 
β-CD does not improve amoxicillin 
water solubility, and does not prevent 
its degradation – No evidence of 
crystallisation 
Hp-β-CD does not improve amoxicillin 
water solubility, and does not prevent 
its degradation – No evidence of 
crystallisation 
Ampicillin 
This combination has not been 
investigated 
This combination has not been 
investigated 
Hp-β-CD improves slightly the water 
solubility of ampicillin however 
ampicillin remains unstable 
Gabapentin Complete dissolution and 
crystallisation after slow evaporation 
Complete dissolution and 
crystallisation after slow evaporation 
No evidence of crystallisation 
L-dopa 
This combination has not been 
investigated 
Complete dissolution and 
crystallisation of two populations 
observed after slow evaporation – L-
dopa is unstable and the solutions 
deteriorates 
This combination has not been 
investigated 
Piracetam This combination has not been 
investigated 
Complete dissolution and 
crystallisation after slow evaporation 
This combination has not been 
investigated 
Succinic acid 
See Chapter 3 
Complete dissolution and 
crystallisation after slow evaporation 
This combination has not been 
investigated 
L-ascorbic acid Complete dissolution and glass 
formation after slow evaporation 
Complete dissolution and 
crystallisation after slow evaporation 
No evidence of crystallisation 
 
 Crystallisation in a DAC 5.3.3.
For the high-pressure experiments, different types of DAC were used: a beryllium-free 
modified Merrill-Bassett DAC,20,21 a beryllium-free DAC of the Ahsbahs type,22 a rectangular-
shaped DAC and a round-shaped DAC both equipped with Beryllium backing plates. All DACs 
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are equipped with 600 μm culet diamonds. In all high-pressure experiments, 718 Inconel gaskets 
with a starting diameter hole in the range of 280–380 μm were used. The pressure inside the 
sample chamber was measured according to the ruby fluorescence method23 using an in-house 
built kit that has a precision of 0.05 GPa.  
Initially, two approaches were adapted to explore inclusion complex formation in a DAC. 
The first one consisted of using a hot equimolar solution of guest and host compounds. Such a 
solution is supersaturated with respect to one of the solutes, as the water solubility of the host and 
guest compounds are different. The second approach is related to the preliminary screening at 
ambient conditions: if a 1:1 inclusion complex forms at ambient-pressure conditions, then loading 
small crystals of the complex into the DAC and subsequently dissolving them in situ is more 
convenient than loading a hot solution, ensuring a larger quantity of the solute is loaded in the 
DAC. Water as pressure transmitting medium enables an exploration range from atmospheric up 
to ca. 1.5 GPa. All explored CD-drug combinations are given below and summarised in Table 5.3. 
 
Table 5.3. Summary of the experimental inclusion complex screening at high-pressure condition.   
 in α-CD∙water in β-CD∙water 
5FU Single crystals obtained in situ by 
temperature and pressure cycling 
Single crystals obtained in situ by 
temperature and pressure cycling 
Amoxicillin This combination has not been 
investigated 
Increased dissolution of amoxicillin 
observed as a function of increasing 
pressure. No crystallisation observed 
once a clear solution is formed. 
Succinic acid No crystallisation observed. See 
Chapter 3 for details 
Single crystals obtained in situ by 
temperature and pressure cycling 
L-ascorbic acid This combination has not been 
investigated 




 α-CD∙5FU  5.3.3.1.
A rectangular-shaped beryllium-DAC was loaded with a hot equimolar solution of α-CD 
and 5FU. Small single crystals crystallised after closing the DAC at 0.24 GPa (Figure 5.2.a). Heating 
the DAC using a heatgun at 343 K led to dissolution at the same pressure conditions (Figure 5.2.b). 
Cooling of the DAC to room temperature promoted the recrystallisation of the material and was 
associated with a drop in the pressure to 0.19 GPa. Increasing the pressure gradually up to 0.84 
GPa did not induce further crystallisation or dissolution events (Figure 5.2.c-g). The single crystal 
in Figure 5.2.g was measured by means of single crystal X-ray diffraction using synchrotron 
radiation (PETRA synchrotron, Hamburg, beamline P02.2). When pressure was released to 
ambient, the crystal partially dissolved (Figure 5.2.h). 




Figure 5.2. Crystallisation attempt of a hot aqueous solution of α-CD∙5FU in a DAC. a) DAC loaded with 
hot and saturated solution of α-CD and 5FU; b) complete dissolution of the crystals at ca. 343 K and ca. 0.24 
GPa; c) a single crystal crystallised after complete cooling of the DAC at 0.19 GPa; d-g) single crystal stable 
after gradual pressure increase of 0.36, 0.45, 0.59, 0.84 GPa, respectively; h) single crystal partially dissolved 
after releasing pressure to ambient.   
 β-CD∙5FU 5.3.3.2.
A round-shaped beryllium-DAC was loaded with a hot equimolar solution of β-CD and 
5FU. Sealing the DAC promoted instantaneous crystallisation (Figure 5.3.a). Increasing the 
pressure inside the DAC to 0.32 (Figure 5.3.b) then 0.43 GPa (Figure 5.3.c-f) induced complete 
dissolution of the crystals. Recrystallisation was not observed at the same pressure. Increasing 
pressure to 0.57 GPa did not promote crystallisation. However, after increasing pressure to 0.78 
GPa, slow crystallisation of a single crystal occurred (Figure 5.3.g). Single-crystal X-ray diffraction 
was carried out on the same crystal using synchrotron radiation (PETRA synchrotron, Hamburg, 
beamline P02.2). 
 
Figure 5.3. Crystallisation attempt of a hot aqueous solution of β-CD∙5FU in a DAC. a) Crystallisation of the 
hot equimolar solution of β-CD and 5FU at 0.11 GPa; b) dissolution of the crystals after pressure increase to 
0.32 GPa; c-f) dissolution is complete after a further pressure increase to 0.43 GPa; g) a single crystal is 
obtained after 12 h at 0.78 GPa. 
 
 β-CD∙L-ascorbic acid 5.3.3.3.
A beryllium-free modified Merrill-Bassett DAC was loaded with a hot solution of an 
equimolar β-CD and L-ascorbic acid (Figure 5.4.a). After sealing the DAC to a pressure of 0.4 GPa, 
crystallisation was not observed (Figure 5.4.b). 12 h of cooling to 283 K (Figure 5.4.c), or 
crystallising ice above 1.5 GPa (Figure 5.4.d) and cycling pressure between 1.13 and 0.52 GPa did 
not promote and crystallisation event (Figure 5.4.e-g).  




Figure 5.4. High-pressure crystallisation attempt of an equimolar solution of β-CD and L-ascorbic acid.  
a) DAC at 0.4 GPa with hot aqueous solution of β-CD and L-ascorbic acid; b) no change after 24 h at the same 
conditions; c) no change after cooling to 283 for 12 h; d) ice VI formed after pressure increase above 1.6 GPa; e) 
final stage of ice after slow growth, P = 1.13 GPa; f) ice melted by releasing pressure, P = 0.77 GPa; g) no 
crystallisation after 12 h at 288 K and 0.52 GPa. 
 β-CD∙succinic acid 5.3.3.4.
A beryllium-free DAC of the Ahsbahs type was loaded with the known β-CD∙SA 
complex.24 Sealing the DAC and increasing pressure to 0.54 GPa induced a slow dissolution of the 
complex (Figure 5.5.a-b). A further increase of the pressure inside the DAC to 0.88 GPa provoked a 
rapid and complete dissolution (Figure 5.5.c-e). Crystallisation occurred after a second pressure 
increase to 1.0 GPa (Figure 5.5.f-g). The crystals were too small for X-ray diffraction experiments 
using a laboratory source and were not analysed further. 
 
Figure 5.5. Recrystallisation attempts of β-CD∙SA complex at high pressure. a) DAC loaded with a crystal of 
β-CD∙SA and sealed at 0.2 GPa; b) dissolution of the complex after pressure increase to 0.54 GPa; c-e) 
dissolution enhanced after further pressure increase to 0.88 GPa, pictures captured at 2 min interval; f) no 
recrystallisation at 0.88 GPa after 3 hours, recrystallisation (top right) after pressure increase to 1.0 GPa; g) 
maximum growth of the single crystals after a few hours at the same pressure.  
 β-CD∙amoxicillin 5.3.3.5.
Crystallising a hot equimolar solution of β-CD and amoxicillin in a DAC was unsuccessful 
and has been related to the low solubility of amoxicillin. The pressure range of the experiment was 
between 0.3 – 0.88 GPa pressure with 12 h cooling at 283 K.  
A further qualitative experiment was also carried out: two single crystals of β-CD (Figure 
5.6.a right) were loaded together with a single crystal of amoxicillin (Figure 5.6.a left) trihydrate 
into a DAC. Sealing the DAC and increasing pressure induces the dissolution of β-CD crystals 
(Figure 5.6.b-g). Interestingly, in the same pressure range we observed a slow dissolution of 
amoxicillin, presumably due to complex formation in solution. The dissolution of amoxicillin 
increases as function of pressure (Figure 5.6.g-j). Cycling pressure and temperature did not lead to 
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any crystallisation apart from that of ice VI. Releasing pressure to ambient and opening the DAC 
led to the formation of an amorphous solid. 
 
Figure 5.6. Exploring the behaviour of single crystals of amoxicillin and β-CD at high-pressure. a) a DAC 
loaded with single crystals of amoxicillin (left) and β-CD (right); b) dissolution of β-CD after sealing the DAC, 
P = 0.23 GPa; c) slow dissolution of β-CD crystal at the same pressure; d-g) Faster dissolution of β-CD crystal 
after pressure increase to 0.65 GPa and slow dissolution of amoxicillin crystal; g-j) faster dissolution of 
amoxicillin crystal after further increase in P to 0.98 GPa; k) crystallisation of ice at after cooling to 277 K for 12 
h; l) clear solution at 1.06 GPa and ambient-temperature conditions. 
 
A subsequent experiment to test the water solubility of amoxicillin as function of pressure 
was carried out. Dissolution of amoxicillin trihydrate crystal did not occur in the atmospheric – 1.5 
GPa pressure range as evidenced in Figure 5.7, confirming that the increased solubility observed in 
the previous experiment was due to interaction of the drug with CD at high pressure. 
 
Figure 5.7. Investigating the dissolution at high pressure of amoxicillin in water. a) Single crystals of 
amoxicillin trihydrate in water at 0.34 GPa; b) ice surrounding the same crystals after gradual pressure 
increase to 1.5 GPa; c) no dissolution of the crystals by pressure release; d) DAC open, atmospheric pressure. 
 
 High-pressure experiment using a stationary gas compressor 5.3.4.
Following the qualitative observation made on the β-CD∙amoxicillin∙water system in a 
DAC, a larger-scale crystallisation experiment was carried out using a stationary gas compressor. 
The aim of the experiment was to repeat the experiment performed with the DAC under more 
controlled conditions and to investigate other crystallisation routes. 
The stationary gas compressor enables compressions up to 0.7 GPa with an accuracy of ca. 
2%. Compression is carried out in two stages and the experiment can be simplified as follows: 1) 
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the system is filled in with a continuous flow of a gas from a cylinder; 2) the gas is pre-compressed 
in a compressor to at least 0.03 GPa; 3) the pre-compressed gas is introduced to the intensifier and 
is compressed further to a desired value below 0.7 GPa; 4) the compressed air is introduced 
gradually to the pressure cell. 
Nitrogen gas was used as pressure transmitting medium. The pressure cell was loaded 
with 7.2 mg of amoxicillin (MM = 365.4 g/mol), 22.5 mg of β-CD (MM = 1135 g/mol) and 1 ml of 
demineralised water (Figure 5.8.a). The cell was subsequently connected to the high-pressure 
system and checked for leakage. The pressure cell was then immersed in a water bath and 
preheated to 313 K. The experiment was undertaken at the same constant temperature at which 
nitrogen hydrate does not form at pressures up to 0.5 GPa, as calculated using CSMGem 
program.25 After 2.5 hours at a constant pressure of 0.5 GPa, the pressure was released gradually 
and the sample was checked under a polarised optical microscope (Figure 5.8.b). The solution was 
filtered and the filtrate was place at 277 K for several days (Figure 5.9). 
 
Figure 5.8. β-CD and amoxicillin solution (a) before and (b) after applying 0.5 GPa pressure.  
 
 
Figure 5.9. Slow evaporation of the filtrate of β-CD∙amoxicillin solution. a) Clear filtrate of β-CD∙amoxicillin 
solution as seen in Figure 5.8.b; b) crystallisation of needle-like crystals after 4 day of slow evaporation at 277 
K; c) a second population of crystals is observed after complete evaporation of the solvent. 
 
 X-ray diffraction 5.3.5.
Single-crystal X-ray diffraction studies on the outcome of the crystallisation at ambient-
pressure conditions were carried out on either 1) a Bruker SMART 6000 Apex II CCD 
diffractometer, equipped with Cu Kα rotating anode radiation of λ = 1.54178 Å, or 2) a Bruker AXS 
SMART Apex II CCD diffractometer equipped with Mo Kα sealed-tube radiation of λ = 0.71073 Å. 
Both diffractometers are equipped with an Oxford Cryosystems Cobra low-temperature device. 
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The diffraction experiments are summarised in Table 5.4. High-pressure data were collected partly 
on the same Bruker AXS SMART Apex II CCD diffractometer, or using synchrotron radiation at 
the extreme conditions beamline P02.2 of the PETRA synchrotron ring at DESY (Hamburg, 
Germany), using a microfocused beam of λ = 0.28962 Å, and a large Perkin Elmer XRD 1621 
detector.  
 Results and discussion 5.4.
A screening of inclusion complex formation using α-, β- and hp-β-CD has been carried out 
at ambient- and high-pressure crystallisation conditions. The primary aim of the study was to 
investigate the solid-state behaviour of CD∙drug∙water system at high pressure, which has been 
previously, to the best of our knowledge, unexplored, and secondly to qualitatively monitor 
improvements in water solubility26,27 of the studied drug compounds.  
 Ambient pressure  5.4.1.
A polarised optical microscopy comparison on the crystallisation rates of pure α-, β- and 
hp-β-CDs has been carried out revealing the following26,27: β-CD crystallises from an 
undersaturated solution within hours and from a supersaturated solution within minutes. α-CD 
crystallises within days after very slow evaporation; a faster evaporation rate promotes glass 
formation; the crystallisation could be accelerated by cooling the solution to 277 K, however, in the 
case of an undersaturated solution the single crystals rapidly dissolve when temperature reaches 
ambient. Slow evaporation of hp-β-CD always yields an amorphous solid. The crystallisation rates 
of α-, β- and hp-β-CDs are inversely proportional to their solubility values (Table 5.1). All the 
results and observations of the ambient pressure investigations of inclusion complexes formation 
are summarised in Table 5.4. 
Table 5.4. Summary of the single-crystal X-ray diffraction results on the inclusion complex screening 
investigated at ambient-pressure conditions.   
 in α-CD∙water in β-CD∙water in hp-β-CD∙water 
Carbamazepine / recrystallisation of carbamazepine 
as a dihydrate (as in refcode 
FEFNOT02)28 
recrystallisation of carbamazepine 
as a dihydrate (as in refcode 
FEFNOT02)28 
Aspartame / recrystallisation of β-CD hydrate  / 
5-fluorouracil 5FU recrystallises in the triclinic 
form (as in refcode FURACL)29 
suspected formation of β-CD∙5-
fluorouracil inclusion complex 
/ 
6-APA / / / 
Amoxicillin / / / 
Ampicillin / / / 
Gabapentin recrystallisation of α-CD hydrate  recrystallisation of β-CD hydrate  / 
L-dopa / L-dopa recrystallises in the 
monoclinic form (as in 
LDOPAS03)30 
/ 
Piracetam / recrystallisation of β-CD hydrate  / 
Succinic acid New inclusion complex 
(See Chapter 3) 
recrystallisation of the known β-
CD∙SA form 
/ 
L-ascorbic acid / Suspected formation of β-CD∙L-
ascorbic acid inclusion complex 
/ 
Chapter 5. Screening of inclusion complex formation at ambient- and high-pressure conditions 90 
 
 
6-APA, amoxicillin and ampicillin belong to the penicillin’s family of antibiotics. It is well 
known that penicillins are unstable in aqueous solution. This effect was already known to their 
discoverer, Alexander Fleming.31 Water, acting as a nucleophile, attacks the strained β-lactam ring 
and opens it. This effect is exacerbated when heating is applied.32 We observed in our experiments 
that the clear transparent solution of α-, β- and hp-β-CDs with penicillins turn first yellow and 
ultimately to dark orange after a few days. The change in colour can be explained by the 
degradation of the penicillins. The same behaviour was noticed for L-dopa: the CD-based solutions 
of L-dopa turned from clear transparent to light then dark brown, as function of time. The 
degradation of L-dopa in aqueous solution is known.33 Studies reported in the literature indicate 
that in solution amoxicillin forms 1:1 complexes with β- and γ- cyclodextrin, whereas no complex is 
formed with α-CD. When complexed with β-CD and at conditions of pH 1.2 and 37°C, the 
degradation rate of the drug is slower.34 
The solubility of carbamazepine has been reported to increase in the presence of β-CD.35 
The formation of a 1:1 complex in the solid state has also been reported but such a complex has not 
been structurally characterised.36 We observed that on cooling an equimolar solution heated to 353 
K, carbamazepine recrystallises faster than CD. Single crystals of the recrystallisation outcome with 
β- and hp-β-CD were tested and gave similar unit cell constants to those of carbamazepine∙2(H2O), 
CSD refcode FEFNOT02.28 Aspartame has been reported to form inclusion complex in solution with 
different CDs and preferentially with β-CD derivatives.37 Aspartame in CD-based solutions formed 
aggregates; following heating and cooling cycles, only recrystallisation of the known form of β-CD 
hydrate was detected.  
The observed increased solubility of 5FU in presence of α-CD was firstly thought to be 
associated with inclusion complex formation, although this observation has not been checked 
experimentally using analytical techniques. Slow evaporation of a clear equimolar aqueous 
solution yields the crystallisation of bulky crystals of 5FU in the triclinic form29 whilst α-CD 
remains in solution. Water solubility of 5FU increased in β-CD solution as well and 
recrystallisation occurred after slow evaporation. X-ray diffraction on the resulting single crystals 
of β-CD∙5FU at 100 K indicated that the unit-cell parameters are those of the known monoclinic P21 
form38 of β-CD hydrate. 5FU is a small molecule that could potentially fit in β-CD cavities. 
Structure solution and refinement show considerable electron density within the β-CD core, which 
could translate to the presence of at least one highly disordered 5FU molecule distributed over at 
least three positions. Although fully restrained 5FU models were used, it was not possible to refine 
the model satisfactorily. In order to prove the presence of 5FU inside β-CD cavity, β-CD hydrate 
structures containing a variable amount of water (CSD refcodes BCDEXD03, BCDEXD04, 
BCDEXD05 and BCDEXD10)38,39 were taken as models for refinement. While water molecules fit 
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partly the electron density inside the cavity, substantial residual density is still present and the 
structure needs further modelling. 5FU has been previously reported to form an inclusion 
compound with carboxymethyl-β-CD;40 Collection of better quality X-ray diffraction data may be 
helpful and complementary techniques, such as Raman spectroscopy, should also be considered to 
confirm the existence of 5FU molecules in the crystal structure.  
Data collected on single crystals resulting from the solutions containing β-CD together 
with piracetam and gabapentin gave unit-cell parameters corresponding to the monoclinic P21 β-
CD hydrate.38 Refinements based on this structure give very good R-factors (5.68 % and 5.25%, 
respectively) and no suspicious residual electron density. Hence, it can be concluded β-CD does 
not form inclusion complex with either piracetam or gabapentin under the tested ambient-pressure 
conditions. Complex formation of β-CD with gabapentin in solution has been previously 
reported.41 
In the case of the crystals resulting from β-CD∙L-ascorbic acid mixtures, refinement of the 
β-CD hydrate model was not satisfactory. The difference Fourier maps reveals high unassigned 
electron density peaks inside β-CD cavity; assigning further water molecules to these peaks did not 
solve the problem as additional peaks appear; it is not unlikely that L-ascorbic acid is extensively 
disordered inside β-CD cavity. A Raman spectroscopy study should be carried out in order to 
confirm inclusion complex formation. However, L-ascorbic acid has been previously reported to 
form inclusion complexes in solution at ambient42 and high hydrostatic pressure of 0.3 GPa.43 
 



















Space group P-1 P212121 P21/c P21 P21 P21 P21 P21/c 
a/Å 8.832(5) 9.5250(3) 10.2773 15.01 14.9071(19) 15.1421(5) 14.9727(8) 10.01(5) 
b/Å 9.276(5) 14.8680(5) 28.9900 10.23 10.1255(13) 10.2078(4) 10.1815(6) 28.21(13) 
c/Å 12.724(6) 34.0068(11) 4.9800 20.83 20.848(3) 20.9376(7) 21.2696(14) 4.85(2) 
α/° 81.375(8) 90 90 90 90 90 90 90 
β/° 80.668(9) 90 103.9888 108.99 108.949(5) 110.876(2) 112.316(2) 103.99(3) 
γ/° 89.248(13) 90 90 90 90 90 90 90 
V/Å3 1017 4815.96 1439.727 3025 2976.3 3023.82 2999.59 1331.147 
Z’ 4 1 1 1 1 1 1 1 
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 High pressure  5.4.2.
The pressure range explored in the high-pressure screening varies from atmospheric to ca. 
1.2 GPa, the upper limit being limited by the use of water as pressure transmitting medium. The 
use of hot aqueous solutions of equimolar host and guest ratio for DAC loading allows to better 
control the concentration of the solutes in the DAC but usually leads the formation of small crystal. 
One of the limitations associated with this type of loading is the preparation of such solutions 
when poorly soluble drugs are used. Drugs with low solubility, and for which crystals of an 
inclusion complex with CDs are known to not form at ambient conditions are particularly 
challenging. Heating the sample can help with increasing solubility but is also of limited use: for 
instance the instability of the β-lactam group and L-dopa are known to increase when temperature 
is increased. If a complex can be obtained at ambient conditions, loading of single crystals of the 
complex in the DAC enables higher concentrations to be reached in situ by dissolving the crystal as 
function of applying pressure. However, this loading route gives very little control over the 
starting concentration of the solutes. This is a relatively small drawback that enables to explore the 
effects of pressure for driving CD complex formation for a wider range of compounds. 
 
Table 5.6. Summary of the single-crystal X-ray diffraction results on the inclusion complex screening 
investigated at high- pressure conditions.    
 in α-CD∙water in β-CD∙water 
5FU 5FU recrystallises in the triclinic form 
(as in refcode FURACL)29 
5FU recrystallises in the triclinic form 
(as in refcode FURACL)29 
Amoxicillin This combination has not been 
investigated 
No crystallisation observed  
Succinic acid No crystallisation observed. See 
Chapter 3 for details 
Crystals too small for analysis using 
laboratory equipment 
L-ascorbic acid This combination has not been 
investigated 




In the high-pressure experiment, an increase of the water solubility of 5FU in presence of 
α-CD was observed, which could be related to α-CD∙5FU inclusion complex formation in solution; 
however, applying pressure to the hot solution induce the recrystallisation of 5FU in the triclinic 
form,29 confirmed by single-crystal X-ray diffraction. Further crystallisation and phase transitions 
have not been observed when increasing pressure up to 0.84 GPa.  
 β-CD∙5FU 5.4.2.2.
The outcome of the crystallisation experiment described in section 5.3.3.2, which occurs at 
pressures higher than 0.6 GPa, is a crystal of the guest compound in the triclinic form I.29 This was 
confirmed by in situ single crystal diffraction at 0.78 GPa. There was no evidence of the 
crystallisation of β-CD or β-CD∙5FU complex at high pressure. 
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 β-CD∙L-ascorbic acid 5.4.2.3.
The high-pressure experiment shows no evidence of crystallisation in the explored 
pressure range. Szente and Szejtli ascribed the amorphousness of hp-β-CD to the random 
hydroxypropylation on the (3×7) β-CD hydroxy groups, giving a combination of more than two 
million different molecules in the pool.44 It is important to note that the authors reported a high 
number, which does not discard distinguishable combinations. Nevertheless, the number of 
species in the solution stays very high even with discarding distinguishable combinations. A 
subsequent experiment on a concentrated aqueous solution of hp-β-CD alone was carried out, and 
also in this case no crystallisation was observed in the full pressure range of liquid water.   
 β-CD∙succinic acid 5.4.2.4.
In the solid state, β-CD is known to form an inclusion complex with succinic acid at 
ambient-pressure conditions.24 By loading a single crystal of the complex into a DAC and 
increasing pressure dissolution was observed (Figure 5.5). Although the amount of starting 
material in the DAC was considerable, the crystals formed at high pressure were small and 
unsuitable for an in house X-ray diffraction study. In subsequent experiments on the same system, 
we observed recrystallisation at high pressure similar to that reported in Figure 5.5.g but of two 
clearly distinct populations of small crystals. This could in theory correspond to crystallisation of 
the solutes as distinct compounds, as observed in the experiment with 5FU and with paracetamol 
(for the latter see Chapter 4 section 4.4.4.2). Raman spectroscopic investigations should be carried 
out to confirm this hypothesis. 
 β-CD∙amoxicillin 5.4.2.5.
As explained earlier, it is difficult to assess the exact amount of material loaded into the 
DAC when single crystals of inclusion complexed are loaded; hence this study is rather qualitative. 
Polarised optical microscopy shows that when single crystals of amoxicillin and of β-CD are loaded 
into a DAC, and by using water as pressure transmitting medium, applying pressure results in the 
expected observation of β-CD dissolving as function of increasing pressure. Interestingly, the 
dissolution of β-CD induces the dissolution of amoxicillin, which in the case of the performed 
experiment completely dissolved at 0.98 GPa. Further pressure and temperature cycles did not 
promote any crystallisation except that of ice VI above 1.5 GPa. A subsequent experiment showed 
that a single crystal of amoxicillin does not undergo dissolution in water when compressed; this 
confirms that the dissolution of amoxicillin observed in the earlier experiment is caused by the 
presence and especially the dissolution of β-CD and gives a strong indication that a complex is 
formed in solution. In the experiment carried out using a stationary gas compressor, β-CD and 
amoxicillin were used in equimolar quantities. The starting solution was not heat treated and 
contained crystals of both the host and guest compounds. After applying pressure (0.5 GPa during 
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2.5 h) and releasing it back to ambient, crystals of β-CD were observed to have apparently 
dissolved completely whereas some amoxicillin crystals remained in the solution. An X-ray 
diffraction experiment would have been performed to confirm this but would not be technically 
straightforward to perform in the laboratory.  In a DAC, we could observe that both crystal 
dissolve when pressure is applied and that an amorphous material is obtained when pressure is 
released to ambient. Further experiments would be required to establish whether the pressure and 
concentration regimes used allow to form complete dissolution of amoxicillin at high pressure. Our 
experience with working with β-CD indicates that concentrations in excess of 0.2 M (ca. 227 g/L) 
can be reached in situ in the DAC by simple compression of β-CD at room temperature, indicating 
that β-CD must have completely dissolved. Filtering the amoxicillin crystals and allowing a slow 
evaporation of the filtrate yielded crystallisation after four days at 277 K. The needle-shaped 
crystals were suspected to be those of amoxicillin trihydrate (Figure 5.9.b), and this was 
subsequently confirmed by single-crystal X-ray diffraction. Further evaporation of the solvent 
induces crystallisation of block-like crystals (Figure 5.9.c), identified as those of β-CD hydrate by 
diffraction.  
The combined DAC and stationary gas compressor experiments, demonstrate that it is 
very likely that β-CD forms inclusion complex in solution with amoxicillin at high-pressure 
conditions. The complex is stable in solution but does not crystallise in the explored pressure and 
temperature ranges. On pressure release amoxicillin trihydrate or amorphous material are 
obtained. It has been shown that lyophilisation is a viable way to retain complexes in the solid state 
when these are known to form in solution.45 Lyophilisation is a common process used in the 
pharmaceutical industry as a viable and useful means for safe storage of labile drug products. 
These observations provide more scope to perform further studies on this and other penicillins. 
Inclusion complex formation in solution should be confirmed by other experimental techniques 
such as NMR spectroscopy or UV-Vis spectroscopy.  
 Conclusions 5.5.
A small-scale screening of inclusion complex formation at ambient- and high-pressure 
conditions has been carried out for α-, β- and hydroxypropyl-β-CDs. The purpose of this screen 
was to acquire working, practical knowledge of handling CD∙drug systems, providing the first set 
of experimental observations at high pressure to be used as a stepping stone for future and more 
targeted investigations in our group and by others.  
At ambient-pressure conditions, two new inclusion complexes were very likely obtained 
for β-CD∙5FU and β-CD∙L-ascorbic acid, as characterised by means of polarised optical microscopy 
and single-crystal X-ray diffraction, the latter showing possible extensive disorder of the guest 
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molecule inside β-CD cavities. In the case of β-CD∙piracetam mixtures and β-CD∙gabapentin, 
refinement of the structural model of β-CD hydrate was satisfactory; however, even in this case the 
presence of an extensively disordered guest cannot be ruled out without access to complementary 
analytical techniques, e.g. Raman spectroscopy, which could be used to confirm or discard 
inclusion complex formation on one hand, and on the other hand, if appropriate, the molar host 
guest ratios. The isolation and characterisation of a new complex of α-CD with succinic acid is 
reported in full in Chapter 3. 
High-pressure investigations on host-guest inclusion complex formation were 
experimentally very demanding to execute; in particular, the low solubility of some of the drugs 
used contributed in making the experiments challenging. Because of the size of the drug molecules 
considered, most experiments were conducted on β-CD. As far as the current data analysis can tell, 
the experiments did not lead to the crystallisation of an inclusion complex; for the α- and β-CD∙5FU 
systems crystallisation of one or both solute components as distinct entities was observed. In the 
case of β-CD∙succinic acid mixtures further experiments will need to be performed to characterise 
the crystalline material obtained by in situ crystallisation. 
CDs crystals undergo dissolution in aqueous solution at high pressure, regardless of 
whether guest molecules are present or absent in the cavities. The mechanism for pressure-induced 
dissolution is currently not fully understood and is the subject of ongoing investigations in our 
group. We succeeded in exploiting this dissolution trend, which was thought to be an 
inconvenience at first, and redesign our experiments to explore qualitatively the solubility of drug 
molecules at high pressure in a β-CD-based solution. This trend could in principle be of practical 
application for the dissolution of poorly-water soluble drug molecules. The first qualitative result, 
demonstrated for amoxicillin, is very promising and suggests that complexation with β-CD is very 
likely to occur in solution. Such a result would be pertinent in pharmaceutical applications, with β-
CD serving a double role: protection of labile drugs through inclusion complex formation, and 
controlled release of the drug formulated as a lyophilised inclusion complex.  
Further studies related to this subject area, in particular the study of the extent of 
complexation in solution at high pressure, should also make use of spectroscopic and calorimetric 
high-pressure techniques to supply quantitative experimental evidence of complexation. These 
techniques are not currently widespread or widely available and may require substantial 
investment of resources for custom development. High-pressure studies should also be 
complemented by the characterisation of CD∙drug systems at ambient pressure by performing 
solubility, spectroscopic and chromatographic studies. 
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Chapter 6. Introduction to Part II  
 Introduction 6.1.
Ionic liquids (ILs) are “designer solvents”1 with a melting point below the boiling point of 
water. They are formed by countless combination of large, usually asymmetric, weakly interacting 
organic and inorganic cations and anions.2 The IL structure-activity relationship can be tuned by 
selecting a suitable set of ions, therefore generating specific physical and chemical properties and 
making ILs ideal in terms of technical applicability. The classification of ILs is commonly based on 











The focus on imidazolium based ILs is due to historical and practical reasons: in the early 
80s, Wilkes started his pioneering work on imidazolium-based ILs. He was attracted initially by 
the electrochemical properties and the wide liquid range of 1-ethyl-3-methylimidazolim chloride.3 
Soon after, his initial interest extended to investigating other compounds within the same family of 
1,3-dialkylimidazolium-based ILs. Together with the discovery of other versatile properties,4–6 this 
was one of the triggers of a worldwide interest in imidazolium-based ILs in the early-mid 90s, 
making them the forefront family of ILs.  
As stated above, physicochemical properties of ILS are tunable. Among the most 
interesting properties are a melting point lower than traditional salts, a wide liquid operating 
range, excellent thermal stability, negligible vapour pressure, high viscosity and high ionic 
conductivity. Thanks to these unique physicochemical properties, ILs are “multipurpose” 
compounds7  and have attracted considerable interest in several branches of chemistry and 
chemical engineering, for instance ILs are attractive green solvents in synthetic and catalytic 
processes.8–10  
Less than a decade ago, Reichert et al. stated that although there is an increasing number of 
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literature.11 The authors followed by explaining that commonly crystallisation is obtained by slow 
or fast evaporation of the solvent, and as ILs have negligible vapour pressure, chemists are 
cautious to investigate ILs as crystallisation solvents. ILs have a wide liquid range and are 
thermostable.9 Hence, ILs can be implemented as crystallisation solvents using thermal shifts and 
solvothermal techniques. Alternatively, other techniques such as slow diffusion, use of co-solvent 
and electro-crystallisation have been proposed by Reichert et al.11 Hence, ILs have found 
application as crystallisation media and were also proven effective in improving the crystallisation 
and crystal quality of macromolecules.12–19 
In a special issue in CrystEngComm, where recent studies on the use of ILs in crystal 
engineering are exemplified, Muldon et al. nicely caught the essence of the current spirit in IL 
research stating:  “Importantly, ionic liquids are not just replacing organic solvents, but they often give 
results that are very different from conventional pathways and therefore have the potential for exciting new 
discoveries. Despite their increasing use in inorganic and materials chemistry, there is still the need for 
fundamental investigations; for example, into the nature of the interactions between the ionic liquid ions and 
the solutes.”20 
Although the attention towards practical applications of imidazolium-based ILs is still 
increasing, much fundamental work remains to be done on understanding their phase diagram. 
Our initial aim was to investigate the use of ILs as crystallisation solvents using high-pressure 
techniques. However we soon realised that phase diagrams of imidazolium-based ILs are either 
largely unexplored or poorly understood and characterised. Unveiling the solid-state behaviour of 
ILs was a necessary step before exploring their application as crystallisation solvents. Liquid at 
room temperature, ILs need external factors to crystallize such as temperature, pressure, the 
addition of solvents and sometimes impurity. This part of the thesis describes the use of high-
pressure and low-temperature techniques for studying the solid-state behaviour of imidazolium-
based ILs. 
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 Pinning down the solid-state polymorphism of [bmim][PF6]  Chapter 7.
 Synopsis 7.1.
The solid-state polymorphism of the ionic liquid 1-butyl-3-methylimidazolium 
hexafluorophosphate, [bmim][PF6], has been investigated via low-temperature and high-pressure 
crystallisation experiments. The samples have been characterised by single-crystal X-ray 
diffraction, optical microscopy and Raman spectroscopy. The solid-state phase behaviour of the 
compound is confirmed and clarified with respect to previous phase diagrams. The structures of 
the previously reported γ-form, which essentially exhibits a G′T cation conformation, as well as 
those of the elusive β- and α-forms, are reported. Crystals of the β-phase are twinned and the 
structure is heavily disordered; the cation conformation in this form is predominantly TT, though 
significant contributions from other less frequently encountered conformers are also observed at 
low temperature and high pressure. The cation conformation in the α-form is GT; the presence of 
the G′T conformer at 193 K in this phase can be eliminated on cooling to 100 K. Whilst X-ray 
structural data are overall in good agreement with previous interpretations based on Raman and 
NMR studies, they also reveal a more subtle interplay of intermolecular interactions, which give 
rise to a wider range of conformers than previously considered. 
 Introduction 7.2.
The liquid structure of ILs has been the subject of numerous theoretical and experimental 
investigations, the latter focusing on X-ray and neutron scattering experiments.1–3 The X-ray crystal 
structures of the most common ILs have also been reported in the literature: the Cambridge 
Structural Database4 (the CSD, V. 5.33 including updates to May 2012 was searched for structure 
with 3-D coordinates, an R-factor below 10% and no errors) contains 212 structures of 1-
methylimidazolium-based salts, of which 90 have a confirmed melting point below 373 K, which is 
the commonly accepted maximum melting temperature for defining an IL. Crystal polymorphism 
in 1,3-dialkylimidazolium-based ILs has been reported on the basis of spectroscopic, diffraction 
and calorimetric data. To the best of our knowledge, the first example also confirmed by single-
crystal X-ray diffraction was that of [bmim]Cl.5 
1-Butyl-3-methylimidazolium hexafluorophosphate, [bmim][PF6], (Figure 7.1), is one of the 
most studied ionic liquids. A wide range of simulations have been undertaken on this compound 
and show significant probability of finding anions around the C2 hydrogen position as well as 
above and below the plane of the imidazolium ring.6,7 As found with other ionic liquids, such as 
the analogous chloride based systems,8,9 steric hindrance from the long alkyl chain, in this case 
butyl, has an effect on the structure with the probability of anion interaction with the other ring 
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hydrogens being dominated by the one closest to the methyl group. The solid-state behaviour of 
[bmim][PF6] at ambient-pressure conditions has been extensively studied by a variety of 
techniques, including Raman and NMR spectroscopy, calorimetry, single-crystal X-ray diffraction, 
as well as wide-angle X-ray scattering. [bmim][PF6] has also been the subject of high-pressure 
Raman and calorimetry experiments. Despite the evidence for crystal polymorphism, only one 
crystal structure has been reported in the literature to date.10,11 A brief summary of the findings to 
date is given in Table 7.1, emphasising the conditions under which different phases have been 
obtained and using the scheme introduced by Endo et al.12 as reference to harmonising the 
polymorph nomenclature. 
 
Figure 7.1. Chemical diagram of [bmim][PF6] with atom numbering scheme 
 
Endo et al.12,13 characterised three crystalline forms, α, β and γ, by calorimetry, Raman and 
NMR spectroscopy, pointing out that the endothermic transition to the γ-phase is difficult to detect 
by DSC measurements. The authors assigned the cation structure in the three phases by comparing 
experimental Raman spectra with calculated ones obtained by full geometry optimisation, using 
DFT methods, of the three most stable rotational isomers of the [bmim]+ cation, GT, TT and G′T 
(see Results and discussion section for details). The isomers were identified on the basis of the 
conformations found in experimental crystal structures and in gas-phase quantum chemical 
calculations.14 According to their Raman spectra, Endo et al. assigned the conformers of the α-, β- 
and γ-phases as GT, TT and G′T, respectively. 
The most recent and comprehensive high-pressure investigation into the polymorphism of 
[bmim][PF6] was carried out by means of Raman spectroscopy up to ca. 1 GPa by Russina et 
al.15 Raman work was also carried out by Yoshimura et al.16and by Su et al. up to 2 GPa;17 Su et 
al. have also carried out differential thermal analysis experiments up to 1 GPa.18 Russina et 
al. identified two high-pressure phases by Raman spectroscopy and constructed an elegant phase 
diagram; at ambient temperature, they determined a crystallisation pressure of ca. 0.048 GPa for 
the phase corresponding to the β-polymorph of Endo et al., in excellent agreement with a value 
of ca. 0.04 GPa reported by acoustic measurements.19 A second high-pressure phase, which the 
authors obtained by ambient-temperature crystallisation above ca. 0.44 GPa, was assigned the GT 
conformer and identified as the α-phase of Endo et al. The preference of this conformer at high 
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pressure was confirmed in a very recent molecular dynamics simulation study, albeit in the liquid 
state.20 
 
Table 7.1. Summary of crystallisation conditions and observed polymorphs of [bmim][PF6] reported in the 
literature. 
 
Author Experimentsa Crystallisation conditions and observed crystalline phasesb 
Endo et al. 12 LT Raman, DSC -form Cool to 192 K, heat and 
crystallise at 226.5 K 
-form Phase transition on 
heating  to 250.3 K 
-form Phase transition on 
heating  to 276 K 
Triolo et al. 3 LT DSC, WAXS cr-II Heat supercooled glass 
and crystallise at 220 K 
 
n.o.c cr-I Phase transition on heating 
cr-II to 245-252 K, or cooling to 
260 K and waiting a few hours. 
WAXS pattern matches 
structures of Dibrov et al. and 
Choudhry et al. 
Note: in the first part of the paper the phase assignment on the basis of comparison with single-
crystal structures is reversed to the one given later 
Choudhry et al.11 LT DSC, SC-XRD Cool to 123 K, crystallise at 233 
K (evidence from DSC curve) 
Evidence of    transition at 
263 K from DSC.f 
Cool to 123 K, crystallise at 233 
K and grow at 243 K. Collect 
data at 193 Kd Evidence of   
 transition at 276 K  from DSCe 
Dibrov and 
Kochi10 
LT SC-XRD n.o. n.o. Shock-induced crystallisation 
after supercooling to 243 K. 
Collect data at 173 K 
Russina et al. 15 HP Raman to        
0.9 GPa 
S1 Keep at 0.44 GPa for 12 hrs; 
crystallise on further 
pressurisation 
S2 Depressurise S1 to 0.04 GPa 
 
n.o. 
Su et al.17,18 HP Raman to 2 
GPa, DTA to 1 
GPa 
Only one phase reported in both papers; re-analysis of the Raman 




HP Raman to 2 
GPa 
Identified as S1 by Russina et al. n.o. n.o. 
This work 
 
HP Raman and 
XRD to 0.8 GPa; 
LT Raman and 
SC-XRD; optical 
microscopy 
-form Flash-cool below glass 
transition, heat and crystallise 
at 228 K. Compression of β-
form above 0.4 GPa 
-form Phase transition on 
heating α to 248 K. Crystallise 
at high pressure below 0.4 GPa 
-form Phase transition on 
heating α or β between 248 and 
258 K; isothermal 
crystallisation of the liquid at 
277 K. Crystallise from an aq. 
mix at 0.8 GPa 
a PLT = low temperature; HP = high pressure; DSC = differential scanning calorimetry; WAXS = wide-angle X-ray scattering; SC-XRD: single-
crystal X-ray diffraction; DTA = differential thermal analysis; b Bold-face phases identified in original publications; c n.o = not 
observed/reported; d  current interpretation of DSC signal. 
 
Intrigued by the observations that polymorphism of [bmim][PF6] was reported at both 
low-temperature and high-pressure conditions yet only one crystal structure is available in the 
CSD, our approach has been to explore how the high-pressure and low-temperature crystallisation 
of [bmim][PF6] might lead to the formation of new polymorphs and to elucidate the crystal 
structures of these polymorphs by single-crystal X-ray diffraction, complementing the results with 
Raman spectroscopy. 
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 Experimental  7.3.
 Material 7.3.1.
The title compound was acquired from our collaborators Dr. Norman and Prof. Hardacre 
(School of Chemistry and Chemical Engineering, The QUILL Centre, Queen's University Belfast, 
Belfast BT9 5AG, UK) who prepared it as follows: Bromobutane (1.1 eq.) was added to a stirred 
solution of methyl imidazole (1 eq.) in acetonitrile. The resulting mixture was stirred at 343 K 
overnight. After cooling, the solvent was concentrated and the crude product was recrystallised 
from ethyl acetate to yield a pale yellow solid. The bromide salt was then redissolved in 
acetonitrile and potassium hexfluorophosphate (1.1 eq.) was added and the suspension was stirred 
vigorously overnight. The mixture was then filtered and the solvent concentrated in vacuo. The 
resulting oil was then redissolved in DCM and refiltered to remove the KBr byproduct. Finally, the 
DCM solution was flushed through a pad of silica/alumina and charcoal and concentrated in vacuo 
to yield a colourless liquid. The 1H, 31P and 13C-NMR were consistent with previous reports. The 
ionic liquid was dried for 4 h at 333 K under high vacuum before use. 
 High-pressure crystallisation: α- and β-phases 7.3.2.
A square-shaped beryllium-free diamond-anvil cell (DAC) of the Ahsbahs type21 (45° half-
cell opening angle) was used for the high-pressure experiments; the cell was equipped with 600 
μm culet diamonds of low fluorescence grade and Inconel gaskets with a starting diameter hole of 
300 μm. The pressure inside the sample chamber was measured according to the ruby fluorescence 
method22 using an in-house built kit that has a precision of 0.05 GPa. Crystallisation was induced 
by increasing the pressure progressively to ca. 0.7 GPa. A single crystal was obtained by slow 
melting of the resulting polycrystalline powder when releasing the pressure to ca. 0.09 GPa 
(isothermal crystal growth) and subsequently increasing the pressure until the crystal was as big as 
the gasket hole (Figure 7.2). The final pressure inside the sample chamber was 0.35 GPa. A second 
single crystal was obtained by cooling the loaded DAC at 0.4 GPa for 12 h at 277 K and 
subsequently warming it to room temperature and adjusting the pressure for optimal crystal 
growth. The final crystal at ca. 0.07 GPa was in equilibrium with the liquid and X-ray diffraction 
data were collected at phase boundary conditions (Figure 7.2). Both single crystals were attributed 
to the β-form. Despite the larger standard uncertainty, our value for the crystallisation pressure is 
in good agreement with that of 0.048(25) GPa by Russina et al.15 On compressing the single crystals 
to pressures above ca. 0.4 GPa, a phase transition accompanied by the disintegration into 
polycrystalline material was observed. Analysis of this phase at 0.8 GPa by Raman spectroscopy 
revealed the presence of the α-phase. 
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Figure 7.2. Stages of isothermal in situ crystal growth of the β-phase of [bmim][PF6] in the DAC at 293 K. 
(a) and (b): melting at ca. 0.09 GPa; (c)–(g): slow growth on increasing pressure; (h): final crystal at 0.35 GPa 
(crystal 1); (i): final crystal at 0.07 GPa (crystal 2) in equilibrium with the liquid phase. 
 
 Crystallisation in capillaries: α- and β-phases 7.3.3.
Initial crystallisation experiments were performed by loading the sample in 0.3 mm glass 
capillaries. The capillaries were sealed to keep the sample dry. The sample was rapidly flash cooled 
by immersing the capillary in liquid nitrogen to induce the crystallisation of a glass. On warming, a 
liquid-mediated transition to needle-like crystals was observed; on further warming these needles 
transformed to plate-like crystals. A single crystal was then grown by temperature cycling; the 
capillary was subsequently transferred to a Bruker Apex diffractometer equipped with a low-
temperature device set to a temperature of 193 K, which was chosen on the basis of the data 
collection temperature reported for the known crystal form. Warming similarly grown crystals to 
room temperature did not result in the formation of another phase. Since the sample was cooled by 
contact with a cotton bud soaked in liquid nitrogen, heating and cooling rates could not be 
monitored but were generally fast. 
 Crystallisation using a Linkam stage: α- β- and γ-phases 7.3.4.
To improve the temperature control, we switched to a Linkam THMS600 heating and 
freezing stage, which enables temperature control within a precision of 0.1 K while still being able 
to view the sample through a quartz glass window (Figure 7.3). Prior to sample cooling, the stage 
was heated to 373 K to remove any moisture trapped inside the sample chamber. Phase assignment 
was performed by a combination of single-crystal X-ray diffraction and Raman spectroscopy. Over 
50 crystallisation trials were performed. Depending on the starting crystalline phase, several 
transition paths are possible: herein, we detail five crystallisation protocols. (1) The α-form was 
reproducibly obtained by cooling the sample below its glass transition temperature and then 
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heating it up to a temperature in the range of 228–248 K, irrespective of the heating rate. Once 
formed, fast heating rates suppressed any further transition. (2) Starting from the α-phase and 
using a slow heating rate (0.5 K min−1) a transition to the β-phase occurred at ca. 248 K, in good 
agreement with the value of 250.3 K reported by Endo et al.12 (3) Starting from a fully crystalline 
sample of the α-phase (i.e. in the absence of any liquid), following an isothermal run at 258 K for 
10–20 min, a transition to the γ-phase was sometimes observed. (4) The γ-phase was, at times, also 
obtained directly from the β-form using a similar isothermal run. (5) The γ-phase, which has the 
lowest crystal growth rate, was reproducibly obtained by leaving the sample at 277 K for a few 
days. As reported by Endo et al.,13 the activation energy of the β → γ phase change is considerable; 
hence, a long isothermal phase may be a key factor for either direct nucleation of the γ-phase from 
the liquid state or for the β → γ transition. Considerations on the reproducibility of the 
crystallisation protocols are further explored in the Results and discussion section. 
 
Figure 7.3. Optical images of crystals of [bmim][PF6] grown on a Linkam stage. (a) Single crystals of the α-
phase growing from the liquid at 262 K; (b) single crystal of the α-phase at 260 K grown on a glass shard 
(coexistence of liquid and solid), and (c) crystal after cooling to 203 K; (d) β-phase melting at 279 K; (e) initial 
and (f) final stages of the α → β phase transition at 248 K; (g) nucleation of the γ-phase from the β-phase at 258 
K and (h) γ-phase coexisting with the melt at 282 K. 
 Single-crystal X-ray diffraction 7.3.5.
Data integration and global-cell refinement were performed using the program SAINT.23 
High-pressure data processing was performed according to the procedure by Dawson et al.24 
Unless otherwise specified the program SADABS25 was used to correct for absorption and 
systematic errors. For the high-pressure data, the program SHADE26 was additionally used. All 
structures were solved with direct methods using SHELXS.27 All non-H atoms were refined with 
anisotropic displacement parameters. All H-atoms were placed geometrically and allowed to ride 
on the parent atoms. Uiso(H) values were assigned in the range 1.2–1.5 times Ueq of the parent atom. 
Full-matrix least-squares structure refinement against F2 was performed using SHELXL5 through 
the SHELXLE GUI.28 Crystallographic data are reported in Table 7.2. 
Chapter 7. Pinning down the solid-state polymorphism of [bmim][PF6]   111 
 α-Phase 7.3.5.1.
Sample transfer to the diffractometer proved to be particularly difficult for this phase as 
any mechanical interference with the crystal at high enough temperatures where the crystal could 
be manipulated resulted in a phase transition. A suitable crystal for diffraction was hence grown 
on a secondary glass shard support placed on the Linkam stage and the shard was subsequently 
mounted on a Bruker SMART 6000 Apex II CCD diffractometer (Figure 7.3). Diffraction data were 
collected using Cu Kα radiation of λ = 1.54178 Å from a rotating anode at 100(2) and 193(2) K. The 
structure at 100 K was found to be ordered. At 193 K disorder could be modelled for the [PF6]- 
anion [0.44(2) : 0.56(2)] and for the atoms C8 and C9 of the butyl side chain [0.752(13) : 0.248(13)] 
using two-site split models. To ensure reasonable anion geometry, restraints on bond distances and 
angles as well as on anisotropic displacement parameters were used. Distance restraints were also 
used for the disordered atoms in the cation. 
 β-Phase 7.3.5.2.
Diffraction data were collected using a Bruker AXS SMART Apex II CCD diffractometer 
equipped with Mo Kα sealed-tube radiation of λ = 0.71073 Å for an in situ grown crystal contained 
in a capillary at 193(2) K. A similar diffractometer equipped with a Ag microsource (Incoatec) of  
λ = 0.56085 Å was used for the 293(2) K high-pressure DAC experiment. Both low-temperature and 
high-pressure structures were found to be pseudomerohedral triclinic twins, with unit-cell 
constants emulating a monoclinic C metric cell and a [-1 1 0] twin direction; the twin law is 
expressed by the matrix (0 -1 0/ -1 0 0/ 0 0 -1). As expected, the lowest deviation from perfect 
monoclinic C symmetry was observed for the high-pressure structure collected at phase-boundary 
conditions and this is also the structure exhibiting the highest degree of pseudosymmetry and 
perfect domain overlap. Further compression of the single crystal to ca. 0.35 GPa resulted in a unit 
cell with a higher degree of deviation from a perfect monoclinic C cell [triclinic unit-cell 
parameters: a = 9.4360(15), b = 9.4899(8), c = 14.4658(8) Å, α = 98.944(5), β = 98.754(9), γ = 
100.586(9)°]. Two orientation matrices were used to integrate the low-temperature data, for which 
the two twin components did not perfectly overlap; the program TWINABS29 was used to correct 
for absorption and systematic errors and a HKLF5 reflection file was used for the refinement of the 
low-temperature structure. The twin scale factors were 0.445(5) and 0.509(18) for the low-
temperature and high-pressure crystals, respectively. The octahedral geometry of the F-atoms was 
enforced through the use of restraints whilst opposite F-atoms were constrained to have the same 
anisotropic displacement parameters. For the high-pressure structure, disordered C-atoms were 
refined with isotropic displacement parameters. Both [PF6]- anions were found to be disordered. A 
two-component disorder model was refined for each of these groups with occupancy factors 
refining to approximately 50:50 values at both low temperature and high pressure (occupancies 
Chapter 7. Pinning down the solid-state polymorphism of [bmim][PF6]   112 
were fixed to these values for the high-pressure refinement). Disorder was additionally found in 
the butyl side chain of the cations: at low temperature disorder was clearly identifiable for carbon 
C10 in one of two symmetry-independent molecules [0.68(4) : 0.32(4)]. At high pressure terminal 
methyl carbons were disordered in both molecules [site occupancies were fixed to 0.7 : 0.3 after 
initial refinement]. Distance, angle, as well as rigid-bond (DELU) and thermal similarity (SIMU) 
restraints were applied to ensure reasonable molecular geometries and ADPs and increase the data 
to parameter ratio, in particular for the high-pressure data. In addition, the independent molecules 
in the asymmetric unit were restrained to have similar geometries. The preference for using a 
heavily restrained anisotropic model over the use of an isotropic model with fewer parameters for 
crystals whose weak diffraction can be ascribed to large thermal motion has been discussed by 
Watkin.30 
Table 7.2. Crystallographic data for the three polymorphs of [bmim][PF6] discussed in this chapter. 
 
Structure α α β β γ γ 
Pressure 0.1 MPa 0.1 MPa 0.1 MPa 0.07 GPa 0.1 MPa 0.1 MPa 
T/K 100(2) 193(2) 193(2) 293(2) 180-193a 263(2) 
Reference This work This work This work This work MAZXOB0117 This work 
Space group Pbca Pbca P-1 P-1 P-1 P-1 
a/Å 9.3855(3) 9.4924(5) 9.3869(8) 9.5818(13) 8.774(5) 8.8215(8) 
b/Å 9.7769(3) 9.8406(5) 9.5879(8) 9.5826(9) 8.944(9) 9.0796(9) 
c/Å 26.7170(7) 26.8817(13) 14.4964(12) 14.5801(10) 9.032(6) 9.0381(8) 
/° 90 90 98.492(5) 99.219(10) 95.95(2) 96.671(7) 
/° 90 90 98.354(6) 99.252(6) 114.93(1) 114.768(6) 
/° 90 90 101.089(6) 99.667(10) 103.01(3) 103.071(7) 
V/Å3 2451.58(13) 2511.0(2) 1245.85(18) 1278.2(2) 610.2(8) 621.82(10) 
Z’ 1 1 2 2 1 1 











6680, 3484, n.a. 7824, 2291, 
1624 
Parameters/restraints 156/0 229/255 349/618 341/809 154/0 174/57 
Rint 0.05 0.06 0.05 0.04 n.a. 0.02 
R1 c 0.037 0.048 0.084 0.074 0.045 0.050 
wR2 d 0.100 0.155 0.275 0.2113 0.128 0.145 
min/max/e- Å-3 -0.31/0.33 -0.39/0.27 -0.41/0.52 -0.14/0.18 -0.29/0.33 -0.34/0.42 
a Three different temperatures are given in the paper (193 K), ESI (180 K) and CIF file (183 K). b Criteria for observed reflections: I > 2σ(I).  
 c [F2 > 2σ(F2)]. d (F2).  
 
 γ-Phase 7.3.5.3.
Diffraction data were collected on a single crystal grown on the Linkam stage and 
transferred to a Bruker AXS SMART Apex II CCD diffractometer with Mo Kα sealed-tube radiation 
of λ = 0.71073 Å at 263(2) K. A minor but significant disordered component of the butyl side chain, 
atoms C8 and C9, could be successfully refined using a split-site model [0.921(8) : 0.079(8)]. The 
residual electron density was distributed around the anion but no disorder could be modelled 
satisfactorily; the resulting anisotropic displacement parameters are not unusually large for a 263 K 
structure. 
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 Raman spectroscopy 7.3.6.
Raman spectra were recorded with a Horiba Jobin Yvon HR800 UV Micro-Raman 
spectrometer equipped with an air-cooled 20 mW 488 nm Ar-laser. Raman spectra were collected 
in the 200–1200 cm−1 range with a spectral resolution of ca. 2.2 cm−1 using a grating of 600 grooves 
per mm and a Peltier-cooled CCD detector (Andor, 1024 × 256 pixels). The spectra were calibrated 
with the Raman scattering frequency of Si before and after each measurement. 
 Results and discussion 7.4.
 Conformation of the [bmim]+ cation in the solid state 7.4.1.
In the present discussion, the rotamer denomination follows the scheme outlined by 
Tsuzuki et al.,14 which is based on the C2–N1–C7–C8 torsion angle (Figure 7.1) being positive. The 
conformations of the N1–C7–C8–C9 and C7–C8–C9–C10 torsion angles, θ1 and θ2, respectively, are 
then assigned to the following angle ranges: T (trans, −150 to +150°), G (gauche, +30 to +90°) and G′ 
(gauche′, −30 to −90°), see Figure 7.5 for details. As noted by Endo et al.,12 the three polymorphs of 
[bmim][PF6] can be identified on the basis of characteristic Raman bands: for the α-phase a band at 
338 cm−1, associated with ring wagging and chain deformation;31 for the β-phase a band at 624 cm−1, 
which is associated with a number of group vibrational modes;32 for the γ-phase a band at 326 cm−1, 
presumably also associated with ring wagging and chain deformation. Endo et al.12 note that these 
bands are characteristic fingerprints for the GT, TT and G′T conformers, respectively. Our 
experimental Raman spectra, shown in Figure 7.4, are in very good agreement with those reported 
at low temperature by Endo et al.12 and at high pressure by Russina et al.15 
 
Figure 7.4. Dihedral angles for N1–C7–C8–C9 and C7–C8–C9–C10 for defining the [bmim]+ cation 
conformation. 
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Figure 7.5. Raman spectra of [bmim][PF6] polymorphs collected at different conditions of temperature (top) 
and pressure (bottom). Solid lines highlight the frequencies of the characteristic bands below 800 cm−1 for the 
α-, β- and γ-forms at 338, 624 and 326 cm−1, respectively. 
 
Whilst Raman spectroscopy enables a rapid and unambiguous phase assignment, single-
crystal X-ray diffraction allows the determination of a more detailed description of the cation 
conformation in the solid state. Gas-phase calculations on the cation, in isolation and in the 
presence of counterions have shown that the nine lowest-energy rotamers adopt a combination of 
the T, G and G′ torsion angles, and that the energy of all rotamers are within 5 kJ mol−1 of each 
other;14 however, our crystallographic study points out to the existence of other conformers, which 
in the previous calculations correspond to saddle points on the torsional potentials, so that 
additional torsion angles are introduced here: S (syn, −30 to +30°), E (eclipsed, +90 to +150°) and E′ 
(eclipsed′, −90 to −150°). The values for the torsion angles θ1 and θ2 observed from single-crystal 
diffraction are summarised in Table 7.3. 
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Table 7.3. Torsion angles and cation conformation for the polymorphs of [bmim][PF6] at different 
experimental conditions. 
 
 -100 K -193 K -193 K -0.07 GPa -193 K17 -263 K 











 molecule 2b 
  167.5(8) 168(2)   












  180.0(8) -178(3) 
[-122(4)] 
  








Conformation molecule 2   TT TT 
(30%TE’) 
  
a Values in square brackets refer to the minor disordered component. b Two molecules in the asymmetric unit for the β-form. 
 
The conformers of the α- and γ-phases are confirmed to be GT and G′T, respectively. The 
coexistence of the GT and G′T conformers in the α-phase, suggested by Endo et al.12 on the basis of 
variable-temperature Raman spectroscopy can also be rationalised: the single-crystal structure at 
193 K indicates the presence of a minor (25%) component attributed to the G′T conformer. On 
further cooling the same crystal, the disorder disappears and the observed conformation is entirely 
GT. This observation points towards the presence of dynamic disorder in the cation, though ideally 
more data points should be collected to confirm this observation. Dynamic disorder or enhanced 
thermal motion in the cation is, to a lesser extent, also present in the γ-form: whilst the structures 
reported by Dibrov and Kochi10 and Choudhury et al.11 determined below 200 K indicate that the 
cation conformer is G′T, our 263 K structure additionally shows the presence of a minor GT 
component (8%). Multiple conformations are also observed for the two molecules in the 
asymmetric unit of the β-phase at 193 K/0.1 MPa and at 293 K/0.07 GPa. When considering the 
main disordered components only, the conformations of the [bmim]+ cation at 193 K/0.1 MPa and 
at 293 K/0.07 GPa are best described as TG′/TT and TT/TT, respectively. When the minor 
disordered components are also taken into account, the description becomes TG′ (30%TE′)/TT at 
low temperature and TT (30%TE′)/TT (30%TE′) at high pressure. Crystal structures of ionic liquids 
crystallising with more than one molecule in the asymmetric unit do in fact often contain different 
conformers; the E and E′ conformers are considerably less common compared to the T, G and G′ 
counterparts, but not unknown. A search for [bmim]+ containing structures in the current version 
of the Cambridge Structural Database (the CSD, V. 5.33 including updates to August 2012, was 
searched for structure containing the [bmim]+ cation with available 3-D coordinates, an R-factor 
below 10%, no errors and excluding powder structures) reveals that out of a total of 96 structures 
(90 unique), 1 contains twelve [bmim]+ cations in the asymmetric unit, another contains five, 9 
contain four, 2 contain three and 19 contain two. The distribution of the observed conformers is 
shown in Figure 7.6. The wide range of different conformations observed in different polymorphs 
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and in the same phase at different conditions of pressure and temperature is a further indication of 
the low barrier to rotational isomerism. In a very recent solid-state 1H NMR relaxation experiment 
study Endo et al.13 reported that the averaged mobility of the cation follows the order γ < β ≤ α and 
that the same trend is also followed by the slow segmented motion of the butyl group. These 
findings are in general good agreement with our observations; moreover, in most cases the 
motions seem to be larger than vibrational motions and are associated with conformational 
changes of the butyl group. 
The TT conformer assignment for the β-phase by Endo et al. and Russina et al. on the basis 
of Raman data is essentially correct when considering the major disorder component; however, the 
availability of single-crystal data provides a higher level of detail. The model presented, herein, 
still represents an averaged model: the data do not allow a deconvolution of electron density and 
thermal motion and the given values should be taken as guidelines; in reality it is possible that a 
range of conformations between TG′ and TE′ exist in the crystal, in particular as a function of 
varying temperature and pressure. 
 
Figure 7.6. Distribution of the conformers of [bmim]+-containing structures found in the CSD. 
 
 Disorder of the [PF6]− anion in the solid state 7.4.2.
Rotational disorder of the [PF6]- group is often observed in the solid state, as expected for a 
highly symmetric molecule. At 193 K the only crystalline phase which does not show evidence of 
anion disorder is that of γ, which incidentally is also the most dense phase at this temperature. In 
the α-phase the nature of the anion disorder is most likely to be dynamic, as exemplified by the 
ordering observed on cooling the single-crystal from 193 to 100 K. In the β-phase at 193 K, the two 
crystallographically independent anions are both extensively disordered about axial F-P-F bonds 
(F101-P1-F103 and F204-P11-F206 for molecules 1 and 2, respectively); at low temperature the [PF6]- 
groups were found to be primarily disordered about an axis rotation, whilst at high pressure an 
additional significant tilt component was observed. A similar but less pronounced type of disorder 
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is also observed in the slightly denser α-phase at 193 K (about the F2-P1-F5 axis). The trends in the 
anion disorder in the crystalline state are in agreement with the results of the spin-lattice rotational 
dynamics study of Endo et al.13 
 Crystal structures of the three polymorphs 7.4.3.
The structure of the γ-phase determined at 263 K is in very good agreement with the low-
temperature structure reported previously. The crystal packing in this form is based on two 
primary building blocks of centrosymmetric cation dimers. In the first, here termed “closed” 
dimer, the butyl groups are pointing inwards, i.e. towards the space between two imidazolium 
rings, and in the second, “open” dimer, they are pointing outwards (Figure 7.7). Both types of 
packing arrangements are found in short- and long-chain ionic liquids.5,33,34 In long alkyl structures, 
“closed” dimers favour hydrophobic alkyl–alkyl interactions. The β-phase also exhibits both types 
of packing arrangements: the “open” dimer is formed between symmetry equivalent molecules, 
whilst the “closed” one, a pseudo-centrosymmetric dimer, is formed between symmetry-
independent molecules. In contrast to the γ- and β-forms, the α-phase only exhibits one type of 
centrosymmetric dimeric arrangement, namely the “open” dimer; in addition, a different, less 
compact closed dimer, with molecules related by glide symmetry, is formed. The nature of the 
“open” dimer also changes across the three structures: in the α- and β-phases the methyl groups of 
the imidazolium ring are aligned, whereas in the γ-form the butyl groups are. When considering 
the entire crystal packing, an overall change from a mixed short-alkyl/long-alkyl to a long-alkyl 
structure-type packing arrangement is observed when going from the γ- through the β- to the α-
phase. The phase that crystallises at the lowest temperature from the supercooled liquid state 
adopts a packing arrangement that is more akin to that encountered in long-alkyl chain 
hexafluorophosphate ionic liquids (Figure 7.8), with layers of interacting butyl side chains 
separated by c/2, similar to what was previously predicted for this compound.34 This is in line with 
the thermodynamic data of Triolo et al.,35 who determined that the supercooled liquid-fragility 
index of [bmim][PF6] is similar to that of longer side chain 1-alkyl-3-methyl imidazolium-based 
salts.36 
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Figure 7.7. Dimeric arrangements in the three polymorphs of [bmim][PF6] viewed along two different 
stacking directions. Anions, H-atoms and minor disorder components have been omitted for clarity. oi = 
centrosymmetric “open” dimer, ci = centrosymmetric “closed” dimer, cpi = pseudo-centrosymmetric “closed” 
dimer, cg = glide “closed” dimer. Symmetry-independent molecules in the β-phase are labelled 1 and 2. 
 
Figure 7.8. Crystal packing of [bmim][PF6]. α-form (top) and of 1-n-dodecyl-3-methylimidazolium 
hexafluorophosphate,34 CSD Ref. code HIWNOQ (bottom). 
 
The geometric parameters describing the centrosymmetric dimeric arrangements are 
detailed in Table 7.4 (see Appendix for details). π–π stacking of cation dimers is observed between 
dimers in the “open” arrangement, and the smallest offset to perfect stacking is found in the β-
phase [2.342 Å at 193 K compared to 3.543 and 3.394 Å in the α- and γ-phases, respectively, at the 
same temperature], although the interplanar distance is also the longest. At 193 K, the interplanar 
distance for the “closed” dimer is shortest in the γ-phase [4.3688(9) Å compared to 5.452(4) Å in the 
β-phase]. From Table 7.4 the more pronounced pseudo-symmetry in the β-form at high pressure is 
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evident: all parameters describing the “open” dimers between symmetry inequivalent molecules 
are more similar at high pressure than they are at low temperature. 
The [PF6]− anions contribute to structural stability by linking the dimeric 
arrangements via several F∙∙∙H contacts. In the structures of the γ- and β-phases, the anions occupy 
the space between the stacked cation columns, whilst in the structure of the α-phase the structure 
motifs formed by cations and anions are intertwined. Void analysis (performed with the program 
Mercury37) reveals that whilst this space forms continuous columns along the b-axis in the γ-form, 
it gradually moves into a double-pocket arrangement and finally into segregated individual 
pockets that fit a single anion on going from γ to β and from β to α (Figure 7.9). 
Interestingly, at 0.07 GPa the density of the β-phase is ca. 2.5% less than the corresponding 
density of the same phase at 193 K. Isothermal compression at 293 K to ca. 0.35 GPa, leads to a 
density increase of ca. 3.4% from 1.477 to 1.527 g cm−3(full structural data not reported here). The 
effect of decreasing temperature on the crystals of the γ- and α-phases is to form denser structures. 
The considerable variation of density as a function of temperature is indicative of the “softness” of 
the intermolecular interactions that govern crystal packing. 
 
 
Figure 7.9. Crystal packing in the three polymorphs of [bmim][PF6]. H-atoms and disordered atoms have 
been omitted for clarity. The space occupied by the anions is depicted by solvent accessible void surfaces 
generated with the program Mercury (probe radius = 1.2 Å, grid spacing = 0.7 Å). Solvent accessible void 
volume at 193 K expressed as % unit cell volume: 5.1% in the α-, 5.3% in the β- and 4.4% in the γ-polymorph, 
respectively. 
 
The attractive energy between imidazolium-based cations and anions is predominantly 
attributable to Coulombic forces. The contact involving the acidic C2–H2 bond and the anion is 
generally accepted as a hydrogen bond, albeit weak (donor-acceptor distance higher than 3 Å) in 
the case of [PF6]−.38,39 Tsuzuki et al., have shown by computational methods that hydrogen bonds in 
ionic liquids involving imidazolium ring hydrogens are not directional and are mainly governed 
by the distance between the ring hydrogen and the anion. In a subsequent publication, the authors 
have shown that a contact between a Br− anion and the C2–H2 group stabilises the GT 
[bmim]+ cation conformer, whilst close contacts to C4–H4 and C5–H5 do not alter the relative 
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stability of the GT, G′T and TT conformers.14 H∙∙∙F contacts less than the sum of the van der Waals 
radii are given in Table 7.5 (see Appendix for details). From this table it can be seen that the 
coordination number of the cation and anion varies across temperature, pressure and crystal phase. 
Within the same phase, the coordination numbers are inversely proportional to crystal density; the 
higher density observed at low temperature is achieved by an increase in the number of close H∙∙∙F 
contacts, defined as contacts whose distance is smaller than the sum of the van der Waals radii. The 
crystal density at 193 K follows the order α < β ≪ γ; the same order is observed in the number of 
close H∙∙∙F contacts, whilst the order is α ~ γ > β when considering both the coordination number of 
cations and anions. These results are in fairly good agreement with the strength of cation–anion 
interactions estimated from Raman spectroscopy that follows the trend γ > β ≥ α.13 
All three crystalline phases are characterised by C∙∙∙F contacts involving H2 to two anions 
on either side of the imidazolium ring. The anion is defined to lie above the ring when it is on the 
same side of the butyl chain and below when on the opposite side. Details of the geometric 
parameters for these contacts are given in the Appendix (Table 7.6). At 193 K, short C2∙∙∙F distances 
are observed for the α-form [two contacts to disordered F-atoms at 3.062(6) and 3.064(9) Å to the 
anion below the ring; note that at 2.993(10) and 3.029(8) Å, C F contacts to the anion above the 
ring are shorter but H∙∙∙F distances are greater than the sum of the van der Waals radii]. In the γ-
form the corresponding distance is slightly longer [3.192(4) Å]; in this form, the distance to the 
anion above the ring is comparatively longer [3.233(5) Å] but more linear (C2–H2∙∙∙F angle 152 and 
120°, respectively). In the β-form a wider range of distances to anions involving H2 are observed 
because of the presence of two molecules in the asymmetric unit and extensive anion disorder, 
thereby making contact analysis more complex. For instance, at 193 K the shortest distance has a 
value of 2.921(16) Å and involves molecule 2 and the anion below the imidazolium ring; the 
disordered counterpart is longer [3.031(17)] Å and at 2.84 Å the H∙∙∙F distance is greater than the 
sum of the van der Waals radii; the associated contact angles are 99 and 92°, respectively. At 0.07 
GPa and ambient temperature, the corresponding distances and angles are 2.74(3) Å, 112° and 
3.19(3) Å, 118°, respectively, and all H∙∙∙F distances are less than the sum of the van der Waals radii. 
At high pressure, the number of short H∙∙∙F contacts is lower than at low temperature, in line with 
the lower density, and the environment around the symmetry independent molecules more similar 
when considering average values, in line with the higher pseudo-symmetry. 
All three polymorphs exhibit close contacts that involve not only H2 but all ring as well as 
the methyl hydrogen atoms; overall, the more linear contacts are associated with longer C∙∙∙F 
distances. The former observation seems to suggest that close contacts between these atoms and 
anions are not directly responsible for the observed cation conformation in the solid state. On 
inspection of Table 7.5 and Table 7.6 deposited as Appendix other more indicative trends emerge. 
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The GT conformer appears to be stabilised by a contact to the hydrogen atom attached to C7 and 
no contacts to C8 or C10 (for which distances are > 3.7 Å); the G′T conformer is additionally 
stabilised to contacts to C10 (the contact to H8 observed at 193 K is long: H8∙∙∙F distance = 2.67 Å 
and C8∙∙∙F distance = 3.662(5) Å). The difference between the TT, TG′ and TE′ conformers is not 
immediately evident but all involve additional contacts to the terminal butyl carbon atom. 
Differences in the number of contacts involving methyl hydrogen atoms are inconclusive given 
that their positions are not reliable. 
 General discussion 7.4.4.
Our experiments indicate that the α-polymorph is very sensitive to temperature changes 
and should be kept well below the transition temperatures to the β- or γ-phases. The temperature 
range used for in situ crystallisation followed by crystal growth on a diffractometer by zone 
melting, e.g. using an Optical Heating and Crystallisation Device (OHCD), is usually quite large 
and difficult to control: this could partially explain why single-crystal structures reported in the 
literature correspond to the γ-phase despite the fact that the crystal was grown at temperatures 
where the α-phase is stable.11 The reproducibility of the crystallisation protocols outlined in section 
7.3.4 seems to be strongly dependent on a number of factors, including sample volume, water 
contamination and coexistence of liquid and solid phases. For instance, nucleation of the α-phase is 
most reproducible with sample volumes greater than ca. 200 μL; similarly, crystallisation of the β-
phase appears to be more reproducible when the sample is contained in a capillary and the heating 
rates are high. Protocols 3 and 4 outlined in section 7.3.4 are most successful when the whole 
sample is crystalline: when the liquid and crystalline phases coexist, the α to liquid phase 
transition can occur at ca. 263 K, without a prior solid–solid phase transition. The presence of water 
as a contaminant, either as a liquid or as ice, also seems to facilitate the formation of the γ-form, 
though this has not been tested systematically. Interestingly, the presence of water also seems to be 
crucial for the crystallisation of the γ-phase under high-pressure conditions: preliminary 
experiments indicate that crystallisation of [bmim][PF6] from very diluted aqueous solutions in the 
0.4–0.7 GPa pressure range results in the formation of the γ-form, as confirmed by single-crystal X-
ray diffraction. In line with other authors, on increasing pressure, we did not observe the 
crystallisation of the γ-phase from the pure liquid, suggesting that, based on density differences, 
the application of modest pressure favours crystallisation of the β-phase. 
The existence of multiple conformers in the liquid state of [bmim][PF6] is well 
documented.12,40 A recent elegant study by Jeon el al. reported the nanocrystallisation of 
[bmim][PF6] at the vapour–liquid interface at 310 K by grazing-angle synchrotron X-ray 
diffraction.41 The sharp Bragg diffraction peaks observed by the authors, arising from 
nanocrystallites at the interface and coexisting with the broad diffraction features of the liquid, 
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were indexed and a quasi-2D long-range ordered structure was extracted which was similar to that 
of the γ-form. Whilst we also observe coexistence of crystalline and liquid states at certain 
conditions of temperature and pressure, our discrete Bragg reflections collected in transmission 
geometry are very starkly dominated by the crystalline bulk: hence, the cation and anion disorder 
were analysed in terms of crystalline disorder. Surface diffraction methods could shed more light 
into the nature of the crystal–liquid interfaces. It could be conceivable, in particular for the β-phase, 
where disorder is more severe, that different cooling rates would result in a different distribution 
of conformers – however, data collected on different crystals suggest that the differences are not 
significant, so that the main trends reported are confirmed. 
As indicated in the Experimental section, crystals of the β-phase obtained at high-pressure 
or low-temperature conditions are characterised by twinning. The β-phase was found to be stable 
between ca. 0.07 and 0.4 GPa. As expected, the lowest deviation from perfect 
monoclinic C symmetry was observed for the high-pressure structure collected at 0.07 GPa, i.e. at 
phase-boundary conditions, and this is also the structure exhibiting the highest degree of pseudo-
symmetry and perfect domain overlap. Further compression of the single crystal from 0.07 to 0.35 
GPa resulted in a unit-cell with a higher degree of deviation from a perfect monoclinic C cell. This 
is a small pressure range to probe the effects of pressure on disorder; however, our data analysis 
indicates no significant changes in disorder on increasing pressure. 
Whilst the study of conformational flexibility and energetic aspects of the [bmim]+ cation in 
the gas phase are useful, it is clear that an extrapolation of the findings to structures adopted in the 
solid state is not entirely justified since DFT gas phase calculations on isolated cations ignore the 
effects of anions and the stabilising energy contributions that arise from crystal packing. It should 
be noted that whilst Tsuzuki et al. have studied anion effects in their conformational analysis, the 
[PF6]−anion was not included in the calculations. Hence, whilst the three most stable conformers in 
the gas phase are GT (0.02 kcal mol−1), TT (0.00 kcal mol−1) and G′T (−0.50 kcal mol−1) (geometries 
optimised at the MP2/6-311G** level and relative energies estimated at the CCSD(T)/cc-pVTZ 
level), the TG′ conformer observed for one of the two independent molecules in the β-phase at 193 
K is only ca. 4 kJ mol−1 less stable than the G′T rotamer and such a small barrier to rotation can be 
easily overcome by other stabilising intermolecular interactions in the solid state. The phenomenon 
of conformational polymorphism in the solid state has been well documented in the literature. 
Nangia summarises this very nicely: “organic molecules with flexible torsions and low-energy 
conformers have a greater likelihood of exhibiting polymorphism because (1) different 
conformations lead to new hydrogen bonding and close-packing modes and (2) the trade-off 
reduces the total energy difference between alternative crystal structures”.42 These observations are 
also applicable in the case of the title compound and confirmed by the values of the phase 
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transition enthalpies from DSC measuraments.12 Whilst it would be interesting to compare the 
difference in lattice and interaction energies of the three polymorphs by means of computational 
calculations, the observed disorder would make the analysis more difficult, and such a study is 
beyond the scope of this work. Despite the widespread conformational flexibility of the alkyl side 
chain and the large number of structures available in the CSD, there are not many examples of 
polymorphs reported for ionic liquids, but those reported are conformational polymorphs; the low 
incidence of polymorphic structures might be partially due to the fact that the polymorphism of 
these compounds has not been extensively investigated; for examples see refs. 5,33,34 and 43–45. 
Although the γ- and α-phases exhibit very similar Raman spectra, their crystal structures 
are profoundly different. The crystal structures of the three polymorphs are substantially different 
from one another: hence, X-ray powder diffraction can be an effective tool for rapid phase 
identification. Two forms were previously identified by Triolo et al.35 using wide-angle X-ray 
scattering (cr-I and cr-II, see Table 7.1). Comparison of simulated patterns (see Figure 7.10 in the 
Appendix) derived from the single-crystal structures of the three forms with the patterns reported 
in this previous paper indicates the following: the patterns labelled cr-I (see Figures 8, 9 and 10 of 
the original paper) correspond to the α-phase, whilst the patterns labelled cr-II correspond to the γ-
phase (see Figures 9 and 10 of the original paper). The β-form was not reported. It is interesting to 
note that the powder data clearly indicate the occurrence of the α → γ transition at 250 K, also 
confirmed by thermal analysis, despite the fact that a similar temperature was reported for the α → 
β transition by Endo et al. Our experiments confirm that sample thermal history, impurities and 
heating/cooling rates are important factors affecting the polymorphic phase transitions in 
[bmim][PF6]. 
 Conclusions 7.5.
The polymorphic behaviour of the ionic liquid [bmim][PF6] has been studied by Raman 
spectroscopy, single-crystal X-ray diffraction and optical microscopy. The existence of three 
polymorphs, α, β and γ, which can be crystallised as a function of low temperature or high 
pressure, has been confirmed and all three have been structurally characterised. The 
conformational flexibility of the [bmim]+ cation, together with the capability of rotational disorder 
of the [PF6]− anion, give rise to different conformations in the solid state not only as a function of 
crystallisation conditions but also of changes in temperature and pressure to the same phase. The 
range of cation conformations identified provides a basis by which to validate simulation and 
modelling data for both fundamental studies and process design. The GT, TT and G′T 
conformations of the cation in the α-, β- and γ-phases, respectively, inferred from previous analysis 
of Raman stretching frequency, is essentially confirmed; however, the availability for the first time 
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of single-crystal X-ray data for all polymorphs reveals a wider range of conformers than previously 
thought. Across the three phases and under different experimental conditions, a large variation in 
crystal packing densities and in structural disorder is observed. These variations are likely 
contributing driving forces for the polymorphic interconversions. Whilst phase transitions do not 
occur in a single-crystal-to-single-crystal fashion and the molecular packing arrangements of the 
three forms are very distinct, some continuity in the structural motifs of the building blocks is 
observed. 
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 Appendix  7.7.
 
 
Table 7.4. Geometric parameters describing the planar or nearly planar centrosymmetric and pseudo-








distance / Å 
Offset / Å d 
α-phase 
"open" dimer 100 K 5.0554(9) a 0 3.5298(7) 3.619 
"open" dimer 193 K 5.0668(14) 0 3.6224(11) 3.543 
β-phase 
"open" dimer 
193 K Cg1 Cg1 b 
4.818(5) 0 3.715(4) 3.068 
"closed" dimer 
193 K Cg1 Cg2 
5.950(5) 6.2(5) 5.452(4) - 
"open" dimer 
193 K Cg2 Cg2 
4.490(5) 0 3.832(4) 2.342 
"open" dimer 
0.07 GPa Cg1 Cg1 
4.762(12) 0 3.877(10) 2.765 
"closed" dimer 
0.07 GPa Cg1 Cg2 
6.082(12) 3.9(13) 5.542(10) - 
"open" dimer 
0.07 GPa Cg2 Cg2 
4.732(10) 0 3.837(8) 2.770 
γ-phase 
"open" dimer 193 K 4.865(6) 0 3.4856(9) 3.394 
"closed dimer 193 K 6.133(7) 0 4.3688(9) 4.304 
"open" dimer 263 K 4.857(2) 0 3.5357(15) 3.330 
"closed dimer 263 K 6.152(2) 0 4.4425(15) 4.255 
a All standard deviations were calculated with the program PLATON10. Atoms N1, C2, N3, C4, C5 were chosen 
to define a ring, the derived centroid and the least-squares plane. b For the β-phase the aforementioned atoms define Cg1. 
Atoms N11, C12, N13, C14, C15 define Cg2. c The interplanar distance is defined as the perpendicular distance between the 
centroid of one ring onto the second ring plane. d The offset is defined as the distance between the centroid of one ring and 
the perpendicular projection of the centroid of the second ring onto the first ring plane. 
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Table 7.5. Coordination numbers for the cation and anion, as well as short H∙∙∙F contacts in the three 
polymorphs of [bmim][PF6]. 
  
Cation 
C. N. a 
Anion 
C. N. 
H∙∙∙F contacts < 
sum vdW 
 
Total number of 
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a C.N. = Coordination number, defined as the number of molecules with distances < sum of van der Waals (vdW) 
radii + 0.2 Å. Contacts were identified using the programs PLATON46 and MERCURY.37 vdW radius for H = 1.20 Å, vdW 
radius for F = 1.47 Å. For the determination of C.N. all disorder components were considered. b H atoms are grouped 
according their chemical environment: Imidazolium (Imid.), Methyl-imidazolium (Me-imid.) and butyl (Butyl). c Total 
number of contacts: contacts involving disordered atoms were weighted according to site occupancies and rounded to the 
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Table 7.6. Short contacts with H…F distances < sum of vdW radii. vdW radius for H = 1.20 Å, vdW radius 
for F = 1.47 Å. The programs MERCURY37 and PLATON46 were used to check these values. 
Phase S. O. F C H X ARU H∙∙∙X /Å C∙∙∙F /Å C–H∙∙∙F /° 
α-form 
100 K 
1 C2 H2 F3 4555.02 2.61 3.4466(18) 146 
1 C2 H2 F5 4555.02 2.29 3.0412(17) 135 
1 C4 H4 F1 8565.02 2.47 3.4128(19) 170 
1 C4 H4 F5 8565.02 2.65 3.2448(18) 121 
1 C5 H5 F1 4545.02 2.54 3.2328(19) 130 
1 C6 H6B F6 8565.02 2.51 3.463(2) 165 
1 C6 H6C F5 6455.02 2.49 3.228(2) 132 
1 C7 H7A F2 6555.02 2.63 3.274(2) 123 
Total of 8 contacts considering site occupancy factors 
α-form 
193 K 
0.5 C2 H2 F51 4555.02 2.32 3.062(6) 134 
0.5 C2 H2 F5 4555.02 2.38 3.064(9) 128 
0.5 C4 H4 F11 8565.02 2.49 3.436(5) 175 
0.5 C4 H4 F1 8565.02 2.57 3.503(9) 167 
0.5 C4 H4 F5 8565.02 2.55 3.207(9) 127 
0.5 C5 H5 F11 4545.02 2.64 3.274(7) 125 
0.5 C6 H6B F61 8565.02 2.45 3.354(12) 154 
0.5 C6 H6C F51 6455.02 2.52 3.247(7) 131 
0.5 C6 H6C F5 6455.02 2.54 3.321(10) 137 
0.375 C7 H7A F21 6455.02 2.61 3.241(9) 122 
0.125 C7 H7C F21 6455.01 2.28 3.241(9) 162 
0.125 C7 H7C F2 6455.01 2.41 3.387(9) 169 
Total of 5.125 contacts considering site occupancy factors 
β-form 
 193 K 
 
Molecule 1 
0.5 C2 H2 F103 1565.03 2.57 3.366(17) 142 
0.5 C2 H2 F206 1565.03 2.3 3.018(18) 132 
0.5 C2 H2 F113 1565.03 2.37 3.130(19) 137 
0.5 C2 H2 F216 1565.04 2.57 3.188(19) 123 
0.5 C4 H4 F205 2665.04 2.45 3.260(2) 143 
0.5 C4 H4 F215 2665.04 2.62 3.561(17) 171 
0.5 C5 H5 F203  2.45 3.308(19) 150 
0.5 C6 H6A F105 1565.03 2.47 3.246(19) 136 
0.5 C6 H6B F205 2665.04 2.65 3.510(2) 146 
0.5 C6 H6B F115 2565.03 2.46 2.860(2) 104 
0.5 C7 H7A F101 1665.03 2.5 3.440(2) 159 
0.5 C7 H7A F111 1665.03 2.38 3.350(2) 166 
0.5 C7 H7B F201 1565.04 2.28 3.210(2) 155 
0.5 C8 H8A F213  2.26 3.205(19) 160 
0.5 C8 H8B F106 1565.03 2.66 3.540(2) 148 





0.5 C12 H12 F101 1565.03 2.43 3.32(18) 156 
0.5 C12 H12 F111 1565.03 2.3 3.193(19) 156 
0.5 C12 H12 F204 1455.04 2.61 2.921(16) 99 
0.5 C14 H14 F204 2666.04 2.57 3.335(19) 138 
0.5 C14 H14 F214 2666.04 2.42 3.16(15) 135 
0.5 C15 H15 F202  2.62 3.198(18) 120 
0.5 C16 H16A F102 1565.03 2.47 3.402(18) 159 
0.5 C16 H16A F112 1565.03 2.51 3.31(2) 139 
0.5 C16 H16B F201 2666.04 2.57 3.46(2) 152 
0.5 C16 H16C F114 2566.03 2.5 2.97(2) 109 
0.5 C17 H17B F104  2.62 3.564(18) 160 
0.5 C18 H18A F206  2.66 3.526(16) 146 
0.5 C18 H18A F213  2.66 3.627(17) 165 
0.5 C20 H20A F101 2555.03 2.57 3.55(2) 175 
Total of 7 contacts considering site occupancy factors 
β-form 
  0.07 GPa 
 
Molecule 1 
0.5 C2 H2 F113 1565.03 2.24 3.08(3) 149 
0.5 C2 H2 F206 1565.04 2.59 3.15(3) 120 
0.5 C4 H4 F205 2665.04 2.54 3.31(3) 140 
0.5 C4 H4 F216 2665.04 2.34 3.16(3) 147 
0.5 C5 H5 F203  2.56 3.33(4) 141 
0.5 C6 H6 F205 2665.04 2.45 3.35(3) 155 
0.5 C6 H6 F105 1565.03 2.38 3.13(4) 134 
0.5 C7 H7 F201 1565.04 2.35 3.21(3) 146 
0.5 C7 H7 F104 1665.03 2.6 3.45(3) 147 
0.5 C7 H7 F111 1665.03 2.54 3.44(4) 155 
0.35 C8 H8 F202  2.46 3.33(3) 151 
0.35 C8 H8 F213  2.4 3.35(3) 176 
0.15 C8 H8 F202  2.51 3.33(3) 144 
0.15 C8 H8 F213  2.55 3.35(3) 142 
Total of 6 contacts considering site occupancy factors 
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β-form 
  0.07 GPa 
 
Molecule 2 
0.5 C12 H12 F101 1565.03 2.51 3.26(3) 138 
0.5 C12 H12 F111 1565.03 2.44 3.20(3) 139 
0.5 C12 H12 F204 1455.04 2.24 2.74(3) 112 
0.5 C12 H12 F214 1455.04 2.64 3.19(3) 118 
0.5 C14 H14 F201 2666.04 2.62 3.43(3) 147 
0.5 C14 H14 F214 2666.04 2.56 3.37(3) 146 
0.5 C15 H15 F202  2.62 3.29(3) 129 
0.5 C16 H16 F102 1565.03 2.66 3.42(4) 136 
0.5 C16 H16 F114 2566.03 2.59 3.04(3) 109 
0.5 C17 H17 F215 1455.04 2.38 3.29(4) 156 
0.5 C17 H17 F103  2.61 3.49(4) 150 
0.5 C18 H18 F213  2.43 3.38(4) 170 
0.35 C20 H20 F101  2.65 3.57(4) 162 
Total of 6.35 contacts considering site occupancy factors 
γ-form 
193 K 
1 C2 H2 F5  2.35 3.233(5) 152 
1 C2 H2 F3 2766.02 2.6 3.192(4) 120 
1 C4 H4 F2 2756.02 2.45 3.38(5) 164 
1 C5 H5 F2 1656.02 2.67 3.563(5) 155 
1 C5 H5 F3 1656.02 2.59 3.418(4) 145 
1 C6 H6A F4 2756.02 2.49 3.342(5) 148 
1 C6 H6B F1 1655.02 2.67 3.382(5) 131 
1 C7 H7B F6 1656.02 2.53 3.309(4) 138 
1 C8 H8A F5 2767.02 2.67 3.622(5) 175 
1 C10 H10A F3 1556.02 2.58 3.503(5) 162 
1 C10 H10C F2 2656.02 2.66 3.553(5) 155 
Total of 11 contacts considering site occupancy factors 
γ-form 
263 K 
1 C2 H2 F5  2.41 3.255(5) 152 
1 C2 H2 F3 2766.02 2.66 3.263(5) 123 
1 C4 H4 F2 2756.02 2.51 3.419(5) 165 
1 C5 H5 F3 1656.02 2.65 3.461(4) 147 
1 C6 H6A F4 2756.02 2.56 3.42(5) 149 
0.92 C7 H7B F6 1656.02 2.57 3.336(4) 136 
0.08 C7 H7D F6 1656.02 2.37 3.336(4) 173 
0.92 C8A H8A F5 2767.02 2.66 3.632(5) 176 
0.92 C10 H10A F3 1556.02 2.6 3.513(6) 159 
0.92 C10 H10C F2 2656.02 2.66 3.592(5) 165 
0.08 C10 H10D F3 2765.02 2.66 3.513(6) 149 
Total of 8.84 contacts considering site occupancy factors 
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α-form at 193 K
β-form at 193 K
γ-form at 183 K
 
Figure 7.10. Powder patterns simulated using the experimentally-determined single-crystal structures as 
input. For the γ-form, MAZXOB01 was used. Solid lines are used as a guide to the eye to facilitate comparison 
with Figures 8, 9 and 10 in the paper for Triolo et al.3 The dotted line at 2θ = 11.3° (Q = 0.8 Å-1) is characteristic 
for the α-form. The program Mercury37 was used to generate the simulated patterns. Input parameters were as 








Chapter 8. Structural Behaviour of [C10mim]Cl–Water Mixtures 133 
 Structural behaviour of long-chain imidazolium-based ionic liquid Chapter 8.
[C10mim]Cl–water mixtures 
 Synopsis 8.1.
The structural behaviour of the long-chain imidazolium-based ionic liquid [C10mim]Cl – 
water mixtures has been investigated in detail by low-temperature and high-pressure 
crystallisation methods and the solid forms fully characterised by single-crystal X-ray diffraction. 
Form I, a monohydrate, crystallises from solutions containing 6-8% (w/w) water; its structure 
exhibits bilayers, in which the cations are alternating from layer to layer to create hydrophobic and 
hydrophilic regions. Form II, which is a Z' > 1 structure, incorporates a variable amount of water 
content (from pseudo hemihydrate to pseudo monohydrate) depending on sample treatment and 
environment, crystallises from solutions containing < 6% (w/w) water, exhibits a double bilayered 
structure characterised by ordered and disordered regions. Form III is a trihydrate that has been 
exclusively obtained under high-pressure conditions above 0.55 GPa from solutions containing > 
80% (w/w) water. This structure is closely related to that of form I. While homeotypic and isotypic 
structures of forms I and II have been previously reported, form III represents, to the best of our 
knowledge, the only example of a highly hydrated long-chain imidazolium-based ionic liquid 
isolated in the solid state. The formation of mesophases in the title compound has also been 
investigated by polarized optical microscopy and the results correlated with previous liquid-
crystal studies on related compounds.  
 Introduction 8.2.
Although the attention towards practical applications of imidazolium-based ILs is still 
increasing, much fundamental work remains to be done on understanding their phase diagram. 
Liquid at room temperature, ILs need external factors to crystallise such as temperature, pressure, 
the addition of solvents and sometimes impurity. There are several articles in the literature 
describing some aspects of the solid-state behaviour of [Cnmim][X] (n ≥ 12, X  halide anion) with 
structures obtained using conventional crystallisation methods of slow and fast evaporation of 
solvent mixtures at ambient and high temperature.1–8 Interestingly, there are no anhydrous X-ray 
structures reported in the Cambridge Structural Database9 (CSD) for these ILs. In addition, for a 
given halide and chain length, there are no anhydrous as well as hydrate structures reported for 
shorter-chain counterparts.10–12  
Imidazolium-based ILs have also attracted interest for their ability to form liquid-
crystalline ionogels; one of the earliest observations on their liquid crystalline behaviour dates from 
1996.13 Subsequently, some 1-alkyl-3-methylimidazolium-based ILs [Cnmim][A] (n ≥ 10 A  anion) 
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were described as either thermotropic liquid crystals,14 or lyotropic liquid crystals.15–19 
Furthermore, it is not uncommon to see mesophase formation for shorter alkyl chain imidazolium-
based halides.20–22 
Following our work on 1-butyl-3-methyimidazolium hexafluorophosphate,23 in which the 
rich phase and crystallisation diagram of the compound was explored and elucidated, in this 
article we report and compare the results of low-temperature and high-pressure crystallisation 
experiments of 1-decyl-3-methylimidazolium chloride, [C10mim]Cl (Figure 8.1), as function of 
variable water content, as revealed by hot-stage microscopy and single-crystal X-ray diffraction.  
 
Figure 8.1. Chemical diagram of [C10mim]Cl with atom numbering scheme. 
 Experimental  8.3.
A combination of Roman numerals and alphabetical letters are the structure identifiers 
used throughout this article. The same Roman numeral is given to structures with similar unit-cell 
parameters, the same space group and crystal packing. The letter following the Roman numeral 
indicates variation in water content and/or position in different crystal structures. 
 Material 8.3.1.
Please refer to the corresponding sections below detailing the treatment of [C10mim]Cl 
[Aldrich, 95.5% purity, H2O  2% (w/w)] prior to use.  
 Low-temperature crystallisation technique 8.3.2.
All low-temperature experiments were conducted using a Linkam THMS600 heating and 
freezing stage. The stage enables temperature control within a precision of 0.1 K and sample 
viewing through a quartz glass window. The experimental setup allows for a protective N2 gas 
flow at the sample for operating temperatures below 328 K. 
 Form I (LT): crystallisation of [C10mim]Cl monohydrate  8.3.2.1.
A drop of an aqueous [C10mim]Cl solution (solutions in the range 6-8% (w/w) H2O were 
tried) was introduced into the sample chamber of the Linkam stage. A slow cooling rate of 0.3 
K/min starting from room temperature promoted the crystallisation of plate-like crystals in a 
temperature range between 269 and 266 K. The crystals melt at ca. 307 K. A single crystal was 
grown by cycling the temperature between 307 and 304 K.  In all cooling cycles, a liquid crystalline 
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phase very sensitive to temperature changes was observed (Figure 8.2). The behaviour of this 
lyotropic phase is highly complex and its presence hinders the growth of another solid phase, 
corresponding to form II, see below for details. Further cooling of a drop of [C10mim]Cl below  
253 K promotes the crystallisation of a second solid phase from the remaining liquid part (form II), 
independent of the cooling rate. Both solid phases can coexist. In some experiments, the 
coexistence of form I form II and the liquid crystalline phase was observed. A single-crystal of form 
I was measured at 263 K by means of X-ray diffraction. 
 
Figure 8.2. Optical microscopy images of the low-temperature crystal growth of forms I and II-a. (a) Form I 
at 298 K; (b) Form II-a coexisting with the lyotropic phase at 305 K; (c) Fragment of a single crystal of form II-a 
at 295 K; (d) The single crystal in (c) transformed to the lyotropic phase after 16 hours at ambient conditions; 
(e) A single crystal of form II-a under a drop of immersion oil coexisting with the liquid state (droplets). 
 Forms II-a/II-b: crystallisation of [C10mim]Cl pseudo-monohydrate 8.3.2.2.
In addition to the protocol outlined above, form II was also obtained according to the 
following crystallisation route. A large drop, 1 mm in diameter, of an aqueous [C10mim]Cl solution, 
as prepared for crystallisation of form I, was introduced into the sample chamber of the Linkam 
stage. In a first step, the drop was heated for 5 minutes at 433 K; the drop was then enclosed with 
crystal mounting oil (perfluoropolyether) and the system heated a second time for 5 minutes at 473 
K. These steps served the purpose of eliminating any excess water, as observed by microscopy, that 
favours the formation of liquid crystals and that might impede the crystallisation of any other 
form. Unlike form I, form II-a crystallises when fast cooling rates are applied. Cooling to 213 K 
using a cooling rate between 50 and 90 K/min leads to the crystallisation of a cluster of needles. The 
phase transition was observed at 253 K; however, the transition temperature depends on the 
sample volume, water content and cooling rate with the latter having most influence. A single 
crystal (Figure 8.2) was obtained by cycling the temperature between 305 and 308 K. To preserve 
crystal quality, the single crystal was separated from the liquid, immersed into mounting oil at 
ambient condition and subsequently transferred to the diffractometer at 200 K. The same 
crystallisation procedure was adopted for obtaining form II-b. As described for form I, formation of 
a liquid crystalline phase between 308 and 305 K was also observed here. 
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 High-pressure crystallisation techniques 8.3.3.
Modified Merrill-Bassett-type24 diamond-anvil cells (DACs) were used for the high-
pressure experiments.25 200 µm Inconel 718 gaskets preindented to ca. 150 µm and with a sample 
chamber 300 µm in diameter were used for the experiments. All sample loadings took place at 
ambient-temperature conditions. Pressure inside the DAC was monitored by the ruby fluorescence 
method26 using an in-house built kit that has an accuracy of 0.05 GPa. 
 Form I (HP): crystallisation of [C10mim]Cl monohydrate at 0.2 GPa  8.3.3.1.
Subsequent to loading and sealing of the DAC with an aqueous [C10mim]Cl solution as 
used for the low-temperature experiments, a liquid crystal phase was observed on increasing 
pressure just above ambient (Figure 8.3). This phase persists up to 0.3 GPa; above this pressure the 
sample undergoes a phase transition to a crystalline powder. A single crystal was grown by cycling 
both pressure and temperature. While the crystal was growing the pressure inside the DAC 
dropped to ambient pressure indicating the crystal is considerably denser than the liquid. Crystal 
growth necessitates careful monitoring because on one hand when the pressure reaches 
atmospheric pressures the crystal comes in contact with air humidity, inducing a solid to gel 
transition, and on the other hand fast pressurisation promotes twinning. The single crystal (Figure 
8.3) was measured by means of in situ X-ray diffraction at 0.2 GPa. 
 
Figure 8.3. Optical microscopy images of the high-pressure growth of form I in a DAC. (a) Lyotropic phase 
at 0.23 GPa; (b) Crystalline powder at 0.35 GPa; (c) Single crystal growing after pressure and temperature 
cycling; (d) Single crystal growing at ca. 0.2 GPa; (e) Pressure dropped to atmospheric pressure, as indicated 
by the presence of an air bubble; (f) Final stage – the single crystal fills the gasket hole at 0.2 GPa. 
 Form II-c: crystallisation of [C10mim]Cl hemihydrate at 0.05 GPa  8.3.3.2.
[C10mim]Cl was dried for 3 hours at 333 K under moderate (0.21 mbar) vacuum to reduce 
the water content and a small drop was transferred into a DAC at ambient conditions. Needle-
shaped crystals grew immediately after closing the DAC at ca. 0.05 GPa (Figure 8.4). At this point, 
growing a single crystal proved a serious challenge as the growing rate of this phase is extremely 
fast; a fast growing rate generates defects in the crystal that act as nucleation points. After several 
attempts of cycling pressure and temperature, a suitable single crystal for X-ray diffraction was 
obtained (Figure 8.4) and measured at ca. 0.5 GPa. Controlled and constant slow heating over the 
course of several hours in a small incubator proved to be crucial for the growth of this form.  
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Figure 8.4. Optical microscopy images of the high-pressure growth of form II-c in a DAC. (a) DAC closed, 
polycrystalline material at ca. 0.05 GPa; (b) A single crystal obtained by cycling temperature; (c) The single 
crystal growing at 323 K; (d) Turning off the heat source induces the growth of multiple crystals; (e) New 
single crystal growing under constant heat of 323 K; (f) Final stage – predominantly single crystal at 0.05 GPa. 
 
 Form II-d: crystallisation of [C10mim]Cl pseudo-hemihydrate at 0.27 GPa 8.3.3.3.
In order to improve humidity control, a nitrogen glove box was used for sample 
preparation. The compound was dried for 5 hours at 333 K under vacuum, and then transferred 
into a DAC inside a nitrogen glove box operating at a relative humidity of 6.4 %. The DAC was 
sealed inside the glove box and pressure increased to 0.13 GPa. Crystallisation was induced by 
keeping the DAC at 0.35 GPa and 277 K for 12 hours. The optimal single-crystal growth conditions 
proved difficult to find. The crystals were very sensitive to temperature and pressure changes and 
thus the multi-nucleation phenomenon was ubiquitous (Figure 8.5). After extensive testing the 
following procedure was established: starting from the crystalline powder at 0.35 GPa, the pressure 
was cycled several times to dissolve all material but a few crystals. The temperature was 
subsequently cycled using a heatgun at 323 K to dissolve all but one single crystal. The DAC was 
then placed into an incubator and the temperature was decreased from 306 to 298 K at a rate of 1 
K/day. The final crystal (Figure 8.5.f) was measured at 0.27 GPa by means of single-crystal X-ray 
diffraction. 
 
Figure 8.5. Optical microscopy images of the high-pressure growth of form II-d in a DAC. (a) DAC Closed. 
Pressure: 0.18 GPa; (b) Crystalline powder at 0.35 GPa obtained after a few hours at 277 K; (c) The crystalline 
powder dissolving by cycling pressure; (d) A slight increase of the pressure promotes fast growth of the 
remaining crystals; (e) A single crystal obtained by cycling pressure and temperature. The DAC was placed 
into an incubator for 10 days with a starting pressure of 0.09 GPa; (f) Final stage at 0.27 GPa. 
 Form III: Crystallisation of [C10mim]Cl trihydrate at 1.14 GPa  8.3.3.4.
A ca. 0.5 M aqueous solution of [C10mim]Cl, corresponding to a water content of ca. 88% 
(w/w), was prepared and loaded into a DAC. By increasing pressure the clear solution crystallises 
instantaneously at about 0.95 GPa (Figure 8.6). The solid to liquid transition takes place at ca. 0.60 
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GPa while releasing the pressure. A second crystallisation path consists of increasing the pressure 
above the transition point to a pressure of ca. 0.7 GPa and promoting crystallisation either quickly 
by putting the DAC in a cold environment (253-277 K), or slowly by leaving the DAC at ambient 
temperature; nucleation is achieved after a certain latency period. A single crystal was successfully 
grown by cycling temperature at ca. 0.55 GPa. The pressure was subsequently increased slowly to 
favour the growth of the crystal. The crystal occupied almost half of the sample chamber in the 
final growth stage at ca. 1.14 GPa (Figure 8.6). The single crystal was measured by single-crystal X-
ray diffraction at the same pressure. 
 
 
Figure 8.6. Optical microscopy images of the high-pressure growth of form III at 1.14 GPa. (a) Clear solution 
at ca. 0.7 GPa; (b) Polycrystalline material at 0.7GPa after 20 min at 263 K; (c) Heating at 373 K and 0.7 GPa; (d) 
Cooling at 363 K; (e) Single crystal growing on cooling at 353 K; (f) Final crystal 1.14 GPa. 
 Form III: Crystallisation of [C10mim]Cl trihydrate at 0.6 GPa 8.3.3.5.
In order to investigate the effects of concentration on the crystallisation outcome, a further 
high-pressure crystallisation experiment of a ca. 1 M aqueous solution of [C10mim]Cl, 
corresponding to a water content of ca. 80% (w/w), was carried out. The pressure was increased to 
0.58 GPa and crystallisation was induced within 2 hours at 263 K; we note that at the same pressure 
conditions no crystallisation occurred after 19 hours at 277 K. A single crystal was grown by 
cycling temperature at slightly higher pressures (ca. 0.63 GPa, Figure 8.7). While the crystal was 
growing, the pressure dropped until the system reached the phase boundary conditions at ca. 0.55 
GPa. The final pressure at which the crystal was measured was 0.60 GPa. 
 
Figure 8.7. Optical microscopy images of the high-pressure growth of form III at 0.60 GPa. (a) Clear solution 
at ca. 0.12 GPa; (b) Polycrystalline material at 0.58 GPa after 2 hours at 263 K; (c) Crystals dissolving at 0.58 
GPa and 323 K using a heat source; (d) Crystal at 0.58 GPa under 323 K; (e) Single crystal growing at 0.63 GPa; 
(f) Final crystal at 0.6 GPa. 
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 X-ray crystallography 8.3.4.
Diffraction data for form II-d were collected on an in-house modified mardtb desktop 
diffractometer equipped with a mar345 image plate detector and an Incoatec (IµS) microfocus X-
ray source using Ag Kα radiation of λ = 0.56085 Å. Diffraction experiments of all other forms were 
performed using a Bruker AXS SMART Apex II CCD diffractometer equipped with Mo Kα sealed-
tube radiation of λ = 0.71073 Å and an Oxford Cryosystems Cobra low-temperature device. The 
low-temperature crystalline phases are probably stable at ambient temperature under negligible air 
humidity (< 2%). After a few hours at ambient air humidity, measured at 30 % in our laboratory, all 
single crystals underwent a phase transition to gel-like lyotropic phases. It was imperative to 
protect the crystals before and after crystal growth at low temperature and immersion oil was used 
for this purpose; single crystals were quickly transferred to the X-ray machine and placed under 
the cold stream.  
 Data processing 8.3.4.1.
Data integration and global-cell refinement were performed using the program SAINT.27 
High-pressure data processing was performed according to the procedure by Dawson et al.28 The 
program SADABS29 was used to correct for absorption and systematic errors. For the high-pressure 
data, the program SHADE30 was additionally used. All structures were solved with 
macromolecular phasing methods using SHELXD31. Partial fragment seeding using 1,3-
dimethylimidazolium was employed to solve the structure of form II-c. Full-matrix least-squares 
structure refinement against F2 was performed using SHELXL201431 through the SHELXLE GUI.32 
Stereochemical restraints for the cations were applied to increase the robustness of the refinement: 
restraints were generated by the GRADE program using the GRADE Web server33. A GRADE 
dictionary for SHELXL contains target values and standard deviations for 1,2-distances (DFIX) and 
1,3-distances (DANG), as well as restraints for planar groups (FLAT). Anisotropic displacement 
parameters were refined using the new rigid bond restraint (RIGU) implemented in the 
SHELXL2014 program.34 All H-atoms of [C10mim]+ were placed geometrically and allowed to ride 
on the parent atoms. H-atoms belonging to ordered water molecules were clearly visible in 
difference Fourier maps and their positions were refined subject to distance restraints. For the 
remaining structures H-atoms were placed based on considerations of H-bonding patterns and 
refined subject to restraints. Uiso(H) values were assigned in the range 1.2–1.5 times Ueq of the 
parent atom. Structures of form II exhibited some type of disorder of one cation, one anion and one 
water molecule, O(3). Full details on the treatment of disorder can be found below. 
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 Treatment of disorder 8.3.4.2.
The very good quality of low-temperature data of form I permits to locate a rotating C(6) 
methyl group with six peaks in the difference Fourier maps corresponding to H atoms. Two 
groups of H atoms were placed geometrically and allowed to ride on the parent atom. Both groups 
have equal site-occupancy factors of 0.5. 
All form II structures exhibit disorder affecting water molecules, the imidazolium ring of 
Res3 and the anion Cl(3): 
 For the low-temperature structures, the positions of the disordered non-hydrogen 
atoms were resolved in the density maps. Site-occupancy factors of all disordered atoms 
were refined, and then subsequently fixed only for water molecules.  
 For the high-pressure structures, the imidazolium ring of Res3 was modelled to fit the 
electron density maps. Due to the lower quality of the data, site-occupancy factors of all 
disordered atoms were fixed to the initially refined values.  
 For both low-temperature and high-pressure structures, H atoms belonging to 
disordered water were not placed during refinement but were taken into account for 
the calculation of F000 and derived properties. 
 Results and discussion 8.4.
A total of eight crystal structures were refined, three obtained using low-temperature 
crystallisation conditions and five at high pressure. Crystallographic data are summarised in Table 
8.1. Form I corresponds to a monohydrate and was obtained under both low-temperature and 
high-pressure conditions. With ten analogous structures reported in the Cambridge Structural 
Database,9 form I is the most common monohydrate (the CSD, V. 5.35 including updates up to May 
2014 was searched using no filters). Form II crystallises with a variable water content of 0.95 and 
0.93 water molecules per cation at low temperature and 0.47-0.5 at high pressure. The CSD contains 
two entries for analogous structures of form II. Form III corresponds to a high-pressure trihydrate 
never reported previously for long-alkyl chain imidazolium-based ILs or other ILs. For our 
database search, analogous structures are not only defined as structures having similar unit cell 
parameters, but also as structures that are homeotypic at least at the level of a 2D network (see 
below for details). Table 8.3 summarises the observed forms of all [Cnmim][X] ILs (n ≥ 8, X  halide 
anion) together with their crystallisation conditions reported in the literature including the 
structures reported in this work. 
Forms I-III crystallise in the triclinic centrosymmetric space group. Similar unit-cell 
settings were chosen to facilitate structural comparison of all forms. The structures obtained at low 
temperature are of good quality. Data completeness of the high-pressure structure is between 33 
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and 48 %; the low completeness is on one hand due to the limited access to reciprocal space caused 
by the geometry of the DAC, exacerbated here by the low crystal symmetry, and on the other hand 
to the crystals’ quality and size. Whereas the structure of form III-b was easily solved thanks to the 
good data collected at 1.14 GPa, data of form I-b and especially data of form II-c were far from 
ideal. Considerable time and effort were required to obtain crystals of good diffraction quality; 
despite the low data-to-parameter ratio for the high-pressure data, the refinement results are very 
satisfactory, with the exception of form II-d for which the maximum resolution is 1.3 Å and the R 
factor is the highest with a value of 0.135; this is directly related to the difficulties of growing 
crystals of this form and hence the limited crystal quality. Despite the high R-factor for this form, 
all structural features can be described with confidence. In the following sections, the X-ray 
structures are described and compared in more details. 
For the description of all structures, a positive C2–N1–C7–C8 torsion angle was chosen 
(Figure 8.1).  
Table 8.1. Crystallographic data for [C10mim]Cl structures discussed in this chapter. The same Roman 
numeral is given to structures with similar unit cell parameters. The letter following the Roman numeral 
indicates variation in water content and/or position in different crystal structures. All structures have been 
solved from single-crystal data. 
 


















Space group P-1 P-1 P-1 P-1 P-1 P-1 P-1 P-1 
a/Å 5.3607(2) 5.3387(19) 7.2807(2) 7.344(6) 7.3494(5) 7.3264(18) 5.3513(5) 5.2844(5) 
b/Å 7.7232(2) 7.7592(12) 8.4710(2) 8.508(7) 8.4551(5) 8.371(2) 7.2152(8) 7.0547(4) 
c/Å 20.4674(6) 20.428(5) 43.0059(11) 43.39(4) 42.735(7) 42.879(16) 22.706(5) 22.364(2) 
α/° 82.1449(12) 82.056(17) 85.0460(13) 84.77(5) 83.125(9) 82.900(7) 83.711(14) 83.949(6) 
β/° 87.2216(12) 87.16(2) 89.8188(14) 89.32(5) 89.000(9) 89.106(11) 89.209(13) 88.487(7) 
γ/° 78.9156(12) 79.09(2) 70.9453(13) 70.73(5) 69.871(4) 69.909(8) 82.429(7) 83.478(6) 
V/Å3 823.56(4) 822.7(4) 2496.80(11) 2548(4) 2474.6(5) 2449.7(13) 863.8(2) 823.64(12) 
Z’ 1 1 3 3 3 3 1 1 
Dcalc/g cm-3 1.116 1.118 1.100 1.077 1.078 1.087 1.203 1.262 
Pressurea 0.1 MPa 0.2 GPa 0.1 MPa 0.1 MPa 0.05 GPa 0.27 GPa 0.6 GPa 1.14 GPa 



















dmax/Å 0.800 1.000 0.930 1.196 1.150 1.293 0.860 0.83 
(Sin(θ)/λ) /Å-1 0.625 0.500 0.538 0.418 0.435 0.387 0.582 0.602 
Completeness 
to dmax 
0.904 0.393 0.976 0.984 0.475 0.467 0.332 0.382 
Rint 0.0173 0.0504 0.0468 0.0724 0.0589 0.0881 0.0310 0.0364 
R1c 0.0372 0.0692 0.0531 0.0499 0.0682 0.1480 0.0463 0.0494 
wR2d 0.1003 0.2173 0.1450 0.1231 0.2060 0.3127 0.1065 0.1433 
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Table 8.2. Summary of the crystallisation conditions of the [Cnmim]X structures (n ≥ 8, X ≡ halide anion) 





Experiments Results – Analogues 
Setup Solvent Conditions Form I Form II Form III 
Chen et al.1 YORNOJ01 
[C14mim]Br ∙ 
1 H2O 


































Acetic anhydride RT X   









RT X   
Wei et al.6 SOXGOC 
[C16mim]Br ∙ 
1 H2O 
Slow evaporation Ethyl acetate 2 weeks X   
Zhao et al.7 SOXGOC01 
[C16mim]Br ∙ 
1 H2O 
Not available   X   
Zhao et al.8 SOXGOC02 
[C16mim]Br ∙ 
1 H2O 
Slow cooling Not available 
Sample dried 24 h 
under vacuum at 
323 K 









DACb 6-8% (w/w) H2O 
Formed above 0.3 
GPa 




Linkam stage < 6% (w/w) H2O 
Preheated / fast 
cooling 




Linkam stage < 6% (w/w) H2O 
Preheated / fast 
cooling 




DAC << 6% (w/w) H2O 
Sample dried 3 h 
under vacuum at 
333 K 




DAC + glove box << 6% (w/w) H2O 
Sample dried 5 h 
under vacuum at 
333 K 




DAC 1 M aq. solution 
Stable above 0.55 
GPa 




DAC 0.5 M aq. solution 
Stable above 0.55 
GPa 
  X 
a RT = room temperature. b DAC = diamond-anvil cell. 
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 Crystal structure of form I  8.4.1.
Form I is the most often encountered structure of a hydrate of a long alkyl chain 
imidazolium-based halide IL in the CSD. An important point to retain from Table 8.2 it that all 
reported form I structures were obtained using slow crystallisation processes, in line with our 
experimental findings. 
The structure of form I has been described several times previously.1–8 The following are 
the main structural features characterising all reported structures, including our determination. 
The structure of form I consists of bilayers, in which the cations are alternating from layer to layer 
creating hydrophobic and hydrophilic regions (Figure 8.2). The hydrophobic region is formed by 
interactions between interdigitated side chains having a linear all-anti conformation. The 
hydrophilic region is formed by an extensive H-bonded network between the imidazolium ring, 
the chloride anion and the water molecule. The main H-bonded contacts include two short 
interactions between the chloride anion and the water molecule [O∙∙∙Cl = 3.3231(17) and  
3.2457(17) Å at low temperature, 3.272(19) and 3.286(19) at high pressure] thereby forming an 
infinite zigzag chain along the [1 0 0] base vector (see Figure 8.2.3). The imidazolium ring is 
connected to two chloride anions through C(4)–H∙∙∙Cl and C(5)–H∙∙∙Cl’ contacts, forming an 
approximately planar H-bonded ring motif (Figure 8.8). The water molecule is accepting a H-bond 
from C(2)–H of the imidazolium ring (Figure 8.8). Hence, the water molecule is a single H-bonded 
acceptor and fulfils its capacity as double H-bonded donor.  
 
 
Figure 8.8. Crystal packing of [C10mim]Cl form I seen along the b-axis. H-atoms have been omitted for 
clarity. (1) Hydrophobic layer with interdigitated cation side chains; (2) Hydrophilic layer; (3) O–H∙∙∙Cl H-
bonded chain along the a-axis; (4) H-bonded ring motif formed between C(4)–H, C(5)–H and [Cl]22-; (5) Water 
imidazolium contact via C(2)–H. 
 
Getsis and Mudring stated that in the solid state [C12mim]Br∙H2O4 is isotypic with 
[C12mim]Cl∙H2O,5 and that [C12mim]Br∙H2O is homeotypic with [C14mim]Br∙H2O.4  Starting from 
these observations, a detailed structural comparison was carried out using the XPac method35 and 
Hirshfeld surface analysis,36 with the aim of confirming and applying Getsis and Mudring’s 
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observation to all known structures of [Cnmim]X∙H2O (n ≥ 10, X  halide anion) crystallising as 
form I monohydrate, including the ones reported in this work. The XPac method is a powerful tool 
for assessing the degree of packing similarities between two or more crystal structures in a 
straightforward, efficient and rapid manner. Structural comparison is simplified to a similarity 
relationship of none-, zero-, one-, two- or three- dimensional supramolecular constructs assessed 
with a computed dissimilarity index.37 Seven crystal structures were compared using the [C10mim]+ 
fragment common to all structures; the XPac program default values were used. The results of this 
analysis are summarised in Table 8.3. The 21 structural comparisons include three 3D and 18 2D 
supramolecular constructs. Other supramolecular constructs of lower dimensionality are not 
observed, indicating that all structures are highly similar. The three 3D supramolecular constructs 
describe comparisons of isotypic [Cnmim][X] structural pairs with identical alkyl chain length and 
have a dissimilarity index that ranges between 2.2 and 4.1: both structures of the [C10mim]Cl∙H2O 
monohydrate obtained at low temperature and at high pressure, [C12mim][Cl]∙H2O with 
[C12mim][Br]∙H2O, and [C14mim][Cl]∙H2O with [C14mim][Br]∙H2O. The 18 2D supramolecular 
constructs describe homeotypic structures, where the missing similar third dimension is ascribed 
to the different alkyl chain lengths. The dissimilarity index values are between 0.8 and 4.5. 
 





[C12mim]Br∙H2O  2.8b 3.8b 
[C12mim]Cl∙H2O 3.1b 4.0b 4.1a 
[C14mim]Br∙H2O 2.8b 3.8b 0.8b 4.5b 
[C14mim]Cl∙H2O 1.6b 2.7b 2.9b 2.2b 3.0a 






[C12mim]Br∙H2O [C12mim]Cl∙H2O [C14mim]Br∙H2O 
[C14mim]Cl∙H2
O 
a 3D supramolecular construct – same alkyl chain length. b 2D supramolecular construct – different alkyl chain length 
 
A further structural comparison based on Hirshfeld surface analysis implemented in the 
Crystal Explorer38 program has been carried out. Hirshfeld surface analysis is a powerful tool for 
elucidating and comparing intermolecular interactions and the packing environment in crystal 
structures.39 The structural comparison presented here is based on the visually informative two-






Dissimilarity index  
low          3D Supramolecular construct          high 
low          2D Supramolecular construct          high 
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Figure 8.9. [C10mim]Cl cluster and its corresponding Hirshfeld surfaces mapped with the dnorm property.39 
(a) H∙∙∙X contacts; (b) H∙∙∙O contacts; (c) C–H∙∙∙H–C contacts 
 
For the generation of the Hirshfeld surface a cluster, as opposed to the traditional 
individual molecule, was chosen. This enables the visualisation of all intermolecular contacts 
formed by the molecules in the cluster with neighbouring clusters in a single fingerprint plot for 
each structure. Each cluster contains a cation, a water molecule and an anion (Figure 8.9).  For 
Hirshfeld surfaces generation a cluster was chosen so that the constituent molecules/ions are not 
directly connected to the others.  This enables the generation of three Hirshfeld surfaces per cluster 
but only one fingerprint plot. The Hirshfeld surfaces generated in this way are identical to the ones 
that would be obtained for each individual molecule/ion. The main difference of this cluster 
approach with respect to the single-molecule one is that our fingerprint plots are necessarily much 
more symmetrical than those of the individual constituents. Inspection of the fingerprint plots 
(Figure 8.10) reveals a high degree of structural similarity, corroborating the results of XPac 
analysis presented earlier.  
 
Figure 8.10. 2D fingerprint plots of the six structures of form I: (a) low-temperature structure of this work;  
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 Crystal structures of forms [II-a – II-d] 8.4.2.
The crystal structures of form II hydrates are homeotypic with respect to [C14mim]Cl∙H2O-I 
and [C18mim]Cl∙H2O reported by Downard et al..2 However, unlike the latter two structures, all 
form II structures presented herein are not genuine monohydrates, hence in our study forms I and 
II are strictly speaking not polymorphic. Similarly to [C14mim]Cl∙H2O-I and [C18mim]Cl∙H2O, form 
II crystallises with three symmetry independent cations and anions in the asymmetric unit. 
Whereas two of the cations (here named Res1 and Res2, where Res stands for residue, Figure 8.11) 
are linear and ordered, the third one (Res3) is bent and disordered over two positions. The chloride 
anion and water molecule associated with Res3 are disordered as well, giving rise to the structures’ 
variable water content. This disorder causes the appearance of a second hydrophilic region 
compared to form I, thereby creating a double bilayered structure that extends along the c-axis.2 
The double bilayer character gives rise to the characteristic long c-axis of all form II structures 
(Figure 8.12).  At high pressure, further structural variability is introduced, with different 
occupancies for O(2), which is located in the (predominantly) ordered hydrophilic region, also 
observed (see Table 8.4 for details). 
 
Figure 8.11. Asymmetric unit of [C10mim]Cl form II-a 
 
 
Figure 8.12. Crystal packing of [C10mim]Cl form II-a seen along the b-axis. H-atoms have been omitted for 
clarity. (1) Hydrophilic disordered layer; (2) Hydrophobic layer showing the interdigitated side chain; (3) 
Hydrophilic layer, ordered at low temperature. 
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Although the crystals were grown under different experimental conditions and hence 
generalizations are difficult to make, it is interesting to note that the effect of reducing the water 
content from 0.95 to 0,47 molecules per cation in the structure manifests itself with the gradual 
removal of water molecules in the disordered region accompanied by partial occupancy of O(2). 
The O(1) water site is always fully occupied; this gives stability to the hydrophilic layer, which 
appears to be essential for structure stability of this form. 
The H-bonded motifs involving Res1 and Res2 are similar to those described previously.2 
Both Cl(1) and Cl(2) chloride anions form an isolated {[H2O]Cl}22- dimer with  O(1) and O(2) water 
molecules. The {[H2O]Cl}22- dimer is not uncommon for hydrated halide structures: a search in the 
CSD (the CSD, V. 5.35 including updates to May 2014 was searched using no filters) shows that the 
dimer is occurring in 551 organic and inorganic crystal structures. This dimer is also present in the 
disordered region though the presence of disorder makes H-bond interpretations difficult. At low 
temperature, all {[H2O]Cl}22- dimers in the disordered region are inter-connected. In structure II-c 
crystallised at high-pressure there are no water molecules in the disordered region. In structure II-
d the {[H2O]Cl}22- dimer is present but in contrast to all other structures it is isolated.  
 
Table 8.4. Summary of the differences in the site occupancies of all form II structures presented in this 
work. 
 Form II-a Form II-b Form II-c Form II-d 
Res 3 (imidazolium ring) 
Part 1 (Res 3) 



























O(1) 1.000 1.000 1.000 1.000 
















A further important factor in the stabilization of the hydrophilic regions is the 
conformation of the cation, which can be either linear, as found in the ordered region, or bent, as 
found in the disordered region, as defined by the values of the N(1)–C(7)–C(8)–C(9)  torsion angle 
listed in Table 8.5. In the bent conformer, the imidazolium ring is approximately orthogonal to the 
plane formed by the alkyl chain, as indicated by the value of the C(2)–N(1)–C(7)–C(8) torsion 
angle. The C(2)–N(1)–C(7)–C(8) and N(1)–C(7)–C(8)–C(9) torsion angles define the tilt and the 
inclination of imidazolium ring, respectively, with respect to the plane formed by the alkyl chain. 
In the hydrophobic layers, the cation side chains form an interdigitated pattern, as found in form I.  
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Table 8.5. Summary of dihedral angles of the decyl side chain of [C10mim]+ cation and the reference angle 
C(2)–N(1)–C(7)–C(8) seen in the low-temperature structures of form I and II-a. Highlighted values for Res2 
of form II-a are responsible for the observed curving of the alkyl chain discussed in the main text. 
Dihedral angle/° Form I (LT) 
Form II-a* 
Res1 Res2 Res3 Res3' 
C(2)–N(1)–C(7)–C(8) 125.51 ( 0.17) 134.32 ( 0.32) 131.84 ( 0.34) 71.46 ( 0.88) 71.56 ( 1.41) 
N(1)–C(7)–C(8)–C(9) -175.95 ( 0.14) -169.59 ( 0.27) -179.45 ( 0.29) 53.78 ( 0.58) 68.26 ( 0.81) 
C(7)–C(8)–C(9)–C(10) -179.12 ( 0.15) -178.33 ( 0.29) 172.38 ( 0.31) 176.22 ( 0.35) 
C(8)–C(9)–C(10)–C(11) -178.80 ( 0.15) -179.10 ( 0.30) -178.08 ( 0.31) 175.71 ( 0.36) 
C(9)–C(10)–C(11)–C(12) 179.67 ( 0.15) 179.46 ( 0.31) 174.83 ( 0.32) -179.83 ( 0.34) 
C(10)–C(11)–C(12)–C(13) 179.68 ( 0.15) 179.90 ( 0.31) -178.78 ( 0.31) 179.15 ( 0.34) 
C(11)– C(12)–C(13)–C(14) 179.70 ( 0.15) 179.60 ( 0.32) 177.52 ( 0.32) 179.30 ( 0.32) 
C(12)–C(13)–C(14)–C(15) 179.13 ( 0.15) -178.62 ( 0.33) -179.76 ( 0.32) 179.45 ( 0.33) 
C(13)–C(14)–C(15)–C(16) 179.76 ( 0.17) 179.06 ( 0.37) 179.73 ( 0.36) 179.12 ( 0.33) 
*other form II structures follow the same conformations as those of form II-a 
A distinctive feature of form II is the linear, curved and linear character of the alkyl side 
chains of Res1, Res2 and Res3 cations, respectively. The slight inclination has been previously2 
ascribed to the imidazolium H-atoms of Res2 acting as a bridge for {[H2O]Cl}22- dimers. The slight 
curving is more pronounced in [C10mim]Cl compared to the structures described previously. 
Furthermore, the plane defining the side chain of Res1 is almost orthogonal to both planes formed 
by Res2 and Res3 side chains (Figure 8.11). The “curving”2 of the alkyl chain was calculated during 
the structural refinement with SHELXL through the input of the command MPLA. A least square 
plane was calculated using the carbon atoms’ positions of the alkyl chain. Deviations of each atom 
position from the calculated least square plane are listed in the following charts. Figure 8.13 shows 
that for a given chain length the curving of Res2 alkyl chain is not affected by the crystallisation 
conditions; however, the curving is clearly dependent on the length of the alkyl chain, as is clearly 
displayed in Figure 8.14.  
 
Figure 8.13. Comparison between the curving of the alkyl chains of Res2 in all form II structures reported 
in this work. A second order polynomial fit has been used to visually clarify the alkyl curving and should 
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Figure 8.14. Comparison between the curving of the alkyl chains of Res2 in: form II-a, [C14mim]Cl and 
[C18mim]Cl structures. A second order polynomial fit (poly.) has been used to visually clarify the alkyl 
curving and should only be used as a guide to the eye. 
 
A notable difference between the low-temperature and high-pressure structures, in 
addition to the differences in the site occupancies of the anions and water molecules, is that the 
imidazolium ring of Res3 exhibits tilting disorder at low temperature and ring flipping disorder at 
high-pressure conditions. Whereas at high pressure the disordered positions are equally occupied, 
this is not the case at low temperature (see Table 8.4). These structural differences can be directly 
ascribed to the different crystallisation conditions under which the structures were obtained. The 
observation of different conformations in the solid state indicate great structural variability in this 
form but should not be surprising given this form is obtained at low temperature by fast cooling 
rates and has a fast growth rate at high pressure, i.e. is obtained under kinetic control. Our 
experiments demonstrate that temperature annealing at high-pressure conditions is insufficient to 
induce complete ordering but results in the two cation positions being equally occupied. 
 
 Crystal structures of form III 8.4.3.
[C10mim]Cl form III is a novel trihydrate form which, to the best of our knowledge, has 
never been reported for imidazolium-based ILs irrespective of alkyl chain length; rapid dissolution 
of the crystal on decompression prevented the investigation of recovery experiments. The structure 
of form III is fully ordered and is closely related to that of form I, with two further water molecules 
embedded in the hydrophilic region. As a consequence of this simple relationship, the main 
structural features describing form I are also valid for form III. The two new water molecules are 
inserted in the hydrophilic layer, increasing the distance between the imidazolium headgroups and 
creating an extended H-bonded network that can be described as a zigzag panel extending along 
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When comparing the common fragments to both form I and form III structures, an 
important difference emerges, namely that the atomic positions of the anion and water molecule 
are interchanged. Whilst this does not alter the direction of the H-bonded zigzag chain, it enables 
the formation of a similar second chain bridged to the first via the additional water molecules 
(Figure 8.15.3). The repeating unit of this 3D H-bonded network is a {[H2O]3Cl}- ring. This motif is 
not uncommon and is found in 40 organic and inorganic structures in the CSD (V. 5.35 including 
updates to May 2014); however, the zigzag panel observed in form III is not seen in any of the 
reported structures. These findings provide further evidence that high pressure is able to combine 
interactions to form motifs that are new or uncommon at ambient pressure.40–44 
 
Figure 8.15. Crystal packing of [C10mim]Cl form III (0.6 GPa) seen along the b-axis. H-atoms have been 
omitted for clarity. (1) Hydrophobic layer with interdigitated cation side chains; (2) Hydrophilic layer; (3) O–
H∙∙∙Cl H-bonded chain along the a-axis; (4) {[H2O]3Cl}- H-bonded ring; (5) H-bonded zigzag panel. 
 
 Liquid crystalline phases 8.4.4.
The title compound undergoes self-assembly and gelation upon water uptake; this 
property is not unknown for 1-alkyl-3-methylimidazolumhalides,2–4,8,15,19,45,46 and was described for 
the first time more than a decade ago by Firestone et al. for [C10mm]Br.19 A follow-up article in 2004 
by the same group details the liquid crystalline changes that [C10mim]Br undergoes upon addition 
of water, using SAXS, infrared and NMR spectroscopy techniques.20 For this compound three 
lyotropic phases have been described having lamellar, hexagonal perforated layer with cubic 
character, and hexagonal structure for added water contents between 11 % and 16 % (w/w), of 17 % 
(w/w) and of 40 % (w/w), respectively, with respect to a dried sample containing 1.5 % (w/w) 
water. Gelation was actually already observed for a composition containing ca. 5 % (w/w) water.  
In our work, we have observed very facile formation of water-rich lyotropic liquid 
crystalline phases of [C10mim]Cl, which can be formed when the neat liquid uptakes air humidity 
or from an aqueous solution after a slow evaporation process (see Appendix 8.7 for details). We 
have observed that an increase in water content widens the temperature range of stability of these 
phases. This is in line with the thermal investigations of [C16mim]Cl∙H2O systems by Wu et al.46 At 
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least two, possibly three, lyotropic phases could be observed by polarised optical microscopy for 
[C10mim]Cl at ambient pressure and, additionally, as described in the experimental section, one at 
high pressure. The ambient-pressure results are qualitatively in good agreement with those on 
[C10mim]Br. We note that our dried sample has a higher starting water content, ca. 2 % (w/w), than 
that of [C10mim]Br;20 we observed instantaneous formation of liquid crystals at ca. 4% added water. 
At ca. 19% (w/w) added water, the liquid crystalline phase looks distinctively different by optical 
microscopy and we presume this is a different phase. A further change was detected by 
microscopy at ca. 50% (w/w). From ca. 57.7 % (w/w) added water, dissolution of the liquid crystals 
is observed; at ca. 76.7 % (w/w) added water, optical microscopy indicates a pure liquid state is 
obtained. We note that technically speaking a ca. 76.7 % (w/w) added water solution corresponds to 
a concentration of ca. 1.1 M solution and that a 1 M solution was used to obtain the trihydrate 
crystalline phase at high pressure The phenomenon of liquid crystal formation at high-pressure 
conditions has not been extensively studied, with research focussed on polymeric compounds, one 
notable example being melting and crystallisation of polyethylene47. Interestingly, as described in 
the experimental section, upon further pressurization, the liquid crystal of [C10mim]Cl transforms 
into a crystalline phase. To the best of our knowledge, this is the first instance of such a pressure-
driven phase transition. We note that for lipids, it has been observed that “The application of 
hydrostatic pressure to lyotropic phases in excess water tends to increase the lattice parameters of 
the phases. This effect is caused by the increase in conformational order of the hydrocarbon chains 
by pressure, and is the opposite effect to that of increasing temperature.”48   
 
 [C10mim]Cl as a crystallisation solvent for active pharmaceutical ingredients 8.4.5.
Having studied the behaviour of the neat IL and its aqueous solutions, our attention 
moved to trying to use this IL as a crystallisation solvent for active pharmaceutical ingredients 
(APIs). The aim of this study was to acquire some experience with using ILs as crystallisation 
media, particularly at high pressure. A recent example of a successful drug polymorphism study 
using water/IL mixtures as a co-solvent and the thermal shift method for crystallisation, is that of 
adefovir dipivoxil, an antiviral agent49 used in the treatment of the hepatitis B virus. For this 
compound a new polymorph and a new hemihydrate have been reported that could not be 
obtained when using conventional organic solvents.50 Subsequently, the same authors reported a 
further new polymorph of the same compound obtained using mixtures of ionic liquids.51 The 
available literature reports experiments performed at ambient-pressure conditions only.  
Preliminary experiments were performed using carbamazepine, 5-fluorouracil and 
paracetamol as APIs. The first two drugs were tested at ambient-pressure conditions, using dilute 
aqueous solutions, and the latter at high pressure using a ca. 1 M aqueous solution of the IL; all 
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materials were characterised by POM and single-crystal X-ray diffraction. For the ambient-pressure 
experiments the API was dissolved in the solution by applying heat (Tmax 323 K); the mixture was 
cooled slowly to room temperature and crystallisation was observed upon slow evaporation. 
Carbamazepine dihydrate and the triclinic form for 5-fluorouracil were obtained in this manner. 
For the high-pressure experiments (Figure 8.16), crystals of paracetamol were dissolved in situ in 
the DAC upon heating to 343 K. Crystallisation of [C10mim]Cl and paracetamol was observed at ca. 
0.9 GPa. By cycling pressure and temperature, single crystals of paracetamol were grown and 
identified as the orthorhombic form of the drug, as confirmed by diffraction. 
 
Figure 8.16. High-pressure crystallisation attempt of paracetamol in [C10mim]Cl solution in a DAC. a) DAC 
loaded at 0.16 GPa with a crystalline powder of paracetamol in ca. 1 M solution of [C10mim]Cl, dissolution 
occurred after heating to 343 K and was complete in b); c) increasing pressure gradually from 0.30 to 0.95 GPa 
through promotes the crystallisation of two populations of crystals; d) pressure dropped to 0.82 GPa after 
complete crystallisation of the solution; e) releasing pressure to 0.29 GPa dissolves the PTM a small crystalline 
cluster grown near the gasket is observed; f) increasing pressure to 0.44 GPa promotes crystal growth; g) two 
single crystals were obtained by cycling temperature up to 443 K; h) cooling to ambient temperature 
promoted the growth of the crystals which was complete at the same pressure of 0.44 GPa. 
 
In a second high-pressure experiment in which a different pressure and temperature range 
for crystallisation was explored, paracetamol monohydrate was crystallised instead (Figure 8.17).  
 
Figure 8.17. High-pressure crystallisation attempt of paracetamol in [C10mim]Cl solution in a DAC. a) DAC 
loaded at 0.10 GPa with single crystals of paracetamol in ca. 1 M solution of [C10mim]Cl; b) complete 
dissolution at the same pressure after heating the DAC to 363 K; c) crystalline powder of the PTM was 
obtained after increasing pressure to 0.70 GPa and cooling the cell to 277 for 12 hours; d) the crystalline 
powder is dissolved after releasing the pressure to 0.56 GPa; e) crystallisation of needles after gentle heating to 
313 K for 2 hours, pressure inside the DAC dropped to 0.47 GPa; f) cycling temperature up to 373 K and 
pressure promoted the growth of a large needle, final pressure inside the DAC was 0.66 GPa.  
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Both paracetamol forms are easily obtained at ambient-pressure conditions and have also 
been reported to form at high pressure when using water, ethanol or methanol as solvents;52,53 at 
high pressure, concentrated solutions favour the crystallisation of paracetamol form II if pressure is 
increased gradually, while pressurisation of less concentrated solutions to pressure as high as  
1 GPa favours the crystallisation of paracetamol monohydrate.53 In our experiments, the different 
forms are obtained as a function of the different pressure and temperature regimes used but not as 
a function of compression rate. 
 General discussion 8.4.6.
[C10mim]Cl is a highly hygroscopic material that that readily forms gel-like mesophases at 
ambient pressure and temperature conditions. In the solid state, both form I, a true monohydrate, 
and form II, which crystallises with variable water content, from a pseudo-hemihydrate at high 
pressure to pseudo-monohydrate at low temperature, undergo a solid to gel phase transition when 
left in contact with air humidity. From the analysis of the hydrate structures obtained in this work, 
including the unprecedented availability of a trihydrate form, form III, uniquely obtained at high 
pressure, we speculate that mesophase formation might follow a mechanism that involves 
incorporation of water molecules in the hydrophilic region of the crystal, where the hydrophilic 
anions reside, and gradual disruption of the long-range crystalline order via cation disordering. On 
the basis of IR stretching frequencies, Firestone et al. commented on the C10 alkyl chain 
conformation in the fluid and the gel states of [C10mim]Br, and reported trans/gauche disorder for 
both.20 This type of disorder was also confirmed by molecular dynamics simulations.54 
Interestingly, single-crystal diffraction techniques show that in [C10mim]Cl hydrates the all-trans 
conformation exclusively exists in the three observed solid-state structures, with the exception of 
form II, where the gauche conformer is also observed in one of the three crystallographically-
independent cations; the fact that this particular conformation is associated with cation disorder in 
the solid state and that form II exhibits the largest variation in water content suggest that form II 
hydrates are “trapped” structures, all close in energy, that give further insight into the 
configurations found in solution. Incidentally, we also note that form II is a Z' > 1 structure that 
appears to be stable with respect to transformation and hence probably qualifies as a "fossil relic of 
the fastest growing crystal nucleus".55  
All low-temperature and high-pressure experiments conducted in this study are 
reproducible. An important parameter for preferential crystallisation of either form I or form II 
hydrates is water content: our experiments suggest that water content less than ca. 6% (w/w) added 
water leads to form II crystals while contents higher than these values favour the formation of form 
I. The formation of hemihydrate and monohydrate structures from solutions in the range of 2-8 % 
(w/w) water is not surprising. Technically speaking, 1:3 1:1 and 1:0.5 mixtures of [C10mim]Cl and 
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water correspond to solutions containing ca. 17.3, 6.6 and 3.4 % (w/w) water. Downard et al. 
already noted that a related compound, [C8mim]Cl, “absorbs approximately 6% (w/w) at ambient 
conditions over a period of 2.5 hours,56 which roughly corresponds to a 1:1 mixture of [C8mim]Cl 
and water”. In the case of [C10mim]Cl this concentration also yields and approximately equimolar 
stoichiometry. In addition to water content, kinetic factors seem to play an important role in 
[C10mim]Cl hydrate formation at low temperature, as exemplified by the influence of slow or fast 
cooling rates and sample history for obtaining either form I or form II crystals, respectively. This is 
in excellent agreement with the thermal polymorphism study on [C14mim]Cl by Downard et al. 2   
Form I and II crystals at high pressure can be distinguished by optical microscopy: form I 
crystallises as well-defined plate-like crystals (Figure 8.3), whereas it is fairly easy to see 
intergrowth regions in form II crystals (Figure 8.4 and Figure 8.5); we speculate that the origin of 
these regions can be ascribed to the extensive disorder in the crystal; it is not unlikely that the 
disordered layer of form II acts as a nucleation point for new crystalline orientations, i.e. twinning. 
Given the variable water content of form II crystals, we investigated whether water uptake or 
release can also take place in the solid state. For this purpose we compressed a crystal of form II-d 
from 0.05 GPa to ca. 1 GPa. Single-crystal X-ray diffraction indicates that this modest pressure 
increase does not result in a structural change. High-pressure crystallisation of solutions containing 
ca. 60% (w/w) water (2.5 M) also yielded a crystallisation event; we suspected the presence of form 
I; however, due to poor solubility and the extremely slow growth rate of the powder material, it 
was not possible to confirm the identity of this form.  
In light of the compound’s hygroscopicity, we have found that the confined, very small-
scale and sealed environment of the DAC is ideally suited for growing hydrates of the compound, 
offering better control over other techniques such as low-temperature crystallisation with a Linkam 
stage or in a capillary. In particular, the small sample volume of the DAC seems to be crucial for 
controlled crystallisation of the desired form: for instance, in the DAC it is easier to monitor and to 
ensure that the liquid-to-solid and the gel-to-solid phase transitions are complete. The coexistence 
of form I and II crystals and gel phases at low temperature can be explained by the much larger 
sample volumes used for these experiments. Interestingly, we have been unable to obtain a true 
monohydrate for form II, although such a hydrate probably does exit. We have also been unable to 
obtain structures with hydration number less than 0.45; as noted by Downard et al., “the nature of 
these layers, particularly the incorporation of water molecules via complex hydrogen-bonding 
interactions, may help to explain the persistent presence of water in imidazolium ionic liquids. It 
seems likely that the strong O-H…Cl hydrogen bonds in these compounds may be the reason that 
they are not easily dehydrated.” 2  Ultra high vacuum drying techniques might be useful towards 
this purpose.57 
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 Conclusions 8.5.
The structural behaviour of the long chain imidazolium-based IL [C10mim]Cl–water 
mixtures has been investigated by low-temperature and high-pressure crystallisation methods and 
the crystalline phases fully characterized by single-crystal X-ray diffraction. On the basis of our 
experimental findings, we have been able to outline reliable crystallisation protocols for all forms; 
in particular we would like to highlight the use of the DAC as an ideal crystallisation vessel for 
hygroscopic compounds, providing both a controlled environment that can be entirely viewed 
with ease under an optical microscope and an effective tool for exploring and extending the 
crystallisation diagram. Form I, a monohydrate, crystallises from solutions containing 6-8% (w/w) 
water and at low temperature its formation is favoured by slow cooling rates; its structure exhibits 
bilayers, in which the cations are alternating from layer to layer to create hydrophobic and 
hydrophilic regions. Form II, which incorporates a variable amount of water content (from pseudo 
hemihydrate to pseudo monohydrate) depending on sample treatment and environment, 
crystallises from solutions containing < 6% (w/w) water; at low temperature its formation is 
favoured by fast cooling rates. The structure of form II exhibits a double bilayered structure 
characterized by ordered and disordered regions. This Z' > 1 structure can be considered a "fossil 
relic of the fastest growing crystal nucelus".55 Form III is a trihydrate that has been exclusively 
obtained under high-pressure conditions above 0.55 GPa from solutions containing > 80% (w/w) 
water. Its structure is closely related to that of form I. While homeotypic and isotypic structures of 
forms I and II have been reported previously for long chain imidazolium-based ILs, form III 
represents, to the best of our knowledge, the first example of a highly hydrated long chain 
imidazolium-based ionic liquid observed in the solid state. Form III has presently only been 
obtained at high pressure; however, we cannot rule out that this form cannot also be formed via a 
low-temperature crystallisation route using less diluted solutions. The formation of mesophases in 
the title compound has also been investigated by polarized optical microscopy and the results 
correlated with previous liquid-crystal studies on related [C10mim]Br. Finally, preliminary 
experiments demonstrate that [C10mim]Cl water mixtures are suitable crystallisation media for 
crystallisation of drug molecules at both conditions of ambient and high pressure. Future studies 
will be performed to assess whether the combination of a long-chain amphiphilic IL together with 
water provides a widely applicable solvent matrix, e.g. for crystallisation by thermal, antisolvent, 
evaporation and high-pressure methods for both hydrophilic and hydrophobic drugs. 
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 Appendix: Qualitative analysis of [C10mim]Cl liquid crystal formation 8.7.
[C10mim]Cl is a transparent yellow liquid. As [C10mim]Cl is hygroscopic, it was dried twice 
prior to use: for 7h at 80°C and for 6h at the same temperature using a 1.4×10-1 and 2.1×10-1 mbar 
vacuum, respectively. 11 vials of [C10mim]Cl + H2O mixtures were prepared inside a nitrogen 
glovebox with an estimated relative humidity of 4.5 to 6% (20-22°C). The vials were sealed inside 
the glovebox. Gentle heating of the vials associated with stirring ensured a homogenous 
distribution of the water in the ionic liquid. The following pictures describe the results of the 
polarised optical microscopy (POM) of [C10mim]Cl∙H2O mixtures for each sample composition. The 
pictures were taken just after opening the sealed vials. There are three distinguishable phases: The 
neat liquid, mesophases (as a function of different water concentration) and [C10mim]Cl∙H2O 
solutions 
Neat compound, ca. 2% 
(w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 0.3 
 
ca. 6% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 0.9 
 
ca. 6% (w/w) H2O, 
Instantaneous 
crystallisation of the 
spherulites after 
oppening the vial 
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ca. 7.5% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 1.1 
 
 
ca. 20.5% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 3.5 
 
 
ca. 29% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
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ca. 34.5% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 7.5 
 
 
ca. 53% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 16 
 
Although the dark 
region looks like a 
liquid, it is a gel. 
The shape of the 
spherulites starts to be 
blurry and not as well 
defined as before 
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ca. 58% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 20 
 
The abundant amount 






ca. 68% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 
stoichiometry of 1 : 30.5 
 
The low amount of 
[C10mim]Cl made it 
difficult to have a 
homogenous solution, 
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but the same effect 
observed in the two 
previous picture is 
observed here as well 
 
ca. 77% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 




ca. 83% (w/w) H2O, 
corresponding to an 
approximate 
[C10mim]Cl : H2O 



















Chapter 9. Summary & Outlook    165 
 
 
Chapter 9. Summary & Outlook   
A series of experiments at high-pressure and low-temperature conditions on cyclodextrin-
based inclusion complexes and on ionic liquids has been successfully carried out. This work shows 
that the application of high-pressure research using diamond-anvil cells can be further broadened 
to study complex systems such as cyclodextrin-based inclusion complexes and ionic liquids. 
High-pressure techniques have been applied to investigate both the formation of 
cyclodextrin complexes in situ at high pressure, as well as the response of known complexes to 
pressure by means of compression studies. The main observation with all systems investigated is 
that water solubility of both α- and β-cyclodextrins drastically increases as a function of pressure. 
In the case of α-cyclodextrin inclusion complexes, no crystals have been obtained by high-pressure 
recrystallisation; this observation is closely related to the use of water as pressure-transmitting 
medium and is probably related to the high water solubility of α-cyclodextrin at ambient pressure. 
Further experiments should focus on probing further guest molecules and particularly on the use 
of non-aqueous solvents. β-cyclodextrin complexes can be crystallised at high pressure and form a 
novel superhydrated packing motif, as it has been shown for the β-cyclodextrin∙paracetamol 
system. Superhydration is accompanied by lower guest occupancy, ca. ⅓, than observed at both 
ambient-pressure and low-temperature conditions, where 1:1 complexes are invariably obtained. 
In some experiments, crystallisation of the drug molecule alone, i.e. not as a complex, was 
observed, e.g. as demonstrated for the β-cyclodextrin∙5-fluorouracil system. The high-pressure 
dissolution trend observed for β-cyclodextrin was used exploited to solubilise poorly-water soluble 
drugs, as illustrated for amoxicillin, showing that inclusion complex formation is very likely to 
occur in solution a high pressure. This mechanism is potentially of practical application and its 
applicability should be further investigated with other drug molecules. Use of spectroscopic 
techniques, such as NMR, Raman and UV-Vis spectroscopy, should also be undertaken to fully 
characterise inclusion complex formation in solution.  
Diamond-anvil cells have revealed themselves as ideal crystallisation vessels for ionic 
liquids and have therefore played a key role in studying the solid-state behaviour of these 
compounds; in particular, a diamond-anvil cell offers a sealed environment, which can for instance 
be useful to control humidity, and the means for in situ microscopy, Raman spectroscopy and X-
ray diffraction. High-pressure and low-temperature studies have been performed on two of the 
most widely studied ionic liquids, namely 1-butyl-3-methylimidazolium hexafluorophosphate, 
[bmim][PF6], and 1-decyl-3-methylimidazolium chloride, [C10mim]Cl. In the case of [bmim][PF6], 
the existence of three polymorphs has been confirmed, with all polymorphs fully characterised by 
means of single-crystal X-ray diffraction. A detailed structural analysis, and most importantly, the 
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availability or the first time of structural data, has demonstrated that a much wider range of cation 
conformers exists in the solid state than previously thought. Across the three phases and under 
different experimental conditions, a large variation in crystal packing densities and in structural 
disorder is observed. These variations are likely contributing driving forces for the observed 
polymorphic interconversions. [C10mim]Cl – water mixtures have also been the subject of an 
extended crystallisation study. By varying the amount of water in the 2-88% (w/w) range, eight 
distinct hydrates have been obtained, which belong to three distinct packing types. A trihydrate 
form has been obtained for a first time for an ionic liquid by using high-pressure crystallisation 
methods. Preliminary investigations of mesophase formation in [C10mim]Cl have revealed a 
potentially rich phase diagram and further studies, in particular at high pressure, should be 
performed to assess whether this phenomenon is widespread and whether it could be exploited for 
practical applications. Preliminary studies have shown that ILs may also be suitable crystallisation 
solvents for drug molecules for both ambient-pressure and high-pressure studies. Given the 
limited number of structural studies on crystalline phases of ILs available in the literature and the 
very large number of ILs available, future crystallisation studies of this class of compounds 
promise to be a very fertile research area. 
 
 
